Page last updated: 2024-11-06

mitomycin and Glaucoma

mitomycin has been researched along with Glaucoma in 689 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas."9.51Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022)
"To investigate the outcome of mitomycin C (MMC)-augmented trabeculectomy with subconjunctival bevacizumab in the management of Fuchs heterochromic iridocyclitis (FHI)-related glaucoma in 1-year follow-up period."9.34The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis. ( Berker, N; Elgin, U; Ozdal, P; Ozdemir, K; Sen, E, 2020)
"To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation."9.22Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016)
"To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications."9.17Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013)
"To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma."9.14A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010)
"To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation."9.11Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004)
"In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure."9.11[Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004)
"To probe the results of trabeculectomy with human amniotic membrane (HAM) or mitomycin(MMC) in the treatment of glaucoma."9.11[The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C]. ( Huang, Y; Huang, Z; Li, H; Xie, M; Zheng, K; Zou, H, 2005)
"To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs."9.10Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002)
"To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma."9.10[Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003)
"To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure."9.10Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003)
"The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery."9.08The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995)
"Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0."9.08Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996)
"To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma."9.08Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997)
"Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons."9.05Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020)
" We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil."8.98Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018)
"To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma."8.79Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997)
"The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0."8.31Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023)
"The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects."8.31ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. ( Armstrong, JJ; Denstedt, J; Hutnik, CML; Liu, H; Teplitsky, JE; Vinokurtseva, A, 2023)
"To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)."8.31The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023)
"To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement."8.31Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023)
"To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)."8.31Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023)
"To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)."8.31A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023)
"This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)."8.12Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022)
"To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma."8.12Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022)
"We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series."8.12Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022)
"To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy."8.12The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022)
"2 mg/mL mitomycin C, either alone or in combination with cataract surgery."8.12Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022)
": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries."8.12Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022)
"To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma."8.12Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022)
"The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy."8.02[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021)
"This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients."8.02Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021)
"To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)."8.02The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021)
"The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma."8.02Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021)
"To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)."7.96Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020)
"The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma."7.91The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019)
"To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma."7.88Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018)
" The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0."7.88Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018)
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients."7.85Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017)
"To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation."7.85Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017)
"To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma."7.85Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017)
"To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma."7.85Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017)
"To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome."7.83Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016)
"To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)."7.83Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016)
"To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)."7.83Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016)
"To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma filtration surgery (GFS) in a rabbit model."7.81Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model. ( Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB, 2015)
"To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion."7.80Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014)
"To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)."7.80Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014)
"To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application."7.80Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014)
"To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery."7.79Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013)
"To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery."7.79Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013)
"To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)."7.78Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012)
"The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)."7.78Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012)
"To compare the histopathologic and morphologic findings of encapsulated blebs following Ahmed glaucoma valve implantation and primary standard trabeculectomy with mitomycin-C."7.78Comparative study of encapsulated blebs following Ahmed glaucoma valve implantation and trabeculectomy with mitomycin-C. ( Bae, K; Kee, C; Suh, W, 2012)
"To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C."7.77Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011)
"To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery."7.77Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011)
"To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients."7.76Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010)
"To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)."7.75Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009)
"To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma."7.74Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008)
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period."7.74Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007)
"The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics."7.74Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007)
"To determine the long-term antiscarring effect of ilomastat treatment after experimental glaucoma filtration surgery (GFS)."7.73Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. ( Khaw, PT; Mead, AL; Wong, TT, 2005)
"To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)."7.73Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005)
"To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)."7.73Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005)
"To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery."7.73Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006)
"Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy."7.73Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006)
"With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes."7.73Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006)
"To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery."7.72Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003)
"Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma."7.72Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003)
"To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma."7.72Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004)
"To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure."7.72Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004)
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease."7.72Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004)
"To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C."7.71Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002)
"In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate."7.71Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001)
"To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery."7.71[Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001)
"The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits."7.70The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998)
"This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study."7.70Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998)
"The purpose of this study was to determine the intraocular pressure (IOP), aqueous humor flow, flare and ocular side effects in eyes with a history of hypotony after trabeculectomy with adjunctive mitomycin C (MMC)."7.70Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy. ( Diestelhorst, M; Ustundag, C, 1998)
"Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995."7.70Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998)
"The use of a sponge impregnated with mitomycin-C is an increasingly common practice in glaucoma surgery."7.70A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma. ( Mehel, E; Péchereau, A; Stork, L; Weber, M, 1998)
"To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty."7.70Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999)
"To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma."7.70Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999)
"To evaluate the outcome of filtering procedures supplemented with mitomycin C in children with glaucoma."7.70Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma. ( Augsburger, JJ; Azuara-Blanco, A; Schmidt, CM; Spaeth, GL; Wilson, RP, 1999)
"To determine the chemical stability of various mitomycin C (MMC) solutions used in glaucoma filtering surgery."7.70A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery. ( Assalian, A; Calleja, K; Francoeur, AM; Guttman, A; Lesk, MR; Morin, I; Pan, SS; Rauth, M; Tétreault, F, 1999)
"To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas."7.70Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000)
"To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma."7.70Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000)
"The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs."7.69Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995)
"Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation."7.69One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995)
"Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C."7.69Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994)
"Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma."7.69Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994)
"Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery."7.69Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995)
"To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis."7.69Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996)
"To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin."7.69Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996)
"To investigate the effects of postoperative mitomycin C (MMC) eyedrop as an adjunct to intraoperative MMC in refractory glaucomas, 15 eyes of 14 glaucoma patients (age; 47."7.69Effects of postoperative mitomycin C eyedrop on trabeculectomy in refractory glaucoma patients. ( Choi, MY; Hyung, SM, 1996)
"The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits."7.69Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996)
"An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)."7.69Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995)
"A 91-year-old woman with a complete rupture of her mitomycin-C filtration bleb associated with eye rubbing while crying was examined."7.69Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations. ( Greenfield, DS; Parrish, RK, 1996)
"Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure."7.69Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996)
"To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences."7.69Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997)
"Adjunctive intraoperative mitomycin C increases the success of glaucoma filtering surgery, but also the postoperative complications."7.69Scleritis after glaucoma filtering surgery with mitomycin C. ( Fourman, S, 1995)
"The quantities of mitomycin-C contained in sponges prepared for glaucoma surgery differed for a given surgeon and between surgeons."7.69[Does the dosage of mitomycin-C applied during filtering surgery of glaucoma vary with the individual surgeon?]. ( Mehel, E; Pechereau, A; Stork Vabres, L; Weber, M, 1997)
"The effects of mitomycin C (MMC, 1 microgram/ml for 5 min) on growth and morphology of six MMC 'sensitive' and four MMC 'resistant' human Tenon's capsule fibroblasts grown from 10 patients who had had trabeculectomy for glaucoma were studied."7.69In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients. ( Madhavan, HN; Vijaya, L, 1997)
"The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation."7.69Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997)
"The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures."7.69Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997)
"Subconjunctival mitomycin C has been used in glaucoma filtration surgery with success."7.69Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits. ( Buffenn, AN; Higginbotham, EJ; Kincaid, MC; Musch, DC; Saetre, SB, 1997)
"To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma."7.69Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997)
"The study was designed to observe the effect of heterogeneous scleral transplantation in treatment of hypotony after filtration surgery of glaucoma with mitomycin C."7.69[The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C]. ( Dong, Q; Yan, L; Zhang, S, 1997)
"We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery."7.68Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993)
"In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C."7.68Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992)
" 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma."7.68Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990)
"Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis."6.72History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021)
"To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture."6.71[Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003)
"To determine the anticicatrization effect of mytomycin C (MMC)."6.68[The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis]. ( Wu, L; Yin, J, 1996)
"Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes."6.68Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995)
"These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation."6.67Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993)
"Glaucoma affects more than 70 million people worldwide, with about 10% being bilaterally blind, making it the leading cause of irreversible blindness globally."6.61Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. ( Foo, VHX; Htoon, HM; Perera, SA; Welsbie, DS, 2019)
"Raised intraocular pressure is a risk factor for glaucoma."6.52Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015)
"Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure."6.43Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2005)
"Mitomycin C is an antimetabolite applied between the sclera and conjunctiva during the initial stages of a trabeculectomy to prevent excessive post-operative scarring and thus reduce the risk of failure."6.41Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2001)
"Mitomycin C seems to be a better treatment than 5 fluorouracil."6.38[Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993)
" Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures."5.91Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023)
"Inflammation-driven scarring is a major contributor to surgical failure after subconjunctival bleb forming glaucoma surgery."5.72Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery. ( Armstrong, JJ; Hutnik, CML; Liu, H; Vinokurtseva, A, 2022)
"To evaluate the efficacy and safety of using Mitomycin-C (MMC) or Ologen implant as an adjunct to combined trabeculotomy-trabeculectomy (CTT) surgery relative to non-augmented CTT surgery in achieving higher success rates in patients with primary congenital glaucoma (PCG)."5.69Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial. ( Al-Nashar, HY; Fawzi, KM; Kenawy, S; Khairy, MA, 2023)
"This unicentric randomized clinical trial was designed to compare the surgical outcomes of mitomycin C-enhanced trabeculectomy (MMC-TRAB) with and without subtenon triamcinolone acetonide (TAAC) injection in patients with non-inflammatory glaucomas."5.51Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial. ( Almeida, I; Dias, DT; Gracitelli, CPB; Kanadani, FN; Lopes, FS; Prata, TS; Ushida, M, 2022)
"Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation."5.51Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis. ( Dong, A; Fan, P; Han, L; Shao, Z; Yuan, H; Zhou, X, 2019)
"Both cataract and glaucoma are significant public health problems."5.40Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014)
"To investigate the outcome of mitomycin C (MMC)-augmented trabeculectomy with subconjunctival bevacizumab in the management of Fuchs heterochromic iridocyclitis (FHI)-related glaucoma in 1-year follow-up period."5.34The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis. ( Berker, N; Elgin, U; Ozdal, P; Ozdemir, K; Sen, E, 2020)
" The dosage of mitomycin-C was 0."5.31Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000)
"To compare the efficacy and safety of trabeculectomy with Ologen versus Mitomycin C in primary glaucoma."5.30Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh. ( Abdullahi, SM; Alam, S; Badmus, S; Hassan, Z; Kabir, J; Mahatma, M; Malek, MI; Rahman, M; Sarker, BK, 2019)
"Mitomycin C is a promising substance which improves substantially the prognosis of complicated cases of glaucoma."5.29[Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery]. ( Liehneová, I; Rozsíval, P, 1994)
"While trabeculectomy with mitomycin C has previously been the gold standard in penetrating glaucoma surgery, glaucoma drainage implants used early within glaucoma surgery were examined in the course of the tube versus trabeculectomy (TVT) study."5.27[Glaucoma Drainage Devices: Tube versus Trabeculectomy Study]. ( Alnawaiseh, M; Bula, AM; Rosentreter, A; Strzalkowski, P, 2018)
"This was a prospective, controlled, cohort study that included 64 eyes of 46 children younger than 12 years with uncontrolled glaucoma, who underwent trabeculectomy with mitomycin C in an institutional setting."5.22Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study. ( Awadein, A; El Sayed, YM, 2016)
"To determine whether adjunctive mitomycin C (MMC) or amniotic membrane transplantation (AMT) improve the outcomes of Ahmed glaucoma valve (AGV) implantation."5.22Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. ( Doozandeh, A; Ghahari, E; Mahboobipour, H; Pakravan, M; Yazdani, S, 2016)
" The purpose of this study was to compare intraocular pressure (IOP)-lowering efficacy and safety of trabeculectomy or combined phacoemulsification and trabeculectomy with mitomycin-C (MMC) vs."5.22Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. ( de Moraes, CG; Godfrey, DG; Rademaker, AW; Ritch, R; Sarkisian, SR; Tanna, AP; Vold, SD, 2016)
" A total of 49 eyes of 45 patients with uncontrolled glaucoma were recruited: 22 eyes in the bevacizumab (BVZ) group, and 27 eyes in the mitomycin C (MMC) group."5.20[Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy]. ( Martín Giral, E; Perucho Martínez, S; Rivera Zori, M; Toledano Fernández, N, 2015)
"This study was a retrospective chart review of 21 children with uveitic glaucoma who underwent TE with administration of mitomycin C including analysis of complications, further interventions, additional surgical procedures to control intraocular pressure (IOP) and of the success rates after a mean follow-up of 5 years."5.19[Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma]. ( Heiligenhaus, A; Heinz, C; Wiese, K, 2014)
"The rate of reoperation for glaucoma was higher following trabeculectomy with mitomycin C than tube shunt surgery in the TVT Study."5.19Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. ( Feuer, WJ; Gedde, SJ; Saheb, H; Schiffman, JC, 2014)
"In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C."5.17Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013)
"To compare the results of subscleral trabeculectomy (SST) augmented with mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control and incidence of complications."5.17Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. ( Ellakwa, AF; Mandour, SS; Marey, HM, 2013)
"Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC 0."5.16Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012)
"Tube shunt (350-mm(2) Baerveldt glaucoma implant) or trabeculectomy with mitomycin C ([MMC]; 0."5.16Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2012)
"A 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC 0."5.14Three-year follow-up of the tube versus trabeculectomy study. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2009)
"Between July 2005 and October 2007, 61 consecutive medically uncontrolled glaucoma patients scheduled for first-time trabeculectomy were randomized to 1 of 3 study topical medication groups: nonsteroidal anti-inflammatory drugs (ketorolac), steroids (fluorometholone), or placebo (artificial tears)."5.14Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. ( Breusegem, C; Fieuws, S; Renier, C; Spielberg, L; Stalmans, I; Van de Veire, S; Van Ginderdeuren, R; Vandewalle, E; Zeyen, T, 2010)
"To evaluate the potential usefulness of a freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C (MMC) in the maintenance of functioning glaucoma surgery in cases of pediatric glaucoma."5.14A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma. ( Almasalamy, SM; Almasary, AM; Anany, HA; Mahdy, RA; Nada, WM, 2010)
"The purpose of our study was to assess intraocular pressure control (IOP) and postoperative complications in nonpenetrating very deep sclerectomy (NPVDS) with reticulated hyaluronic acid implant (SKGEL) and Mitomycin C (MMC)."5.13Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment. ( Forminśka-Kapuścik, M; Gierek-Ciaciura, S; Leszczyński, R; Mrukwa-Kominek, E; Rokita-Wala, I, 2008)
"350 mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC)."5.12Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. ( Brandt, JD; Budenz, DL; Feuer, WJ; Gedde, SJ; Herndon, LW; Schiffman, JC, 2007)
"To evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in eyes undergoing Ahmed Glaucoma Valve implantation."5.11Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. ( Arcieri, ES; Azuara-Blanco, A; Costa, VP; Lesk, MR; Netland, PA, 2004)
"In one-year-follow up patients after trabeculectomies with or without topical use of mitomycin C were controlled for early and late complications, and levels of intraocular pressure."5.11[Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications]. ( Szaflik, J; Zaleska-Zmijewska, A, 2004)
"Study patients were randomized to undergo placement of a 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (0."5.11The tube versus trabeculectomy study: design and baseline characteristics of study patients. ( Brandt, JD; Feuer, WJ; Gedde, SJ; Heuer, DK; Parrish, RK; Schiffman, JC, 2005)
"To evaluate subconjunctival mitomycin C (MMC) injection efficacy and safety in patients with failing glaucoma non-penetrating filtering blebs."5.10Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery. ( Iester, M; Mermoud, A; Ravinet, E, 2002)
"To investigate the long-term therapeutic effect of Hunan aqueous drainage (HAD) implantation with and without adjunctive intraoperative mitomycin C (MMC) for refractory glaucoma."5.10[Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma]. ( Duan, X; Jiang, Y; Qing, G, 2003)
"To verify if partial intraoperative Tenon's capsule resection (PTCR) with adjunctive mitomycin C is effective in developing thin, avascular blebs in eyes undergoing Ahmed glaucoma valve insertion, and to assess the efficacy and safety of this procedure."5.10Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. ( Susanna, R, 2003)
"Trabeculectomy augmented with mitomycin C application at both sites could produce a greater lowering of intraocular pressure with low incidence of postoperative complications, and could provide an increased chance of long-term success."5.10Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. ( Fang, CT; Gu, YS; Ma, XQ; You, YA, 2002)
"To compare the efficacy and safety of subconjunctival and intrascleral applications of mitomycin C (MMC) in trabeculectomy for high-risk glaucomas."5.09Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies. ( Agarwal, HC; Saigal, D; Sihota, R, 2001)
"The perioperative use of oral prednisone did not alter the surgical outcome of filtering procedures associated with antifibrosis agents in this population of glaucoma patients."5.09Oral prednisone in guarded filtration procedures supplemented with antimetabolites. ( Augsburger, JJ; Azuara-Blanco, A; Spaeth, GL, 1999)
"To evaluate the efficacy and safety of application of mitomycin-C (MMC) in combined and separate trabeculectomy and penetrating keratoplasty for the treatment of coexisting corneal disease and glaucoma."5.09Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty. ( Chowers, I; Ticho, U, 1999)
"The intraoperative application of the antimetabolite mitomycin C has been recommended extensively in the literature for trabeculectomy in eyes with poor prognosis glaucoma."5.08[Effect of mitomycin C on aqueous humor flow after trabeculectomy]. ( Diestelhorst, M; Krieglstein, GK, 1995)
"The use of adjunctive intraoperative mitomycin C has considerably improved the success rate of glaucoma filtering surgery."5.08The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. ( Mégevand, GS; Murray, AD; Salmon, JF; Scholtz, RP, 1995)
"The authors assessed the efficacy of adjunctive intraoperative mitomycin C to produce lower intraocular pressures (IOPs) in patients with complicated glaucoma who underwent double-plate Molteno implantation."5.08Adjunctive mitomycin C in Molteno implant surgery. ( Cardakli, UF; Eisele, JR; Heatley, GA; Kaufman, PL; Perkins, TW, 1995)
"The concentration of the antitumor antibiotic mitomycin (CAS 50-07-7, mitomycin C, MMC), used in ophthalmic surgery for its antiproliferative effects, was measured in the aqueous humor of 7 glaucoma patients undergoing trabeculectomy."5.08Mitomycin-C concentration in human ocular aqueous humor after topical administration during trabeculectomy. ( Biederbick, W; Botvinik-Helling, S; Conrady, S; Diestelhorst, M; Krieglstein, GK; Matthey, B; Rump, AF; Schierholz, J; Stemmler, M; Theisohn, M, 1995)
"Twenty-eight eyes of 28 patients with advanced primary open-angle glaucoma undergoing primary trabeculectomy were randomized to either mitomycin C (0."5.08Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. ( Comegno, PE; Costa, VP; José, NK; Malta, RF; Vasconcelos, JP, 1996)
"The purpose of the study is to determine whether the intraoperative application of subconjunctival mitomycin C (MMC), during combined phacoemulsification and trabeculectomy, is an effective means of improving filtration, defined as overall lower intraocular pressure (IOP) and less antiglaucoma medication use."5.08A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. ( Alward, WL; Barad, JP; Carlson, DW; Carney, BL; Zimmerman, MB, 1997)
"To evaluate the adjunctive use of mitomycin-C (MMC) during trabeculotomy and trabeculectomy for eyes with high-risk congenital glaucoma."5.08Mitomycin-C in congenital glaucoma. ( Agarwal, HC; Honavar, SG; Sanga, L; Sihota, R; Sood, NN, 1997)
"Mitomycin-C (MMC) is a useful adjunct to high risk glaucoma surgery."5.08Intraoperative mitomycin C and the corneal endothelium. ( Agarwal, HC; Sharma, T; Sihota, R, 1998)
"The authors assess whether adjunctive mitomycin C improves Molteno tube shunt surgery in terms of intraocular pressure (IOP), visual acuity, and complication rates."5.08The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. ( Bhavnani, V; Brizendine, E; Burgoyne, J; Cantor, L; Hoop, J; Sanders, S, 1998)
"Although there is a currently a revolution in angle-based procedures, subconjunctival filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for glaucoma surgeons."5.05Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions. ( Fellman, RL; Grover, DS; Kornmann, HL, 2020)
" We concluded mitomycin C might be more effective in reducing intraocular pressure and increasing qualified success compared to 5-fluorouracil."4.98Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma? ( Pimentel, E; Schmidt, J, 2018)
"The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin C (MMC) in eyes with previous cataract and/or failed glaucoma surgery."4.88The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. ( Feuer, WJ; Gedde, SJ; Schiffman, JC; Singh, K, 2012)
"The Tube Versus Trabeculectomy (TVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube-shunt surgery to trabeculectomy with mitomycin (MMC) in eyes with previous cataract and/or unsuccessful glaucoma surgery."4.86Review of results from the Tube Versus Trabeculectomy Study. ( Gedde, SJ; Heuer, DK; Parrish, RK, 2010)
"With the increased use of intraoperative antifibrotic (eg, mitomycin and fluorouracil) as an adjunct to standard trabeculectomy, an increased incidence is seen of late-onset filtering bleb-related infections."4.82Glaucoma-filtering bleb infections. ( Mac, I; Soltau, JB, 2003)
"The use of antifibrotic agents, namely, 5-fluorouracil and mitomycin C, in conjunction with glaucoma surgery has resulted in lower postoperative intraocular pressures after trabeculectomy or combined cataract and glaucoma surgery."4.82Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. ( Singh, K; Yoon, PS, 2004)
"Agents such as the antimetabolites 5-fluorouracil (5FU) and mitomycin-C (MMC) have revolutionised glaucoma surgery in patients with a high risk of surgical failure."4.82Wound healing after glaucoma surgery: how to manage it? ( Collignon, NJ, 2005)
"The preponderance of evidence from the literature suggests a small (2-4 mmHg) benefit from the use of mitomycin-C (MMC), but not 5-fluorouracil (5-FU), in combined cataract and glaucoma surgery (evidence grade B)."4.81Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. ( Bass, EB; Congdon, N; Friedman, DS; Jampel, HD; Kempen, JH; Levkovitch-Verbin, H; Lubomski, LH; Quigley, H; Robinson, KA, 2002)
"To examine why most ophthalmologists routinely use mitomycin C or 5-fluorouracil (antimetabolites) in association with filtering surgery for glaucoma."4.81The use of antimetabolites with trabeculectomy: a critical appraisal. ( Mutlukan, E; Spaeth, GL, 2001)
"Intraoperative Mitomycin C may be a helpful adjunct in achieving low final intraocular pressure after trabeculectomy in high-risk glaucoma filtering surgery, and Mitomycin C may be a viable alternative to postoperative 5-Fluorouracil."4.79[Trabeculectomy with mitomycin C. Study apropos of 30 cases]. ( Ballion, JC; Bazin, S; Ducousso, F; Poirier, L; Verin, P; Williamson, W, 1995)
"To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma."4.79Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997)
"Trabeculectomy (TE) with mitomycin C (MMC) is considered the gold standard in glaucoma surgery."4.31[Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy]. ( Helmers, G; Löw, U; Munteanu, C; Seitz, B, 2023)
"To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome."4.31Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome. ( Gedde, SJ; Krishnadas, SR; Mani, I; Nagdev, N; Puthuran, GV; Ramesh, S; Senthilkumar, VA; Tara, TD, 2023)
"This was a single-center, nonrandomized retrospective cohort study of 998 eyes from 854 patients with glaucoma who underwent trabeculectomy with mitomycin C."4.31Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections. ( Higashide, T; Mambo, Y; Ohkubo, S; Okayama, M; Sugiyama, K; Tsuchiya, S; Udagawa, S; Wajima, R; Yamashita, Y, 2023)
"The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0."4.31Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023)
"We retrospectively reviewed primary glaucoma patients who underwent mitomycin C-augmented trabeculectomy and completed 2 years of follow-up."4.31Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma. ( Chansangpetch, S; Itthipanichpong, R; Manassakorn, A; Ratanawongphaibul, K; Rojanapongpun, P; Tantisevi, V; Winuntamalakul, Y, 2023)
"To evaluate the efficacy and safety of the Preserflo MicroShunt with mitomycin C in patients with complicated glaucoma."4.31One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma. ( Erokhina, M; Haus, A; Seuthe, AM; Szurman, P, 2023)
" Mitomycin C has been used adjunctively in various procedures, including pterygium excision."4.31Inadvertent filtering bleb due to extracapsular cataract extraction wound reopening after mitomycin C use: a case report. ( Chaidaroon, W; Pathanapitoon, K; Upaphong, P, 2023)
"The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects."4.31ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts. ( Armstrong, JJ; Denstedt, J; Hutnik, CML; Liu, H; Teplitsky, JE; Vinokurtseva, A, 2023)
"To investigate the efficacy of nintedanib on preventing postoperative scar in formation following glaucoma filtering surgery (GFC) in rabbits in comparison with Mitomycin-C (MMC)."4.31The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits. ( Demirci Küçük, K; Furat Rençber, S; Öztürk, A; Yazır, Y; Yüksel, N; Yüksel, R, 2023)
"In this 4-year retrospective cohort study, medical records of glaucoma patients older than 18 who underwent primary trabeculectomy with Mitomycin-C between 2012 and 2020 were reviewed."4.31Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study. ( Ghanbarnia, MJ; Yadgari, M, 2023)
"To evaluate the effect of intraoperative mitomycin C (MMC) on the surgical outcomes of ciliary sulcus (CS) Ahmed glaucoma valve (AGV) tube placement."4.31Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement. ( Bae, HW; Choi, W; Kim, CY; Kim, NE; Kim, SS; Lee, JS; Lee, K; Lee, SY, 2023)
"The purpose of this study was to evaluate the effectiveness and safety of an open bleb revision with mitomycin- C (MMC) for bleb fibrosis after PreserFlo MicroShunt implantation."4.31Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. ( Hoffmann, EM; Pfeiffer, N; Schuster, AK; Strzalkowska, A; Strzalkowski, P, 2023)
"Trabeculectomy with mitomycin C was the most common primary surgery performed in Thai patients with JOAG, and successfully reduced intraocular pressure without significant complications."4.31Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand. ( Annopawong, K; Friedman, DS; Seresirikachorn, K; Thiamthat, W; Vu, DM; Wanichwecharungruang, B, 2023)
"To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)."4.31Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023)
"To discuss the first case of mitomycin C (MMC) toxicity after XEN® gel stent implantation in a glaucoma patient, conducted using the XEN "air" technique with an ophthalmic viscosurgical device (OVD)."4.31A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. ( Baeg, JY; Choi, HS; Lee, SH, 2023)
"Although mitomycin C is commonly used in glaucoma filtering surgeries, reports of postoperative posterior segment toxicity are rare."4.31RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY. ( Desai, R; Jampol, LM, 2023)
"This study aimed to compare the effectiveness of combination therapy consisting of low-dose mitomycin C (MMC) and valproic acid (VPA) against high-dose MMC for improving the scar phenotype in minimally invasive glaucoma surgery (MIGS)."4.12Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery. ( Chu, SWL; Ibrahim, FI; Seet, LF; Teng, X; Toh, LZ; Wong, TT; Yap, ZL, 2022)
"To determine surgical outcomes and risk factors for failure of trabeculectomy with mitomycin C (TMMC) in pediatric traumatic glaucoma."4.12Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study. ( Jain, E; Mohan, A; Peeush, P; Prasad, K; Sen, A; Sen, P; Shah, C; Tripathi, S, 2022)
" Trabeculectomy with or without augmentation with Mitomycin C(MMC) was the first-choice glaucoma incisional surgery for 96."4.12Surgical trends in glaucoma management: The current Indian scenario. ( Bhartiya, S; Ichhpujani, P; Kalra, G; Kumar, S; Singla, E, 2022)
"To report outcomes and assess the risk factors for failure of trabeculectomy (trab), trabeculectomy with mitomycin-C (trabMMC), and combined trabeculectomy with cataract extraction (CT) in vernal keratoconjunctivitis (VKC) eyes with steroid-induced glaucoma (SIG)."4.12Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma. ( Ali, MH; Choudhari, N; Dikshit, S; Garudadri, C; Krishnamurthy, R; Rao, HL; Sastry, R; Senthil, S, 2022)
"We performed retrospective analysis of 31 eyes with myopia that underwent canaloplasty modified with mitomycin C in a consecutive single-surgeon case series."4.12Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022)
"To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy."4.12The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022)
"2 mg/mL mitomycin C, either alone or in combination with cataract surgery."4.12Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022)
"Cytotoxic agents such as mitomycin C (MMC) are part of the mainstay treatment for limiting subconjunctival scarring following glaucoma filtration surgery (GFS)."4.12Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts. ( Chan, EC; Edgley, AJ; Fan Gaskin, JC; Kong, RCK; Peshavariya, HM; Shah, MH, 2022)
" We included 27 eyes of 27 patients with glaucoma who underwent needling procedure using mitomycin C and were subsequently treated with ripasudil-a rho-associated protein kinase inhibitor (ripasudil group)-or without ripasudil (control group)."4.12Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study. ( Hirooka, K; Kiuchi, Y; Mizuno, Y; Okada, N; Okumichi, H; Onoe, H; Tokumo, K, 2022)
"We aim to compare the outcomes of trabeculectomy with mitomycin-C by a fellowship-trained glaucoma surgeon in the first hundred compared to second hundred surgeries."4.12Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon. ( Ali, ZC; Khoo, DI; Rattanasirivilai, P; Shankar, V, 2022)
": To evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgeries."4.12Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention. ( Battula, M; Dangeti, D; Garudadri, C; Rao, HL; Senthil, S, 2022)
"To compare the intraocular pressure-lowering effect and success rate of trabeculectomy with OloGen to that of trabeculectomy with mitomycin C (MMC) in cases of silicone oil-induced glaucoma."4.12Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma. ( Hashem, NH; Shalaby, HS, 2022)
"The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy."4.02[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C]. ( Bedar, MS; Kellner, U, 2021)
"This paper reports a retrospective consecutive case series investigating the efficacy of Mitomycin C-augmented trabeculectomy in the treatment of primary and secondary pediatric glaucoma in a mixed etiology, multiethnic cohort of patients."4.02Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort. ( Ahmad, M; Gurney, SP; Makanjuola, T; Parulekar, MV; Ramm, L, 2021)
"To determine the incidence of postoperative complications following combined trabeculotomy trabeculectomy with mitomycin C (CTTM) for congenital glaucoma (CG), in addition to documentation of some unusual complications and possible ways to manage these complications safely with minimal morbidity."4.02Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study. ( Sayed, KM, 2021)
"To investigate the effects of halofuginone and pirfenidone on wound healing in experimental glaucoma filtration surgery (GFS)."4.02The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery. ( Akin, MM; Demir, T; Gungor Kobat, S; Kasar, K, 2021)
"The purpose of this study was to determine the long-term outcomes of Ahmed glaucoma valve (AGV) implantation with intraoperative application of mitomycin-C (MMC) for the treatment of childhood glaucoma."4.02Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. ( Lyons, CJ; Promelle, V, 2021)
"Aniridic glaucoma can be managed efficiently by medications in early glaucomatous neuropathy, and with trabeculectomy augmented with mitomycin-C and releasable sutures for more advanced glaucomas, offering favourable long-term IOP control, visual stability and safety."4.02Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma. ( Azmira, K; Dada, T; Gupta, A; Selvan, H; Sharma, A; Sihota, R; Upadhyay, A, 2021)
"A prospective, noncomparative case series of 30 eyes of 30 Chinese patients with mixed types of glaucoma who underwent fornix-based trabeculectomy combined with intraoperative mitomycin C application."3.96The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients. ( Baig, N; Chan, PP; Chan, TCY; Lai, G; Wong, LYN, 2020)
"Adult patients who have undergone glaucoma surgery including a tube shunt, trabeculectomy with mitomycin C, trabectome, or transcleral cyclophotocoagulation from June 1, 2015 to August 30, 2017 at a single institution."3.96Reoperations for Complications Within 90 Days After Glaucoma Surgery. ( Al-Aswad, LA; Blumberg, DM; Chu, CK; Cioffi, GA; Liebmann, JM, 2020)
"PRéCIS:: Glaucoma drainage devices (GDD) by Australian and New Zealand glaucomatologists are implanted superotemporally under a peribulbar anesthesia without the use of mitomycin C."3.96Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand. ( Craig, JE; Danesh-Meyer, HV; Lee, GA; Liu, L, 2020)
" The greatest absolute success rate (= IOD ≤ 15 mmHg without antiglaucoma medication) was in the group with exclusive goniotrepanation + mitomycin C (MMC; 72."3.96[Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety]. ( Heinz, C; Koch, JM; Lommatzsch, C; Rothaus, K, 2020)
"To examine the efficacy and safety of current trabeculectomy with mitomycin C in Japan for glaucomatous eyes with low intraocular pressure (IOP)."3.96Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. ( Higashide, T; Hirooka, K; Kiuchi, Y; Ohkubo, S; Sugimoto, Y; Sugiyama, K; Yuasa, Y, 2020)
"A total of 1,098 eyes of patients with glaucoma who underwent trabeculectomy with mitomycin C at 34 clinical centers included in CBIITS were analyzed."3.91Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study. ( Arimura, S; Gozawa, M; Inatani, M; Iwasaki, K; Takamura, Y, 2019)
"In a retrospective clinical study, 806 patients with advanced glaucoma were treated with trabeculectomy combined with mitomycin C0."3.91[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant]. ( Fili, S; Kohlhaas, M; Seddig, S, 2019)
"To report a new approach for the treatment of severe ocular hypotony secondary to glaucoma filtering surgery with mitomycin C by injecting autologous eye platelet-rich plasma (E-PRP) in the anterior chamber to block excessive diffuse filtration through an abnormally thinned sclera."3.91Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report. ( Abdalrahman, O; Alio Del Barrio, JL; Alio, JL; Rodriguez, AE, 2019)
"To report on the frequency, efficacy, and safety of laser goniopuncture (LGP) in lowering intraocular pressure (IOP) following mitomycin-C-augmented nonpenetrating deep sclerectomy (NPDS) in a large cohort of eyes."3.91Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study. ( Akesbi, J; Blumen-Ohana, E; Laplace, O; Leleu, I; Nordmann, JP; Penaud, B, 2019)
"The aim of this study is to describe the effectiveness of trabeculectomy with mitomycin C and releasable suture in Posner-Schlossman syndrome (PSS) with secondary glaucoma."3.91The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series. ( Artini, W; Bani, AP, 2019)
"Rabbit model studies suggested better morphology blebs with equal intraocular pressure (IOP) efficacy as a standard mitomycin C (MMC) trabeculectomy using a novel slow-release drug delivery antifibrotic system delivering small quantities of MMC and 5-fluorouracil (5-FU)."3.91Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model. ( Ayyala, RS; Blake, D; Fullerton, M; Greenberg, E; John, V; Le, C; Mancera, N; Margo, C; Muddasani, N; Satija, C; Singh, S; Swann, FB; Wall, J; Zhang, Z; Zurakowski, D, 2019)
"Phacotrabeculectomy with adjunctive mitomycin C is a good option for the management of coexisting cataract and glaucoma."3.91Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study. ( Balekudaru, S; Biswas, J; Ganesh, SK; George, AE; George, R; Lingam, V; Wadke, V, 2019)
"Wider area bleb revision using bleb knife with adjunctive mitomycin C (MMC) had a good success rate, according to strict success criteria, except in patients with neovascular glaucoma (NVG)."3.91Outcomes of Wider Area Bleb Revision Using Bleb Knife With Adjunctive Mitomycin C. ( Asaoka, R; Kiuchi, Y; Nakakura, S; Noguchi, A; Tabuchi, H; Tanabe, H, 2019)
"The purpose of this article is to analyze the results achieved in lowering intraocular pressure (IOP) after trabeculectomy or combined surgery (phacotrabeculectomy) with low-dose mitomycin C (MMC) using the Ologen Collagen Matrix (Ologen CM) implant."3.88Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. ( Bolivar, G; Castaño, B; Castejón, MA; Paz-Moreno-Arrones, J; Teus, MA, 2018)
"To evaluate outcomes of trabeculectomy with adjunctive mitomycin C in patients with uncontrolled intraocular pressure (IOP) after glaucoma drainage device implantation."3.88Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery. ( Akil, H; Alizadeh, R; Caprioli, J; Law, SK; Tan, J, 2018)
"To compare the effect of two exposure durations of mitomycin C in combined angle and filtering surgery for primary congenital glaucoma."3.88Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations. ( Bayoumi, NH, 2018)
"We report a case of a rare complication after trabeculotomy combined with a small trabeculectomy with mitomycin C in a young patient with juvenile glaucoma."3.88Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery. ( Gericke, A; Hoffmann, EM; Klezlova, A; Liebezeit, S; Pfeiffer, N; Prokosch-Willing, V, 2018)
"The objective of this study is to investigate the results of an adaptive approach of bleb revision surgery for late onset hypotony after trabeculectomy with mitomycin C because of bleb leakage and/or scleral melting."3.88Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C. ( Hoffmann, EM; Lamparter, J; Pfeiffer, N; Prokosch-Willing, V; Toshev, AP; Ul Hassan, SN, 2018)
" The triamcinolone + mitomycin C acetate group presented better indices as for the maximum bleb height and vascularization of the bleb central area (p=0."3.88Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study. ( Araújo, ID; Cronemberger, S; Rangel, HMDA; Rolim, HT; Vidigal, P, 2018)
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients."3.85Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017)
"After a failed filtration surgery, a low-diffuse bleb was reestablished by pretreating with subconjunctival mitomycin C followed by ab interno bleb revision with the Grover-Fellman biplanar sclerostomy spatula, decreasing further more invasive glaucoma procedures."3.85Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula. ( Fellman, RL; Grover, DS, 2017)
"A prospective study was conducted on 39 eyes (26 right eyes) of 39 children (20 boys; 19 girls) who had primary congenital glaucoma treated with combined trabeculotomy-trabeculectomy with mitomycin C and scleral flap closure with regular or releasable sutures."3.85Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma. ( Bayoumi, NH, 2017)
"To examine outcomes of trabeculectomy with mitomycin C for uncontrolled glaucoma when performed by glaucoma trainee surgeons."3.85Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil. ( Abe, RY; Costa, VP; Shigueoka, LS; Vasconcellos, JPC, 2017)
"To examine the effect of mitomycin c and 5-flurouracil on treatment outcomes following Ahmed glaucoma valve implantation."3.85Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. ( Cui, QN; Han, Y; Hsia, YC; Lin, SC; Mehta, N; Naseri, A; Porco, TC; Rose-Nussbaumer, J; Stamper, RL, 2017)
"To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma."3.85Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma. ( Crouch, ER; Nash, DL, 2017)
"To evaluate the intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma."3.85Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017)
"To report the outcomes of primary trabeculectomy with mitomycin-C (MMC) in eyes with glaucoma secondary to iridocorneal endothelial (ICE) syndrome."3.83Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome. ( Chandran, P; Choudhari, NS; Garudadri, CS; Mandal, AK; Rao, HL; Senthil, S, 2016)
"To evaluate the short-term outcomes of lensectomy, combined with vitrectomy, scleral-fixated intraocular lens (SFIOL), and trabeculectomy with adjunctive mitomycin C (MMC) in patients with subluxated/dislocated crystalline lenses with associated elevated intraocular pressure (IOP)."3.83Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens. ( Balekudaru, S; David, RL; George, RJ; Lingam, V; Sen, P, 2016)
" Antimetabolites, such as mitomycin C and 5-fluorouracil, have been used for many years to increase survival time of filtration surgeries by preventing bleb fibrosis and scarring."3.83A role for antimetabolites in glaucoma tube surgery: current evidence and future directions. ( Amoozgar, B; Han, Y; Kuo, J; Lin, SC, 2016)
"To evaluate the outcomes of trabeculectomy with mitomycin-C (MMC) in uveitis associated with Vogt-Koyanagi-Harada disease (VKH)."3.83Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2016)
" In total, 120 eyes included in this study had a glaucoma diagnosis and undergone to Trab with mitomycin."3.83Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study. ( Bigheti Pereira, C; Cena de Oliveira, T; Issa de Fendi, L; Pereira Bigheti, C; Viani, GA, 2016)
"To compare the complication rate and effectiveness of mitomycin C (MMC), Ologen alone, and Ologen with 5-fluorouracil (5-FU) as adjunctives with Ex-PRESS mini shunt for medically uncontrolled glaucoma."3.81Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. ( Han, Y; Lowry, EA; Menda, SA; Porco, TC; Rubin, MR; Stamper, RL, 2015)
"A retrospective comparative case series review was performed on 31 eye surgeries in 20 patients with primary congenital glaucoma who underwent trabeculectomy or Ahmed glaucoma valve implantation after a previous failed trabeculectomy with mitomycin C."3.81Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients. ( Bae, HW; Hong, S; Hong, YJ; Kim, CY; Lee, N; Ma, KT; Seong, GJ, 2015)
"To determine the optimum administration route of bevacizumab after glaucoma filtering surgery (GFS) and to investigate whether a reduced dose of mitomycin-C (MMC) in combination with bevacizumab could improve surgical outcome with a reduced incidence of side-effects."3.81Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery. ( Moons, L; Stalmans, I; Van Bergen, T; Vandewalle, E, 2015)
"To evaluate the long-term effectiveness and safety of mitomycin C (MMC)-augmented trabeculectomy undertaken within the first 2 years of life for the surgical management of glaucoma."3.81Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life. ( Bunce, C; Chiang, M; Jayaram, H; Khaw, PT; Papadopoulos, M; Pooley, F; Scawn, R; Strouthidis, NG, 2015)
" Data included patient demographics, pre- and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates."3.81Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. ( Anand, N; Mercieca, K; Shevade, B, 2015)
"To compare intraocular pressure (IOP) at one year with the InnFocus MicroShunt(®) with or without cataract surgery with according to placement and concentration of mitomycin C (MMC) DESIGN: A retrospective two-center, two-surgeon study (France and Dominican Republic)."3.81[One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C]. ( Batlle, J; Kato, YP; Parel, JM; Pinchuk, L; Riss, I; Weber, BA, 2015)
"To determine if sequential treatment with Bevacizumab (Avastin), a monoclonal, VEGF antibody that blocks angiogenesis; Saratin, a 12 kD polypeptide with anti-inflammatory and anti-thrombotic properties; and Ilomastat, a matrix metalloproteinase (MMP) inhibitor, prolongs bleb life following glaucoma filtration surgery (GFS) in a rabbit model."3.81Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model. ( Levine, MA; Lukowski, ZL; Martorana, GM; Meyers, CA; Min, J; Schaefer, JL; Schultz, GS; Sherwood, MB, 2015)
"To compare the incidence of upper eyelid blepharoptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification surgeries and the relationship of bleb morphology to the incidence of ptosis."3.81Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification. ( Amrith, S; Chew, PT; Koh, V; Tatsios, J, 2015)
"To evaluate the long-term success of trabeculectomy with mitomycin C for glaucoma after vitreoretinal surgery with silicone oil insertion."3.80Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. ( Chandra, A; Gupta, V; Kumar, S; Sihota, R; Singh, D, 2014)
"To compare outcomes between patients undergoing trabeculectomy with an Ex-PRESS mini glaucoma device using mitomycin-C (MMC) to those undergoing the same procedure using a subconjunctival collagen matrix implant (Ologen)."3.80Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. ( Johnson, MS; Sarkisian, SR, 2014)
"NPDS without implant placement and with intraoperative mitomycin C application seems to be an effective and well-tolerated method to reduce IOP with long-term effectiveness, casting doubt on the mandatory use of intrascleral implants in nonpenetrating glaucoma surgery."3.80Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use. ( González-Mesa, A; Gutiérrez-Ortíz, C; Moreno-Salgueiro, A; Pérez-Rico, C; Teus, MA, 2014)
"To investigate the safety and efficacy of Nd:YAG laser goniopuncture (LGP) in lowering intraocular pressure (IOP) in eyes having late bleb failure following trabeculectomy with mitomycin C administration."3.80Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C. ( Alencar, LM; De Moraes, CG; Ritch, R; Susanna, R, 2014)
"To report the 5-year incidence of bleb-related infection after mitomycin C-augmented glaucoma filtering surgery and to investigate the risk factors for infections."3.80The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. ( Araie, M; Kuwayama, Y; Mayama, C; Ohkubo, S; Sawada, A; Sugiyama, K; Yamamoto, T, 2014)
"The purpose of this work was to look into the effects of infliximab on wound healing in experimental glaucoma filtration surgery and to compare the antifibrotic effects of this agent to that of mitomycin-C (MMC)."3.80Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery. ( Akın, MM; Demir, T; Eren, K; Kobat, S; Turgut, B, 2014)
"To evaluate the surgical outcome of Ahmed glaucoma valve (AGV) implantation with a new technique of mitomycin C (MMC) application."3.80Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique. ( Huang, W; Wang, W; Zhang, X; Zhou, M, 2014)
"This retrospective case series noncomparative study included 9 eyes of 6 consecutive patients with coexistence of corneal edema resulting from Fuchs dystrophy or pseudoexfoliation keratopathy and medically uncompensated glaucoma; these patients underwent combined DSAEK and DS with mitomycin C and an absorbable collagen implant."3.80Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty. ( Caramello, G; Giudiceandrea, A; Riso, M; Salgarello, T; Sammarco, MG; Vaiano, AS, 2014)
"To compare the effects of silver nanoparticles (AgNPs) and mitomycin C (MMC) on intraocular pressure (IOP) and external, histologic, and immunohistochemical bleb characteristics in a rabbit model of filtration surgery."3.79Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery. ( Butler, MR; Chevez-Barrios, P; Frankfort, BJ; Orengo-Nania, S; Prospero Ponce, CM; Weinstock, YE, 2013)
"The aim of this study is to demonstrate a drug delivery system with the capacity to adjust the release of mitomycin C (MMC), based on polymer composition, and inhibit fibroblast proliferation to a better effect than is currently used in glaucoma filtration surgery."3.79Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery. ( Merritt, SR; Velasquez, G; von Recum, HA, 2013)
"To evaluate the prognostic factors for surgical outcomes of subsequent trabeculectomy with mitomycin C (MMC) after prior incisional glaucoma surgery."3.79Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2013)
"To compare intraocular pressure (IOP) reduction after trabeculectomy with mitomycin C (MMC) in eyes that had prior clear-corneal phacoemulsification to those in a control group of phakic eyes."3.79Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes. ( Caprioli, J; Law, SK; Nouri-Mahdavi, K; Supawavej, C, 2013)
"To report outcomes of deep sclerectomy (DS) with intraoperative mitomycin C (MMC) application in eyes with previous failed glaucoma surgery (GS) and/or cataract extraction (CE)."3.78Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia. ( Anand, N; Wechsler, D, 2012)
"The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)."3.78Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012)
"Patients within an institutional setting who underwent trabeculectomy with mitomycin C (MMC) for uncontrolled elevated intraocular pressure (IOP) after corneal graft surgery were included."3.78Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty. ( Boey, PY; Ho, CL; Mehta, JS; Tan, DT; Wong, TT, 2012)
"A total of 908 eyes of 908 glaucoma patients who had undergone mitomycin C-augmented trabeculectomy or trabeculectomy combined with phacoemulsification and intraocular lens implantation performed at 34 clinical centers."3.77Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study. ( Kuwayama, Y; Yamamoto, T, 2011)
"To determine the medium-term intraocular pressure (IOP) control and visual outcomes for patients with advanced glaucoma undergoing trabeculectomy with mitomycin C."3.77Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. ( King, AJ; Stead, RE, 2011)
"To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery."3.77Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011)
"To evaluate the efficacy of cyclodialysis-enhanced Mitomycin c (MMC) trabeculectomy in post-keratoplasty glaucoma."3.76Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma. ( Gupta, V; Sihota, R; Srinivasan, G, 2010)
"To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients."3.76Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010)
"To examine the rates of intermediate-term intraocular pressure (IOP) control after trabeculectomy with adjunctive mitomycin C (MMC) and assess for associated complications."3.76Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years. ( Booth, F; Karim, R; Kubay, O; Lusthaus, JA; Wechsler, D, 2010)
"This study was conducted to evaluate cytotoxicity due to co-treatment with low-dose Mitomycin-C (MMC) and the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA) for glaucoma filtration surgery."3.76An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with mitomycin-C and a histone deacetylase inhibitor. ( Ahn, HB; Jeung, WJ; Kim, TH; Oh, HC; Park, WC; Rho, JH; Rho, SH; Yoo, YH, 2010)
"The authors report two cases of mid- to long-term reversal of optic disc cupping after trabeculectomy with mitomycine-C in young adult patients suffering from secondary glaucoma."3.76Reversal of optic disc cupping with improvement of visual field and stereometric parameters after trabeculectomy in young adult patients (two case reports). ( Stalmans, A; Stalmans, I; Swinnen, S; Zeyen, T, 2010)
"To evaluate the safety and efficacy of deep sclerectomy with implant and mitomycin C in uveitic glaucoma."3.75Efficacy and safety of deep sclerectomy in uveitic glaucoma. ( Abu El-Asrar, AM; Al Obeidan, SA; Al-Muammar, AM; Osman, EA, 2009)
"Retinal hemorrhages secondary to decompression retinopathy occurred following combined trabeculotomy-trabeculectomy with mitomycine-C (MMC) in one eye of a case of congenital glaucoma and pars plana vitrectomy-lensectomy in a case of vitreous condensation secondary to pars planitis."3.75Decompression retinopathy and possible risk factors. ( Guven, D; Hasiripi, H; Kalayci, D; Karakurt, A; Saricaoglu, MS, 2009)
" We compare and contrast the histopathology of a normally functioning mitomycin-C trabeculectomy site obtained from an eye enucleated for iris melanoma with abnormal blebs discussed in the literature."3.75Histopathology of a functioning mitomycin-C trabeculectomy. ( Lee, GA; Liang, SY; Whitehead, K, 2009)
"To analyse clinical outcomes of trabeculectomy with mitomycin C (MMC) in eyes with uveitic glaucoma (UG) with inactive uveitis and compare them to those in eyes with primary open-angle glaucoma (POAG)."3.75Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. ( Araie, M; Kaburaki, T; Kawashima, H; Koshino, T; Numaga, J; Shirato, S; Tomidokoro, A, 2009)
"To evaluate the effect of intraoperative mitomycin-C (MMC) on polypropylene Ahmed glaucoma valve (AGV) survival 2 years after implantation during the first 2 years of life."3.75Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. ( Al-Mobarak, F; Khan, AO, 2009)
"To evaluate long-term outcomes after Ahmed valve implantation in patients with glaucoma when using adjunctive intraoperative mitomycin C (MMC) and postoperative 5-fluorouracil (5-FU)."3.74Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. ( Alvarado, JA; Hollander, DA; Juster, RP; Lee, LC, 2008)
"To compare the effects of variable mitomycin-C (MMC) applications during trabeculectomy on target intraocular pressure (IOP), number of antiglaucomatous therapy, bleb morphology and surgical complications."3.74Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application. ( Aktaş, Z; Hasanreisoğlu, B; Onol, M, 2008)
"To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma."3.74Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008)
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period."3.74Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007)
"The purpose of this study was to compare the outcomes of mitomycin C (MMC)-augmented trabeculectomy in glaucoma patients with uveitis to those without uveitis but with other high-risk characteristics."3.74Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. ( Birt, C; Derzko-Dzulynsky, L; Noble, J; Rabinovitch, T, 2007)
"The objective of this study was to look at the long-term safety, and the effectiveness on intraocular pressure, of trabeculectomy and mitomycin C (MMC) applied under the scleral flap."3.74Long-term results of trabeculectomy with mitomycin C applied under the scleral flap. ( Kumar, V; Kyprianou, I; Nessim, M; O'Neill, E, 2007)
"The aim of the study was to assess the outcomes of surgical revision with reopening of the scleral flap in eyes with failed glaucoma surgery and adjunctive mitomycin C (MMC)."3.74Surgical revision of failed filtration surgery with mitomycin C augmentation. ( Anand, N; Arora, S, 2007)
"To report the experience with trabeculectomy augmented with mitomycin C and 5-fluorouracil for the treatment of paediatric glaucoma."3.73Augmented trabeculectomy in paediatric glaucoma. ( Ehrlich, R; Friling, R; Gaton, DD; Lusky, M; Snir, M; Weinberger, D, 2005)
"To determine the preference of members of the American Glaucoma Society for the use of antifibrotic agents (mitomycin C or 5-fluorouracil or both) and glaucoma drainage devices in ten clinical settings."3.732002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. ( Feuer, WF; Joshi, AB; Parrish, RK, 2005)
"To investigate the comparative efficacy and safety of deep sclerectomy with and without intraoperative mitomycin C (MMC) application for lowering the intraocular pressure (IOP)."3.73Deep sclerectomy augmented with mitomycin C. ( Anand, N; Atherley, C, 2005)
" Eyes classified with moderate glaucoma had a 13%, 40%, and 80% success rate respectively for goniotomy, trabeculotomy, and combined trabeculotomy-trabeculectomy with mitomycin C."3.73Correlation between surgical success rate and severity of congenital glaucoma. ( Al-Hazmi, A; Al-Jadaan, I; Al-Mesfer, SA; Al-Mohammed, A; Awad, A; Zwaan, J, 2005)
"Combined trabeculotomy and trabeculectomy with mitomycin C was performed in the left eye for primary congenital glaucoma."3.73Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C. ( Gupta, V; Sihota, R; Sony, P, 2005)
"To determine the long-term antiscarring effect of ilomastat treatment after experimental glaucoma filtration surgery (GFS)."3.73Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. ( Khaw, PT; Mead, AL; Wong, TT, 2005)
"The routine use of mitomycin C to enhance glaucomatous filtering surgery has found wide acceptance."3.73Bullous keratopathy as a complication of trabeculectomy with mitomycin C. ( Krieglstein, GK; Mietz, H; Roters, S, 2005)
"We studied 119 eyes of 149 patients who had undergone fornix-based trabeculectomy with mitomycin C as their primary surgery between 2000 and 2002 and in whom we could evaluate the characteristics of filtering blebs after a follow-up period of 6 months or more, and whose intraocular pressure at the evaluation time was 18 mmHg or less."3.73[Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y, 2005)
"To assess intraocular pressure (IOP) changes of the contralateral eyes of eyes undergoing trabeculectomy with mitomycin C (MMC)."3.73Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C. ( Flammer, J; Haefliger, IO; Shaarawy, T; Vysniauskiene, I, 2005)
"To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)."3.73Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005)
"Inflammation was controlled with topical steroids and the patient underwent a combined phacoemulsification and trabeculectomy with mitomycin-C for uncontrolled glaucoma."3.73Corneal honeybee sting. ( Fam, HB; Lee, JJ; Teoh, SC, 2005)
"In comparison with mitomycin C, neither intraoperative nor postoperative treatment with cyclosporin was associated with a decrease in intraocular pressure or prolonged bleb survival."3.73Cyclosporin as an adjunct to glaucoma filtration surgery. ( Allen, RC; Crouch, ER; Lattanzio, FA; Mitrev, PV; Williams, PB, 2005)
"To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery."3.73Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006)
"To determine the efficacy and safety of trabeculectomy with mitomycin-C (trabMMC) compared with that of single-site phacotrabeculectomy with mitomycin-C (phacotrabMMC) in glaucoma patients at increased risk for filtering surgery failure."3.73Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. ( Damji, KF; Hodge, WG; Murthy, SK; Pan, Y, 2006)
"Antimetabolites, especially mitomycin C (MMC), increase the incidence of late bleb-related endophthalmitis in trabeculectomy."3.73Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C. ( Flesner, P; Jensen, PK; Kessing, SV, 2006)
"The technique of mitomycin C (MMC) drug delivery and its application in glaucoma surgery are not standardized with resultant inconsistencies in the results."3.73Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels. ( Arosemena, A; Ayyala, RS; Blake, DA; Clinton, AD; Galler, KE; John, VT; Johnson, PY; Sahiner, N; Walsh, M, 2006)
"With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes."3.73Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006)
"To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery."3.72Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003)
"The present findings indicate that the additional use of mitomycin C may be justified in trabeculectomies in patients with severe glaucoma."3.72Five-year results of trabeculectomy with mitomycin C. ( Beckers, HJ; Kinders, KC; Webers, CA, 2003)
"In this prospective interventional case series of 45 consecutive uncomplicated glaucoma patients, 45 eyes with thick Tenon's capsule underwent primary trabeculectomy with intraoperative mitomycin-C (0."3.72Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C. ( Akarsu, C; Hasanreisoglu, B; Onol, M, 2003)
"Mitomycin C (MMC) used as an additive agent in glaucoma surgery has been shown to improve the postoperative results of intraocular pressure (IOP), but may also lead to higher incidences of postoperative wound healing disorders and of hypotonia with choroidal detachment."3.72[Clinical experiences and results of application of mitomycin C in trabeculectomy]. ( Hudde, T; Laube, T; Ritters, B; Selbach, M, 2003)
"Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma."3.72Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003)
"To evaluate the results of trabeculectomy with and without the use of mitomycin C in children with primary congenital glaucoma."3.72Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. ( de Arruda Melo, PA; Júnior, AP; Montezano, FT; Prata, J; Rodrigues, AM, 2004)
"To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure."3.72Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004)
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease."3.72Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004)
"A retrospective chart review of 44 eyes of 44 patients with uveitic glaucoma who underwent trabeculectomy with mitomycin C or 5-fluorouracil."3.71Trabeculectomy with antiproliferative agents in uveitic glaucoma. ( Beck, AD; Ceballos, EM; Lynn, MJ, 2002)
"The authors performed a nonrandomized retrospective review of patients who received the Molteno implant (n = 27), Krupin Eye Valve with Disc (n = 13), or Ahmed Glaucoma Valve (n = 13), with adjunctive mitomycin C."3.71Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant. ( Gangnon, R; Heatley, GA; Kaufman, PL; Perkins, TW; Taglia, DP, 2002)
"To describe the surgical technique and clinical outcomes of a procedure for refractory glaucoma, concurrent Baerveldt glaucoma implant (BGI) and trabeculectomy with mitomycin C."3.71Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002)
"Episcleral application of mitomycin-C (MMC) during glaucoma surgery hinders the post-operative wound healing but may lead to side effects to the ciliary body."3.71Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. ( Georgopoulos, M; Vass, C; Vatanparast, Z, 2002)
"To determine and compare the effectiveness of octreotide, mitomycine-C and corticosteroids on wound-healing reaction after glaucoma surgery."3.71Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery. ( Akyol, N; Colakoğlu, N; Demir, T; Kükner, A, 2001)
"In medically uncontrolled post-traumatic angle recession glaucoma trabeculectomy with mitomycin C is an effective surgical procedure with an acceptable complication rate."3.71Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. ( Barron, A; Manners, T; Murray, AD; Salmon, JF; Willies, C, 2001)
"02% mitomycin C (MMC) in glaucoma patients at risk for failure of filtration surgery."3.71Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. ( Casson, R; Rahman, R; Salmon, JF, 2001)
"A chromatographic method, which can quantitate mitomycin C (MMC) along with two antiglaucoma drugs, is described."3.71Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection. ( Chew, P; Lat-Luna, M; Lim, BA; Tan, D; Xiong, X, 2001)
"To investigate the changes of tear film functions due to the use of postoperative 5-fluourouracil (5-Fu) and intraoperative mitomycin C (MMC) in glaucoma filtration surgery."3.71[Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery]. ( Li, J; Pang, L, 2001)
" Trabeculectomy with mitomycin C controlled IOP on last visit in 8 of 13 eyes with aphakic glaucoma."3.70Surgical results of secondary glaucomas in childhood. ( Ellis, FD; Helveston, EM; Plager, DA; Raiesdana, A; Snyder, SK; Wallace, DK, 1998)
"The authors develop a simple and economical method of applying reproducible intraoperative doses of mitomycin C for glaucoma filtering surgery."3.70Half corneal light shield as a delivery system for standardized application of mitomycin C. ( Davis, D; Joos, KM; Khoury, JM; O'Day, DM; Shen, JH, 1998)
"Primary trabeculectomy with the use of intraoperative mitomycin lowered the IOP by 30% or more in 78% (at 2 years) to 86% (at 1 year) of the cases and is associated with a marked reduction in the percentage of patients who require glaucoma medication."3.70Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. ( Greenfield, DS; Nicolela, MT; Palmberg, PF; Rueda, JC; Schiffman, J; Scott, IU; Tsai, JC, 1998)
"The authors examine the intermediate-term effects of adjunctive intraoperative mitomycin C (MMC) in a cohort of patients who received double-plate Molteno implants for complicated glaucomas."3.70Molteno implant with mitomycin C: intermediate-term results. ( Gangnon, R; Kaufman, PL; Ladd, W; Libby, CM; Perkins, TW, 1998)
"Bleb leakage occurred in 14 eyes following trabeculectomy (mitomycin C treatment, 10 eyes; 5-fluorouracil treatment, 3 eyes; no antifibrosis agent, 1 eye) and in 1 eye following combined cataract and glaucoma surgery with adjunctive mitomycin C therapy."3.70Late-onset bleb leaks after glaucoma filtering surgery. ( Greenfield, DS; Jee, J; Liebmann, JM; Ritch, R, 1998)
"The authors determine if the intraoperative placement of paclitaxel powder in the subconjunctival space improves the outcome of glaucoma filtration surgery in rabbits."3.70The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. ( Jampel, HD; Moon, JI, 1998)
"The authors investigated the safety and intraocular pressure (IOP) lowering effectiveness of trabeculectomy augmented with mitomycin C application beneath the scleral flap, and assessed the influence of preoperative risk factors on the surgical outcome."3.70Trabeculectomy augmented with mitomycin C application under the scleral flap. ( Beatty, S; Kheterpal, S; O'Neill, EC; Potamitis, T, 1998)
"This study aimed to compare the surgical outcomes of mitomycin C trabeculectomy glaucoma drainage device (GDD) surgery and laser neodymium:YAG (Nd:YAG) cyclophotocoagulation (CPC) in the management of intractable glaucoma after penetrating keratoplasty (PKP) in a retrospective study."3.70Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. ( Ayyala, RS; Cooper, ML; Dreyer, EB; Frangie, JP; Goldstein, MH; Mattox, C; Netland, PA; Pieroth, L; Schuman, JS; Vinals, AF; Wu, HK; Zurakowski, D, 1998)
"To determine whether intrascleral exposure to mitomycin-C (MMC) improves the control of intraocular pressure (IOP), increases the incidence of complications, or both."3.70Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy. ( Menapace, R; Rainer, G; Strenn, K; Vass, C, 1998)
"The purpose of this study was to determine the efficacy of initial mitomycin C (MMC)-augmented trabeculectomy for uncomplicated glaucoma in young patients."3.70Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients. ( Dietlein, TS; Jacobi, PC; Krieglstein, GK, 1998)
"The results of primary trabeculectomy with and without mitomycin C (MMC) were evaluated in young glaucoma patients."3.70The results of trabeculectomy with and without mitomycin C in young patients. ( Duman, S; Kahraman, C; Kasim, R; Nurözler, A; Yalvac, IS, 1998)
"Retrospective review of consecutive cases of pediatric glaucoma that underwent mitomycin C augmented trabeculectomy between January 1991 and December 1995."3.70Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. ( Beck, AD; Lynch, MG; Lynn, MJ; Noe, R; Wilson, WR, 1998)
"Mitomycin C trabeculectomy after dissection of conjunctival scar tissue may be useful for treating refractory glaucoma."3.70Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva. ( Honda, Y; Honjo, M; Inatani, M; Tanihara, H, 1998)
" Procedures for the control of glaucoma were silicone oil removal (SOR), trabeculectomy with mitomycin C, cyclocryotherapy, semiconductor diode laser contact transscleral cyclophotocoagulation (TSCPC) and anterior chamber tube shunt to encircling band (ACTSEB)."3.70Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. ( Dandona, L; Goyal, M; Honavar, SG; Majji, AB; Naduvilath, T; Sen, PK, 1999)
"To evaluate corneal graft survival and intraocular pressure control in eyes that have undergone combined penetrating keratoplasty and trabeculectomy with mitomycin C (MMC)."3.70Combined penetrating keratoplasty and trabeculectomy with mitomycin C. ( Alfonso, E; Palmberg, PF; WuDunn, D, 1999)
"To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty."3.70Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999)
"Trabeculectomy with mitomycin C might be effective in Cogan-Reese cases with glaucoma resistant to medical treatment."3.70Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome. ( Coşar, CB; Kural, G; Onder, F; Ozdemir, Y; Usubütün, A, 1999)
"To evaluate the surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma."3.70Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999)
"The use of adjunctive antimetabolites such as 5-fluorouracil (5-FU) and mitomycin C (MMC) in trabeculectomy has caused an increased concern as to the risk of bleb-associated endophthalmitis."3.70Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. ( Frucht-Pery, J; Solomon, A; Ticho, U, 1999)
"To evaluate the effectiveness and safety of trabeculectomy with mitomycin-C (MMC) in the management of childhood glaucomas."3.70Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. ( Belmonte, SJ; Liebmann, JM; Ritch, R; Sidoti, PA, 2000)
"Mitomycin C has improved the success rate of glaucoma filtering surgery in patients at high risk for surgical failure."3.70Midterm follow-up of necrotic bleb excision and advancement of the fornical conjunctiva. ( Ahn, DG; Hyung, SM, 1999)
"Retrospective analysis of all eyes that underwent phacoemulsification surgery for symptomatic cataracts and had a preoperative diagnosis of chronic hypotony (intraocular pressure [IOP] mitomycin C."3.70Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery. ( Doyle, JW; Smith, MF, 2000)
"To investigate the effect of trabeculectomy with and without mitomycin C in post-keratoplasty glaucoma."3.70Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. ( Fujishima, H; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yamagami, J, 2000)
" Visually significant cataract developed in 5/15 re-examined eyes that underwent trabeculectomy alone (33%), possibly associated with pre-existing cataract and diagnosis of angle closure glaucoma, but not with mitomycin C use."3.70Long term results of glaucoma surgery among participants in an east African population survey. ( Buhrmann, RR; Isseme, I; Oliva, MS; Quigley, HA; Scudder, M; West, SK, 2000)
"A concurrent series (from January 1, 1987, to October 1, 1997) of one surgeon's consecutive 585 (456 patients) combined cataract extraction, intraocular lens implantation, and trabeculectomy surgeries, some with intraoperative mitomycin C and/or postoperative subconjunctival 5-fluorouracil."3.70Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries. ( Hahn, J; Larive, B; Rockwood, EJ, 2000)
"Adjunctive chemotherapy with Mitomycin C (MMC) has been used in an attempt to modulate the wound healing response in glaucoma filtration surgery."3.69Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. ( Chawla, HB; O'Brien, C; Singh, J, 1995)
"The effects of mitomycin-C on intraocular pressure (IOP), facility of outflow (C), and Tenon's capsule fibrosis were studied over 60 days in 10 clinically normal dogs."3.69Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs. ( Davidson, MG; Glover, TL; Nasisse, MP, 1995)
" In patients with lower risk for failure a reduction of concentration and application time of Mitomycin C should minimise side effects while maintaining the beneficial effect of lower intraocular pressure."3.69[Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study]. ( Annen, DJ; Stürmer, J, 1995)
"To determine whether there is increased risk to the corneal endothelium when mitomycin C is used in trabeculectomy surgery instead of fluorouracil, and whether these agents play a role in accelerating cataract formation."3.69Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. ( Chaturvedi, N; Dreyer, EB; Zurakowski, D, 1995)
"We evaluated the effectiveness of combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C in patients with coexisting cataract and glaucoma."3.69Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. ( Alward, WL; Munden, PM, 1995)
"Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation."3.69One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995)
"A 45-year-old male underwent a trabeculectomy with mitomycin C for a secondary glaucoma after complicated cataract surgery."3.69Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. ( Greve, EL; Nuyts, RM; Van Diemen, HA, 1994)
"Twenty-one eyes of 21 patients with refractory glaucoma underwent glaucoma surgery involving placement of a modified Molteno implant and intraoperative application of mitomycin C."3.69Mitomycin C as adjunctive therapy with glaucoma implant surgery. ( Nicolela, MT; Susanna, R; Takahashi, WY, 1994)
"We prospectively investigated the postoperative intraocular pressure (IOP) level, visual prognosis, and complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma."3.69[Trabeculectomy for normal-tension glaucoma]. ( Ichien, M; Kitazawa, Y; Suemori-Matsushita, H; Yamamoto, T, 1994)
"Mitomycin C (MMC) was used as a perioperative adjunct during trabeculectomy for 51 consecutive cases of complicated glaucoma."3.69Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months. ( Krieglstein, GK; Mietz, H, 1994)
"In patients with uncertain prognosis for the intraocular pressure after trabeculectomy, the intraoperative application of Mitomycin C seems to improve considerably the operative success rate."3.69[Experiences with mitomycin C]. ( Flammer, J; Gaspar, AZ; Orgül, S, 1994)
"Intraoperative mitomycin-C application has been well accepted recently as a useful adjunctive procedure to enhance the filtering effect in glaucoma surgery."3.69Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery. ( Hsieh, JW; Hung, PT; Lin, LL; Wang, TH, 1995)
"To evaluate the timing, efficacy, and complications of laser suture lysis (LSL) after mitomycin C trabeculectomy in patients with glaucoma at high risk for failure of filtering surgery."3.69Laser suture lysis after mitomycin C trabeculectomy. ( Baerveldt, G; Heuer, DK; LaBree, L; Lee, PP; Minckler, DS; Morinelli, EN; Sidoti, PA, 1996)
"To evaluate intraocular pressure (IOP) control and surgical complications following trabeculectomy with 5-fluorouracil (5-FU) or mitomycin at the inferior limbus."3.69Trabeculectomy at the inferior limbus. ( Caronia, RM; Cohen, H; Friedman, R; Liebmann, JM; Ritch, R, 1996)
"To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis."3.69Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996)
"To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin."3.69Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996)
"The purpose of this study was to assess the effects of intraoperative mitomycin-C (MMC) on the function of Baerveldt glaucoma implants in rabbits."3.69Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. ( Baerveldt, G; Mermoud, A; Minckler, DS; Prata, JA, 1996)
"Thirteen patients with normal-tension glaucoma with a cystic filtering bleb who had undergone unilateral trabeculectomy with mitomycin C only once at least 1 year previously were subjected to the study."3.69Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C. ( Haque, MS; Kinoshita, S; Kitazawa, Y; Komuro, A; Mochizuki, K; Taniguchi, T; Yamamoto, T; Yokoi, N, 1996)
"An attempt was made to observe the possibility of controlling intraocular pressure (IOP) without hypotony and ocular motility disorder by installing an experimentally designed glaucoma implant through a small conjunctival incision with the aid of a stylet and maintaining the aqueous reservoir using mitomycin C (MMC)."3.69Experimentally designed glaucoma implant surgery with mitomycin C in rabbit. ( Kee, C; Youn, DH, 1995)
"Administration of subconjunctival 5-fluorouracil (5-FU) and topical mitomycin-C (MMC) has been shown to improve the success rate of glaucoma-filtering surgery."3.69A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies. ( Akata, RF; Gökçe, M; Kiremitçi-Gümüşderelioglu, M, 1996)
"A 91-year-old woman with a complete rupture of her mitomycin-C filtration bleb associated with eye rubbing while crying was examined."3.69Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations. ( Greenfield, DS; Parrish, RK, 1996)
"Both large- and small-incision phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative Mitomycin-C provide good intermediate range (1 year) postoperative IOP in eyes with coexisting cataract and glaucoma."3.69Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions. ( Wand, M, 1996)
"Combined penetrating keratoplasty and trabeculectomy with mitomycin-C should be considered for selected patients with uncontrolled glaucoma and corneal disease who have sufficient conjunctiva for a filtering procedure."3.69Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996)
"To determine the surgical outcome of mitomycin trabeculectomy in patients with refractory glaucoma."3.69Surgery for refractory glaucoma. ( Hagiwara, Y; Kitazawa, Y; Sawada, A; Yamamoto, T, 1996)
"The records of 157 eyes of 157 consecutive patients, aged 18 or older, who underwent mitomycin C trabeculectomies for uncontrolled glaucoma of various causes were reviewed."3.69Intermediate-term outcome of variable dose mitomycin C filtering surgery. ( Cheung, JC; Murali, S; Pederson, JE; Wright, MM, 1997)
" Combined phacoemulsification and mitomycin C trabeculectomy appears to be safe and effective for treating selected patients with coexisting glaucoma and cataract."3.69Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. ( Berestka, JS; Brown, SV, 1997)
"Hypotony maculopathy after glaucoma filtering surgery with adjunctive mitomycin C has been reported to occur in 3% to 14% of cases."3.69Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. ( Greenfield, DS; Miller, MP; Nicolela, MT; Palmberg, PF; Suñer, IJ, 1997)
"To inhibit the wound healing process and to achieve a better intraocular pressure lowering effect, we applied mitomycin-C (MMC) topically in trabeculectomy at different time sequences."3.69Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma. ( Bair, JS; Chen, CW, 1997)
"Adjunctive intraoperative mitomycin C increases the success of glaucoma filtering surgery, but also the postoperative complications."3.69Scleritis after glaucoma filtering surgery with mitomycin C. ( Fourman, S, 1995)
"After trabeculectomy with mitomycin C, the filtering blebs of 117 eyes from 117 patients with various types of glaucoma were examined using ultrasound biomicroscopy."3.69An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy. ( Kitazawa, Y; Sakuma, T; Yamamoto, T, 1995)
"Twenty-nine consecutive eyes of 26 patients with cataract and glaucoma that had undergone combined phacoemulsification, posterior chamber lens implantation, and limbus-based trabeculectomy with mitomycin-C applied after the cataract removal and trabeculectomy had a minimal follow-up time of 12 months (mean follow-up 20 +/- 6."3.69Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. ( Belyea, DA; Dan, JA; Lieberman, MF; Stamper, RL, 1997)
"The effects of mitomycin C (MMC, 1 microgram/ml for 5 min) on growth and morphology of six MMC 'sensitive' and four MMC 'resistant' human Tenon's capsule fibroblasts grown from 10 patients who had had trabeculectomy for glaucoma were studied."3.69In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients. ( Madhavan, HN; Vijaya, L, 1997)
" Also, to elucidate time-dependent changes in corneal epithelium barrier function, we measured fluorescein uptake before and after trabeculectomy prospectively in the central and peripheral cornea of six glaucomatous eyes in six patients."3.69Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy. ( Honda, Y; Kinoshita, S; Komuro, A; Tanihara, H; Yokoi, N, 1997)
"The authors studied the efficacy and complications of intraoperative mitomycin-C in glaucoma associated with ocular inflammation."3.69Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. ( McGehee, RF; Pederson, JE; Wright, MM, 1997)
"The purpose of the study is to determine the safety and efficacy of mitomycin C-augmented trabeculectomy in children with developmental glaucoma treated previously by conventional procedures."3.69Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. ( Jayagandan, A; John, T; Mandal, AK; Walton, DS, 1997)
"The precise mechanism whereby mitomycin C enhances IOP reduction in glaucoma filtering surgery still eludes us."3.69Transconjunctival application of mitomycin C in combination with laser sclerostomy ab interno: a long-term morphological study of the postoperative healing process. ( England, C; Frankhauser, F; Iliev, ME; van der Zypen, E, 1997)
"To evaluate the effectiveness of combined phacoemulsification and trabeculectomy with mitomycin-C with respect to visual rehabilitation and control of intraocular pressure in patients with coexisting cataract and glaucoma."3.69Combined phacoemulsification and trabeculectomy with mitomycin-C. ( Schuman, JS; Zacharia, PT, 1997)
"Subconjunctival mitomycin C has been used in glaucoma filtration surgery with success."3.69Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits. ( Buffenn, AN; Higginbotham, EJ; Kincaid, MC; Musch, DC; Saetre, SB, 1997)
"To evaluate the safety and efficacy of trabeculectomy with mitomycin-C in the management of postkeratoplasty glaucoma."3.69Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study. ( Gupta, A; Kumar, S; Ram, J; Sharma, A, 1997)
"The clinical appearance of cystic blebs and the incidence of bleb infection were retrospectively evaluated in 215 trabeculectomies with mitomycin C."3.69[The long-term cystic bleb appearance and safety after trabeculectomy with mitomycin C]. ( Kadowaki, H; Kuroda, S; Matsumura, M; Mizoguchi, T; Nagata, M; Terauchi, H, 1997)
"The purpose of the study is to assess the effect of adjunctive intraoperative mitomycin C (MMC) in Molteno drainage device implantation for patients with recalcitrant glaucomas."3.69The effect of adjunctive mitomycin C in Molteno implant surgery. ( Birt, CM; Khatana, AK; Kim, C; Kupin, TH; Lee, D; Olivier, MM; Reed, SY; Shin, DH, 1997)
"To evaluate the outcome of Baerveldt implantation with adjunctive mitomycin-C in cases of complicated glaucoma."3.69Simultaneous use of mitomycin-C with Baerveldt implantation. ( Azuara-Blanco, A; Moster, MR; Schmidt, CM; Wilson, RP, 1997)
"The study was designed to observe the effect of heterogeneous scleral transplantation in treatment of hypotony after filtration surgery of glaucoma with mitomycin C."3.69[The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C]. ( Dong, Q; Yan, L; Zhang, S, 1997)
"We studied the efficacy and safety of using topical mitomycin C (MMC) as an adjunct to glaucoma filtration surgery."3.68Effects of topical mitomycin C on glaucoma filtration surgery. ( Hong, C; Hyung, SM; Kim, DM; Song, KY; Youn, DH, 1993)
"A short-term pilot study used mitomycin C at the time of trabeculectomy in a population of southern Indians with various forms of glaucoma."3.68Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study. ( Krishnadas, R; Michon, J; Ramakrishnan, R; Robin, AL, 1993)
"Rabbits undergoing full-thickness glaucoma filtering surgery were exposed for 5 minutes to one of three intraoperative treatments: (1) distilled water; (2) fluorouracil, 50 mg/mL; or (3) mitomycin C, 0."3.68Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. ( Doyle, JW; Grierson, I; Khaw, PT; McGorray, S; Schultz, G; Sherwood, MB, 1993)
"We measured aqueous flare in 16 glaucomatous eyes after trabeculectomy in which 5-fluorouracil (5-FU) or mitomycin C (MMC) had been used as an adjunctive therapy."3.68Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study. ( Jikihara, S; Kawase, K; Kitazawa, Y; Nishimura, K; Yamamoto, T, 1993)
"In this study, an experimental model of glaucoma filtration surgery was used to evaluate the clinical and histologic effects of a single intraoperative topical application of mitomycin C."3.68Effect of topical mitomycin C on glaucoma filtration surgery in monkeys. ( Dorman-Pease, ME; Jampel, HD; Pasquale, LR; Quigley, HA; Thibault, D, 1992)
" 1989 trabeculectomy with per-operative topical application of mitomycin C was performed on eyes with refractory glaucoma."3.68Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. ( Bair, JS; Chen, CW; Huang, HT; Lee, CC, 1990)
"Mean intraocular pressure was significantly reduced compared with baseline in both groups (P < 0."2.79Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). ( Ahmed, II; Condon, G; Moster, MR; Netland, PA; Salim, S; Sarkisian, SR; Sherwood, MB; Siegfried, CJ, 2014)
"New-onset persistent diplopia was reported in 5 patients (5%) in the tube group and no patients in the trabeculectomy group at 1 year (P = ."2.74Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up. ( Barton, K; Feuer, WJ; Gedde, SJ; Lee, RK; Rauscher, FM; Schiffman, JC, 2009)
"Mitomycin C (MMC) is an alkylating agent with extraordinary ability to crosslink DNA, preventing DNA synthesis."2.72History, presence, and future of mitomycin C in glaucoma filtration surgery. ( Al Majidi, R; Beckers, HJM; Gorgels, TGMF; Pinchuk, L; van Mechelen, RJS; Webers, CAB; Wolters, JEJ, 2021)
"To study the clinical effect of trabeculectomy combined with Mitomycin C and removed suture."2.71[Trabeculectomy combined with mitomycin C and removed suture in glaucoma]. ( Feng, Y, 2003)
"5-Fluorouracil and MMC were found to be equally safe and effective adjuncts to primary trabeculectomy in the short- and medium-term postoperative periods."2.69Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. ( Baerveldt, GS; Budenz, DL; Chen, PP; Cohen, JS; Greenfield, DS; Mehta, K; Moster, MR; Shaikh, NM; Shaikh, S; Singh, K; Tsai, JC, 2000)
"To determine the anticicatrization effect of mytomycin C (MMC)."2.68[The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis]. ( Wu, L; Yin, J, 1996)
"Late postoperative complications are similar with the exception of an increased incidence of Tenon cyst formation in the MMC-treated eyes."2.68Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. ( Bergstrom, TJ; Higginbotham, EJ; Johnson, AT; Katz, GJ; Lichter, PR; Musch, DC; Skuta, GL, 1995)
"These include young patients, those with pigmentary glaucoma, secondary glaucoma, angle recession glaucoma, aphakic or pseudophakic glaucoma, and patients requiring reoperation."2.67Intraoperative mitomycin C in complicated glaucomas. ( Dogra, A; Kaur, J; Singh, G, 1993)
"The objective of this study was to evaluate the efficacy and safety of bevacizumab combined with antimetabolite as an adjunctive therapy in primary trabeculectomy for glaucoma."2.58Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials. ( Chen, HJ; Chen, YH; Lee, CH; Lin, C, 2018)
"Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP)."2.53Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery. ( Cheng, JW; Cheng, SW; Lu, GC; Wei, RL, 2016)
"Raised intraocular pressure is a risk factor for glaucoma."2.52Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. ( Cabourne, E; Clarke, JC; Evans, JR; Schlottmann, PG, 2015)
"In cases where such treatment fails, glaucoma-filtering surgery is considered, most commonly trabeculectomy surgery with variations in technique, for example, the type of conjunctival flap (fornix- or limbal-based)."2.52Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma. ( Abdulaal, M; Al-Haddad, C; Al-Moujahed, A; Ervin, AM, 2015)
"The healing and scarring determine the percentage of patients achieving low final intraocular pressures (IOPs) that are associated with virtually no glaucoma progression."2.44Modulation of wound healing during and after glaucoma surgery. ( Brocchini, S; Dahlmann-Noor, A; Georgoulas, S; Khaw, PT, 2008)
" These specific ocular side effects are described, caution being taken to precise the strength of the association between each side effect and the related drug by using the classification of World Health Organisation (WHO) (certain, probable, possible or unlikely)."2.44[Ocular side effects of glaucoma treatment agents]. ( Bremer, F; Ehongo, A, 2007)
"Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure."2.43Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2005)
"Mitomycin C is an antimetabolite applied between the sclera and conjunctiva during the initial stages of a trabeculectomy to prevent excessive post-operative scarring and thus reduce the risk of failure."2.41Intra-operative mitomycin C for glaucoma surgery. ( Indar, A; Wilkins, M; Wormald, R, 2001)
"The mean follow-up time after treatment for endophthalmitis was 6."2.41Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. ( Budenz, DL; Flynn, HW; Scott, IU; Song, A, 2002)
" New anti-glaucoma drugs, latanoprost and nipradilol, have been shown to effect a reduction in IOP equal to that achieved with the equivalent dosage of timolol, with no adverse systemic side effects."2.39[Current topics in glaucoma]. ( Masuda, K, 1996)
"Cataract and glaucoma are two very common conditions that frequently are coincident within the same patient."2.39Management of coincident glaucoma and cataract. ( Samuelson, TW, 1996)
"The use of antiscarring agents, particularly the antimetabolites 5-fluorouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade."2.39Current techniques in wound healing modulation in glaucoma surgery. ( Khaw, PT; Migdal, CS, 1996)
"Mitomycin C seems to be a better treatment than 5 fluorouracil."2.38[Mitomycin C in glaucoma surgery]. ( Collignon-Brach, J, 1993)
" Outcome measures included IOP reduction from baseline, mean IOP change from baseline at month 6, medication use at 6 months, complications, adverse events, and need for further procedures."1.91Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries. ( Burgos-Blasco, B; Fernandez-Vigo, JI; García-Feijóo, J; Gines-Gallego, C; Martinez de la Casa, JM; Mendez-Hernandez, CD; Morales-Fernandez, L; Perucho-Gonzalez, L; Saenz-Frances, F, 2023)
"Mitomycin C (MMC) was used in 54,8% of the cases, collagen matrix (Ologen®, Aeon Astron Corporation, Taipei, Taiwan) was used alone in 8."1.72Survey of glaucoma surgical preferences among glaucoma specialists in Spain. ( Balboa Miró, M; Botella García, J; Duch, S; Loscos Arenas, J; Moreno-Montañés, J; Romera Romero, P, 2022)
"Inflammation-driven scarring is a major contributor to surgical failure after subconjunctival bleb forming glaucoma surgery."1.72Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery. ( Armstrong, JJ; Hutnik, CML; Liu, H; Vinokurtseva, A, 2022)
"Eyes with primary open angle glaucoma (OAG), secondary OAG or pseudophakic primary angle closure glaucoma (PACG) were included."1.72Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique. ( Ang, GS; Chung, IY; Kong, YXG, 2022)
"Mitomycin C is a routinely used antimetabolite which effectively limits the scarring process."1.62National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. ( Arain, UR; Khan, SA; Razzaq, MA; Whittaker, K, 2021)
"Choroidal detachment is a major postoperative complication of trabeculectomy."1.56Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report. ( Abe, T; Sakurai, Y; Takayama, K; Takeuchi, M, 2020)
"Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation."1.51Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis. ( Dong, A; Fan, P; Han, L; Shao, Z; Yuan, H; Zhou, X, 2019)
"For Taiwanese children, the combined trabeculotomy-trabeculectomy using the modified Safer Surgery System offered an efficient and safe surgical option for treating glaucoma with long-term satisfactory control of IOP."1.48Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children. ( Chen, YH; Hsu, CR; Lu, DW; Tai, MC, 2018)
"Mitomycin C was used in 15/19 eyes."1.46Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens. ( Garudadri, CS; Gollakota, S; Mohamed, A; Senthil, S, 2017)
" A single subconjunctival injection of MMP inhibitor during the experimental trabeculectomy showed a less toxic affect in the rabbit cornea, conjunctiva, and ciliary body compared to MMC."1.46Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery. ( Han, JR; Han, KE; Suh, W, 2017)
"Mitomycin-C was used in most cases."1.43The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma. ( Mandalos, A; Parmar, T; Sung, V; Tailor, R, 2016)
"Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)."1.43Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016)
"To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment."1.43Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016)
"Secondary glaucoma is a serious complication in patients with transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP)."1.40Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. ( Ando, Y; Eiki, D; Hara, R; Inoue, T; Kawaji, T; Tanihara, H, 2014)
"The meiboscores of the bleb-contacting upper eyelid areas were significantly higher than those for the bleb-noncontacting upper eyelid areas (P < 0."1.40Meibomian gland loss due to trabeculectomy. ( Horikiri, H; Noji, H; Ogasawara, M; Sagara, H; Sekiryu, T; Sugano, Y, 2014)
"Mitomycin C (MMC) was loaded into this hydrogel for controlled released to prolong the efficacy and to reduce the long-term toxicity."1.40Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery. ( Ge, J; Li, X; Liu, J; Luo, J; Quan, D; Wang, T; Xi, L; Zhao, F; Zheng, Q, 2014)
"Both cataract and glaucoma are significant public health problems."1.40Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy. ( Kunhammad, S; Singh, P, 2014)
"MMC-augmented revision appears to be a safe and useful tool in reducing intraocular pressure after trabeculectomy failure."1.39Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results. ( Kosior-Jarecka, E; Tomaszewska, J; Tulidowicz-Bielak, M; Zarnowski, T, 2013)
"The frequency of LT1009 dosage was determined initially using an enzyme-linked immunosorbent assay assay measuring LT1009 eye tissue retention in 6 New Zealand White rabbits."1.39Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. ( Beattie, AR; Levine, MA; Lukowski, ZL; Meyers, CA; Min, J; Samuelson, DA; Schultz, GS; Sherwood, MB; Stoller, G, 2013)
" Additional postoperative treatments, such as bleb needling, and adverse events were secondary outcomes."1.39Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. ( Aung, T; Hoh, ST; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Wong, TT, 2013)
"Needling revision with adjunctive MMC is effective for reviving flat filtering blebs and controlling IOP, even several years after the original trabeculectomy, and seems to be safe for the corneal endothelium."1.37Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. ( Cronemberger, S; Diniz, AF; Ferreira, GA; Filho, AD; Maestrini, HA; Matoso, HD; Mérula, RV; Reis, JR; Sakurai, E, 2011)
"Congenital glaucoma is a global problem and poses a diagnostic and therapeutic challenge to the ophthalmologist."1.37Update on congenital glaucoma. ( Chakrabarti, D; Mandal, AK, 2011)
"In newborns with unilateral buphthalmos and presumed congenital glaucoma, the differential diagnosis should include the rare condition of orbitotemporal neurofibromatosis."1.37Childhood orbitotemporal neurofibromatosis masked by congenital glaucoma and buphthalmos. ( Boboridis, KG; Kanonidou, ED; Ziakas, NG, 2011)
"Filtering blebs with various types of glaucoma were examined using Stratus OCT."1.36Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap. ( Baba, T; Hirooka, K; Shiraga, F; Takagishi, M; Takenaka, H, 2010)
"Bleb wall reflectivity of developing blebs on AS-OCT 2 weeks postoperatively was correlated with mature bleb function at 6-month postoperative visit."1.36Early trabeculectomy bleb walls on anterior-segment optical coherence tomography. ( Hangai, M; Hirose, F; Inoue, R; Nakanishi, H; Nakano, N; Ojima, T; Unoki, N; Yoshimura, N, 2010)
"Mitomycin C(MMC) was administered to 15 patients (58%) with needling being performed on 10 (38%) of these patients."1.36Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma. ( Bissig, A; Feusier, M; Mermoud, A; Roy, S, 2010)
"Mitomycin C was used in 12% and 0."1.35Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery. ( Khaw, PT; Liu, L; Siriwardena, D, 2008)
"SDOCT showed the bleb cavity (23."1.35High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment. ( Aquino, MC; Chew, PT; See, JL; Singh, M; Thean, LS, 2009)
"Thirty-one blebs of 24 patients underwent noncontact in vivo confocal microscopy using the Rostock Cornea Module of the Heidelberg Retina Tomograph II (50x noncontact Nikon lens, 1-2 mum resolution, field of view: 500x500 mum)."1.35Noncontact in vivo scanning laser microscopy of filtering blebs. ( Liebmann, JM; Palmiero, PM; Ritch, R; Sbeity, Z; Tello, C, 2009)
"We report a case of suprachoroidal hemorrhage following removal of a releasable suture after combined phacoemulsification-trabeculectomy."1.34Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy. ( Eong, KG; Prashanth, S; Raman, GV; Sathyan, P; Singh, G, 2007)
"The mean intraocular pressure was significantly decreased from 22."1.33[Clinical results of fornix-based trabeculectomy with a scleral tunnel]. ( Kano, K; Kuwayama, Y; Mizunoya, H, 2005)
"Twenty-four glaucoma filtering blebs in 24 eyes of 17 patients."1.33Comparison of two clinical Bleb grading systems. ( Ashraff, NN; Hall, RC; Purdie, G; Wells, AP, 2006)
"Each bleb was incised segmentally and the cut edges of the conjunctiva and Tenon capsule were sutured to the underlying sclera."1.33Surgical reduction of symptomatic, circumferential, filtering blebs. ( Anis, S; Liebmann, J; Ritch, R; Shihadeh, W, 2006)
"Mitomycin-C release was measured in vitro using spectrophotometry."1.33[Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye]. ( Adjadj, E; Drewe, J; Flammer, J; Mermoud, A; Roy, S; Shaarawy, T; Zimmermann, C, 2006)
"Two additional filtering blebs were treated with balanced saline solution (BSS), two received mitomycin-C (MMC) (0."1.33A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). ( Sherwood, MB, 2006)
"Mitomycin C treatment over the secondary plate alone permits removal of this plate if MMC-related complications occur without requiring removal of the whole implant."1.32Mitomycin C eliminates the short-term intraocular pressure rise found following Molteno tube implantation. ( Ellingham, RB; House, PH; Morgan, WH; Westlake, W, 2003)
"Glaucoma is a common eye disease associated with elevated intraocular pressure (IOP)."1.32Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. ( Dawson, DG; Faha, B; Gleiser, J; Heatley, G; Kaufman, PL; Kiland, J; Maneval, D; Nickells, RW; Schlamp, CL; Seeman, J, 2004)
" The consultants were asked to estimate the number of trabeculectomies they performed per year, how often they used 5-fluorouracil (5-FU) in primary and redo surgery, their usual method of administration of 5-FU, how often they used mitomycin (MMC) in primary and redo surgery, and their usual dosage regimen of MMC."1.32National survey of antimetabolite use in glaucoma surgery in the United Kingdom. ( Edmunds, B; Khaw, PT; Siriwardena, D; Wormald, RP, 2004)
"In the study 6 patients with cystic blebs after trabeculectomy with mitomycin C was presented."1.32[Surgical management of pathologic filtering blebs in pediatric glaucoma]. ( Chipczyńska, B; Grałek, M; Kanigowska, K; Klimczak-Slaczka, D, 2004)
"We study the efficacy of treating ocular cicatricial pemphigoid (OCP) with subconjuctival mitomycin C (MMC)."1.31[Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid]. ( Celis Sánchez, J; García Largacha, M; González del Valle, F; López Ferrando, N; Ortiz de la Torre, MJ, 2002)
" The dosage of mitomycin-C was 0."1.31Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000)
"Mitomycin C was administered intraoperatively in the dose of 0."1.31[Antimetabolites in glaucoma surgery--long-term results]. ( Ferková, S; Jakabovicová, E; Michalíková, L; Strmen, P, 2002)
"Mitomycin-C (MMC) has been shown to improve the surgical success of trabeculectomy; however, the advantages of MMC have been evaluated almost entirely as an adjunct to limbal-based trabeculectomy."1.30Fornix-based trabeculectomy with mitomycin-C. ( Goldenfeld, M; Levkovitch-verbin, H; Melamed, S, 1997)
" A dose-response effect of the concentration of MMC and IOP levels is present, suggesting that the higher concentration leads to lower IOP values."1.30Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. ( Krieglstein, GK; Mietz, H, 1998)
"Intraocular pressures were lower in the group that received MMC compared to the 5-FU group, but not in the group that did not receive antimetabolites, at all time intervals measured (P < ."1.30Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. ( Budenz, DL; Gordon, J; Keates, EU; Piltz-Seymour, J; Pyfer, M; Singh, K, 1999)
" The dose-response to 5-fluorouracil (5FU) and mitomycin C (MMC) was determined."1.30Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid. ( Gross, RL, 1999)
"In these eyes, intraocular pressure is between 8 and 12 mmHg."1.29Treatment of postfiltration bleb leaks with autologous blood. ( Betchkal, J; Doyle, JW; Magauran, RG; Smith, MF, 1995)
"Mitomycin C is a promising substance which improves substantially the prognosis of complicated cases of glaucoma."1.29[Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery]. ( Liehneová, I; Rozsíval, P, 1994)
"Intraocular pressure was controlled successfully in 97."1.29Effects of topical mitomycin C on primary trabeculectomies and combined procedures. ( Costa, VP; Gandham, S; Moster, MR; Schmidt, CM; Smith, M; Wilson, RP, 1993)
"Mitomycin (0."1.29Intraoperative use of mitomycin in trabeculectomy. ( Fan, Z; Hu, Y; Mai, C; Wei, H; Zeng, S; Zhang, M, 1996)

Research

Studies (689)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's189 (27.43)18.2507
2000's194 (28.16)29.6817
2010's205 (29.75)24.3611
2020's101 (14.66)2.80

Authors

AuthorsStudies
Wong, YL1
Walkden, A1
Mercieca, K6
Kido, A1
Akagi, T1
Ikeda, HO1
Kameda, T1
Suda, K1
Miyake, M1
Hasegawa, T1
Numa, S1
Tsujikawa, A1
Seet, LF1
Yap, ZL1
Chu, SWL2
Toh, LZ2
Ibrahim, FI1
Teng, X1
Wong, TT4
Shah, C1
Sen, P2
Mohan, A1
Peeush, P1
Jain, E1
Prasad, K2
Sen, A1
Tripathi, S1
Ichhpujani, P1
Singla, E1
Kalra, G1
Bhartiya, S1
Kumar, S3
van Mechelen, RJS2
Wolters, JE1
Bertens, CJF1
Webers, CAB2
van den Biggelaar, FJHM1
Gorgels, TGMF2
Beckers, HJM2
Senthil, S6
Rao, HL4
Ali, MH1
Krishnamurthy, R1
Dikshit, S1
Choudhari, N1
Sastry, R1
Garudadri, C2
Romera Romero, P1
Duch, S1
Moreno-Montañés, J1
Botella García, J1
Balboa Miró, M1
Loscos Arenas, J1
Szigiato, AA1
Touma, S1
Jabbour, S1
Lord, F1
Agoumi, Y1
Singh, H1
Tanner, A1
Haddad, F1
Fajardo-Sanchez, J1
Nguyen, E1
Thong, KX1
Ah-Moye, S1
Perl, N1
Abu-Bakra, M1
Kulkarni, A1
Trikha, S1
Lascaratos, G1
Parnell, M1
Kailani, O1
King, AJ3
Agrawal, P1
Stead, R1
Giannouladis, K1
Rodrigues, I1
Goyal, S6
Hysi, PG1
Lim, S1
Yu-Wai-Man, C1
Dooling, V1
Lappas, A1
Dietlein, TS3
Lee, GA3
Liu, L3
Casson, RJ2
Danesh-Meyer, HV2
Shah, P1
Tekcan, H1
Mangan, MS1
Alpogan, O1
Imamoglu, S1
Kose, AO1
Ercalık, NY1
Ibarz Barberá, M1
Martínez-Galdón, F1
Caballero-Magro, E1
Rodríguez-Piñero, M1
Tañá-Rivero, P1
Dias, DT1
Almeida, I1
Ushida, M1
Lopes, FS1
Kanadani, FN1
Gracitelli, CPB1
Prata, TS4
Al-Mugheiry, TS1
Clark, A1
Broadway, DC1
Mandal, AK7
Gothwal, VK2
Gedde, SJ20
Feuer, WJ15
Lim, KS4
Barton, K9
Ahmed, II3
Brandt, JD10
Saeed, E1
Zalewska, R1
Konopińska, J1
Wong, MOM1
Yu, AHY1
Chan, CKM1
Carré, C1
Baudin, F1
Buteau, B1
Martine, L1
Grégoire, S1
Vasku, G1
Berdeaux, O1
Béduneau, A1
Pellequer, Y1
Jamoussi, J1
Desrumeaux, C1
Aho, S1
Bron, AM1
Acar, N1
Creuzot-Garcher, C1
Gabrielle, PH1
Muñoz-Negrete, FJ3
Aguado-Casanova, V1
Huelin, FJ1
Rebolleda, G3
Helmers, G1
Munteanu, C1
Löw, U1
Seitz, B1
Fan Gaskin, JC1
Kong, RCK1
Shah, MH1
Edgley, AJ1
Peshavariya, HM1
Chan, EC1
Malyugin, BE1
Sidorova, AV1
Starostina, AV1
Zhuravlev, AS1
Khaletskaya, AA1
Eliseeva, MA1
Smirnova, EA1
Senthilkumar, VA1
Puthuran, GV1
Tara, TD1
Nagdev, N1
Ramesh, S1
Mani, I1
Krishnadas, SR2
Lee, JY1
Wu, J1
Liu, Y1
Saraswathy, S1
Zhou, L2
Bu, Q1
Su, Y1
Choi, D1
Park, E1
Strohmaier, CA1
Weinreb, RN2
Hong, YK1
Pan, X1
Huang, AS1
Mambo, Y1
Higashide, T5
Ohkubo, S4
Udagawa, S1
Yamashita, Y1
Tsuchiya, S1
Okayama, M1
Wajima, R1
Sugiyama, K6
Khairy, MA1
Kenawy, S1
Fawzi, KM1
Al-Nashar, HY1
Vinokurtseva, A2
Armstrong, JJ2
Liu, H2
Hutnik, CML2
Kankainen, T1
Harju, M1
Mizuno, Y1
Okada, N1
Onoe, H1
Tokumo, K1
Okumichi, H1
Hirooka, K3
Kiuchi, Y4
Weber, C3
Brinken, R3
Holz, FG3
Cutolo, CA3
Bonzano, C3
Catti, C3
Pizzorno, C3
Bagnis, A3
Traverso, CE3
Iester, M4
Gupta, VP3
Beri, N3
Rohatgi, J3
Balekudaru, S5
Shah, D3
Lingam, V5
George, R4
George, AE4
Ganesh, SK4
Biswas, J5
Dutta Majumder, P3
Baskaran, M3
Burgos-Blasco, B1
García-Feijóo, J1
Gines-Gallego, C1
Perucho-Gonzalez, L1
Fernandez-Vigo, JI1
Martinez de la Casa, JM1
Saenz-Frances, F1
Morales-Fernandez, L1
Mendez-Hernandez, CD1
Sharma, R1
Nappi, V1
Empeslidis, T1
Winuntamalakul, Y1
Chansangpetch, S2
Ratanawongphaibul, K1
Itthipanichpong, R1
Manassakorn, A2
Tantisevi, V2
Rojanapongpun, P2
Vinod, K3
Prum, BE2
Seuthe, AM1
Erokhina, M1
Szurman, P1
Haus, A1
Lüke, JN1
Enders, P1
Lappa, A1
Upaphong, P1
Pathanapitoon, K1
Chaidaroon, W1
Teplitsky, JE1
Denstedt, J1
Yüksel, R1
Yüksel, N1
Yazır, Y1
Öztürk, A2
Furat Rençber, S1
Demirci Küçük, K1
Angmo, D1
Mahalingam, K1
Gowtham, L1
Elancheliyan, P1
Velpandian, T1
Sihota, R9
Dada, T3
Yadgari, M1
Ghanbarnia, MJ1
Lee, YJ1
Ha, A1
Kang, D1
Shim, SR1
Jeoung, JW1
Park, KH3
Kim, YK1
de Waard, P1
Wubbels, RJ1
Fang, CEH1
Hakim, MT1
Siddiqui, MM1
Armstrong, D1
Shankar, V2
Kim, NE1
Kim, SS1
Lee, JS1
Lee, K1
Bae, HW2
Lee, SY1
Choi, W1
Kim, CY2
Ramesh, PV1
Ramesh, SV1
Kodnani, A1
Velumani, V1
Sainath, D1
Pannerselvam, P1
Strzalkowska, A1
Strzalkowski, P2
Hoffmann, EM5
Pfeiffer, N4
Schuster, AK1
Sun, CQ1
McSoley, MJ1
Lum, F1
Chang, TC1
Vanner, EA1
Seresirikachorn, K1
Thiamthat, W1
Annopawong, K1
Wanichwecharungruang, B1
Friedman, DS2
Vu, DM1
Hwang, SY1
Ahn, HB2
Jin, SW1
Baeg, JY1
Choi, HS1
Lee, SH1
Majtanova, N1
Keri, P1
Kriskova, P1
Kurilova, V1
Cholevik, D1
Majtan, J1
Kolar, P1
Lenzhofer, M2
Strohmaier, C1
Hohensinn, M1
Hitzl, W1
Steiner, V1
Baca, B1
Moussa, S1
Motloch, K1
Reitsamer, HA1
Salimi, A1
Kovalyuk, N1
Harasymowycz, PJ2
Arimura, S1
Iwasaki, K1
Gozawa, M1
Takamura, Y1
Inatani, M4
Ahmed, IIK3
Elgin, U3
Sen, E2
Ozdemir, K1
Ozdal, P1
Berker, N2
Nemoto, E1
Kojima, S2
Sugiyama, T1
Jin, D1
Takai, S1
Maeda, M1
Kohmoto, R1
Ueki, M1
Oku, H1
Ikeda, T1
Grover, DS4
Kornmann, HL3
Fellman, RL4
Sakurai, Y1
Takayama, K1
Abe, T2
Takeuchi, M1
Chan, PP1
Wong, LYN1
Chan, TCY1
Lai, G1
Baig, N1
Chu, CK1
Liebmann, JM7
Cioffi, GA2
Blumberg, DM1
Al-Aswad, LA1
Lim, MC1
Hom, B1
Watnik, MR1
Altman, AR1
Paul, T1
Tong, MG1
Seth, PK1
Sharma, S2
Martins, TGDS1
Halili, A1
Kessel, L1
Subhi, Y1
Bach-Holm, D1
Venkataraman, P1
Manapakkam, M1
Mohan, N1
Rolim-de-Moura, C1
Esporcatte, BLB1
F Netto, C1
Paranhos, A1
de Oliveira, CM1
Ferreira, JLM1
Hengerer, F1
Klabe, K1
Schargus, M1
Thieme, H1
Voykov, B1
Gagrani, M1
Garg, I1
Ghate, D2
Craig, JE1
Adachi, K1
Asada, Y1
Hirakata, T1
Onoue, M1
Iwamoto, S1
Kasuga, T1
Matsuda, A1
El Maamoun, TA1
Shalaby, HS2
Chiu, HI1
Su, HI1
Ko, YC1
Liu, CJ1
Bedar, MS1
Kellner, U1
Wolters, JEJ1
Al Majidi, R1
Pinchuk, L2
Klapstova, A1
Horakova, J1
Tunak, M1
Shynkarenko, A1
Erben, J1
Hlavata, J1
Bulir, P1
Chvojka, J1
Gurney, SP1
Ahmad, M1
Makanjuola, T1
Ramm, L1
Parulekar, MV1
Khan, SA1
Whittaker, K1
Razzaq, MA1
Arain, UR1
Swogger, J1
Conner, IP1
Happ-Smith, C1
Kemmerer, MC1
Julian, DR1
Davis, R1
Wells, A1
Schuman, JS5
Yates, CC1
Sayed, KM1
Inobhas, A1
Ho, DCW1
Perera, SA3
Hla, MH1
Ho, CL3
Kasar, K1
Demir, T3
Akin, MM2
Gungor Kobat, S1
Lim, FPM1
Rattanasirivilai, P1
Ali, ZC1
Khoo, DI1
Promelle, V1
Lyons, CJ1
Almobarak, FA3
Alharbi, AH3
Aljadaan, I3
Aldhibi, H1
Dangeti, D1
Battula, M1
Hashem, NH1
Kong, YXG1
Chung, IY1
Ang, GS3
Desai, R1
Jampol, LM1
Selvan, H1
Azmira, K1
Sharma, A2
Gupta, A3
Upadhyay, A1
Komae, K1
Takamoto, M1
Tanaka, R1
Aihara, M1
Ohtomo, K1
Okinaga, K1
Matsuda, J1
Nakahara, H1
Fujino, Y1
Kaburaki, T2
Schlenker, MB1
Gulamhusein, H1
Conrad-Hengerer, I1
Somers, A1
Stalmans, I5
Reitsamer, H1
Hengerer, FH1
Bayoumi, NH2
Chong, RS1
Lee, YS1
Wong, TTL1
Gollakota, S1
Garudadri, CS3
Mohamed, A1
Sobeih, DH1
Cotran, PR1
Abe, RY1
Shigueoka, LS1
Vasconcellos, JPC1
Costa, VP5
Nikita, E1
Murdoch, I1
Wasielica-Poslednik, J1
Schmeisser, J1
Weyer-Elberich, V1
Bell, K1
Lorenz, K1
Castejón, MA1
Teus, MA4
Bolivar, G1
Paz-Moreno-Arrones, J1
Castaño, B1
Quist, MS1
Brown, N1
Bicket, AK1
Herndon, LW6
Drury, B1
Bhargava, A1
Fenerty, C1
Alizadeh, R1
Akil, H1
Tan, J1
Law, SK7
Caprioli, J6
Pimentel, E1
Schmidt, J1
Klezlova, A1
Liebezeit, S1
Prokosch-Willing, V2
Gericke, A1
Lamparter, J1
Ul Hassan, SN1
Toshev, AP1
Shi, W3
Brandt, J1
Kerr, NM1
Wang, J1
Sandhu, A1
Hsu, CR1
Chen, YH2
Tai, MC1
Lu, DW1
Chen, HJ1
Lin, C1
Lee, CH1
Thakur, SKD1
Fili, S1
Seddig, S1
Kohlhaas, M1
Sarker, BK1
Abdullahi, SM1
Hassan, Z1
Kabir, J1
Badmus, S1
Alam, S1
Rahman, M1
Malek, MI1
Mahatma, M1
Koike, KJ1
Chang, PT1
Nguyen, AH1
Fatehi, N1
Romero, P1
Miraftabi, A1
Kim, E1
Morales, E1
Giaconi, J1
Coleman, AL2
Nouri-Mahdavi, K3
Palmberg, P1
Rangel, HMDA1
Rolim, HT1
Vidigal, P1
Araújo, ID1
Cronemberger, S2
Lin, S1
Byles, D1
Smith, M2
Abdalrahman, O1
Rodriguez, AE1
Alio Del Barrio, JL1
Alio, JL1
Penaud, B1
Leleu, I1
Laplace, O1
Akesbi, J1
Blumen-Ohana, E1
Nordmann, JP1
Nishino, T1
Sakaguchi, K1
Yamada, Y1
Esfandiari, H2
Loewen, NA2
Hassanpour, K2
Fatourechi, A2
Yazdani, S4
Wang, C2
Yaseri, M3
Pakravan, M4
Fang, C1
Ma, N1
Qian, L1
Rajendrababu, S1
Shroff, S1
Patil, SV1
Uduman, MS1
Vardhan, A1
Artini, W1
Bani, AP1
Dong, A1
Han, L1
Shao, Z1
Fan, P1
Zhou, X1
Yuan, H1
Waibel, S1
Spoerl, E1
Furashova, O1
Pillunat, LE1
Pillunat, KR1
Lommatzsch, C1
Heinz, C2
Rothaus, K1
Koch, JM1
Swann, FB1
Singh, S1
Blake, D1
John, V1
Le, C1
Fullerton, M1
Margo, C1
Zhang, Z2
Muddasani, N1
Wall, J1
Satija, C1
Greenberg, E1
Mancera, N1
Zurakowski, D3
Ayyala, RS4
Wlaź, A1
Wilkos-Kuc, A1
Rozegnał-Madej, A1
Żarnowski, T3
El Mazar, HM1
Mandour, SS2
Mostafa, MI1
Elmorsy, OA1
Foo, VHX1
Htoon, HM2
Welsbie, DS1
Wadke, V1
E Graf, N1
Müller, M1
Gerlach, F1
M Meyer, L1
Philipp, S1
Distelmaier, P1
Klink, T1
Schönfeld, CL1
Nakakura, S1
Noguchi, A1
Tanabe, H1
Tabuchi, H1
Asaoka, R1
Chan, G1
Coste-Verdier, V1
Chan, H1
Schweitzer, C1
Delyfer, MN1
Korobelnik, JF1
Yuasa, Y1
Sugimoto, Y2
Anand, N11
Bong, C1
El Sayed, Y1
Awadein, A2
Singh, D1
Chandra, A1
Gupta, V3
Khan, N1
Khaleque, MA1
Hossain, MS1
Islam, MS1
Uddin, MS1
Butler, MR1
Prospero Ponce, CM1
Weinstock, YE1
Orengo-Nania, S2
Chevez-Barrios, P1
Frankfort, BJ1
Ono, T2
Yuki, K2
Ozeki, N1
Shiba, D2
Tsubota, K3
Zarbin, MA1
Liu, W1
Xing, X1
Liu, A1
Ji, J1
Merritt, SR1
Velasquez, G1
von Recum, HA1
Awai-Kasaoka, N2
Inoue, T5
Takihara, Y2
Ogata-Iwao, M2
Tanihara, H8
Eslami, Y1
Samarai, V1
Mohammadi, M1
Fakhraie, G1
Zarei, R1
Eslami, S1
Moghimi, S1
Wiese, K1
Heiligenhaus, A1
Rao, A1
Chatterjee, S1
Kouyama, K1
Netland, PA3
Sarkisian, SR3
Moster, MR7
Condon, G1
Salim, S2
Sherwood, MB9
Siegfried, CJ1
Olawoye, O1
Lee, M1
Kuwayama, Y6
Kee, C4
Johnson, MS1
De Fendi, LI1
Arruda, GV1
Scott, IU4
Paula, JS1
Pérez-Rico, C2
Gutiérrez-Ortíz, C2
Moreno-Salgueiro, A2
González-Mesa, A2
Susanna, R4
De Moraes, CG4
Alencar, LM1
Ritch, R11
Dulku, S2
Kivelä, T1
Kujala, E1
Forsman, E1
Vesti, E1
Yamamoto, T11
Sawada, A3
Mayama, C1
Araie, M4
He, M1
Wang, W2
Zhang, X3
Huang, W2
Kwong, A1
Kule, RR1
Giaconi, JA1
Saheb, H1
Schiffman, JC9
Leahy, K1
Whittles, W1
White, A1
Yip, KP1
Ngai, LY1
Kumarasamy, M1
Tulidowicz-Bielak, M2
Tomaszewska, J1
Kosior-Jarecka, E2
Napoli, PE1
Zucca, I1
Fossarello, M1
Ma, J1
Li, X3
Zhang, W1
Huang, L1
Chen, M1
Xi, L2
Duan, L1
Quan, D2
Ge, J3
Kawaji, T1
Hara, R1
Eiki, D1
Ando, Y1
Turgut, B1
Eren, K1
Kobat, S1
Sagara, H1
Sekiryu, T1
Noji, H1
Ogasawara, M1
Sugano, Y1
Horikiri, H1
Menda, SA1
Lowry, EA1
Porco, TC2
Stamper, RL4
Rubin, MR1
Han, Y3
Wang, T1
Zhao, F1
Zheng, Q1
Luo, J1
Liu, J1
Zhou, M1
Sethi, P1
Patel, RN1
Goldhardt, R1
Koukkoulli, A1
Musa, F1
Naruo-Tsuchisaka, A1
Maruyama, K1
Arimoto, G1
Goto, H1
Mandalos, A1
Tailor, R1
Parmar, T1
Sung, V1
Gutierrez Ortiz, C1
Vaiano, AS1
Salgarello, T2
Giudiceandrea, A1
Riso, M1
Sammarco, MG1
Caramello, G1
Sangtam, T1
Mermoud, A8
Karolina, C1
Baril, C1
Bourret-Massicotte, D1
Anctil, JL1
Caron, L1
Goyette, A1
Des Marchais, B1
Rafuse, PE1
Martín Giral, E1
Rivera Zori, M1
Perucho Martínez, S1
Toledano Fernández, N1
Nakashima, K1
Fukushima, A1
Hirakawa, S1
Yun, ST1
Chua, B1
Clement, CI1
Wang, X1
El Sayed, YM1
Arnalich-Montiel, F1
Casado, A1
Olayanju, JA1
Hassan, MB1
Hodge, DO1
Khanna, CL1
Lee, N1
Ma, KT1
Hong, S1
Seong, GJ1
Hong, YJ1
Chandran, P1
Choudhari, NS1
Mahboobipour, H1
Doozandeh, A1
Ghahari, E1
Van Bergen, T2
Vandewalle, E2
Moons, L2
Kaplan, A1
Kocatürk, T1
Dayanır, V1
Takahashi, N1
Mochizuki, K2
Katada, T1
Jayaram, H1
Scawn, R1
Pooley, F1
Chiang, M1
Bunce, C4
Strouthidis, NG1
Khaw, PT15
Papadopoulos, M1
Shevade, B1
Riss, I1
Batlle, J1
Kato, YP1
Weber, BA1
Parel, JM1
Michael, KB1
Montgomery, DM2
Li Yim, JF1
Martorana, GM1
Schaefer, JL1
Levine, MA3
Lukowski, ZL3
Min, J3
Meyers, CA3
Schultz, GS4
Mochizuki, H1
Scuderi, G1
Iacovello, D1
Pranno, F1
Plateroti, P1
Scuderi, L1
Cabourne, E1
Clarke, JC1
Schlottmann, PG1
Evans, JR1
David, RL1
George, RJ1
Al-Haddad, C1
Abdulaal, M1
Al-Moujahed, A1
Ervin, AM1
Kinast, RM1
Akula, KK1
Mansberger, SL1
Barker, GT1
Gardiner, SK1
Whitson, E1
DeBarber, AE1
Amoozgar, B1
Lin, SC3
Kuo, J1
Panarelli, JF2
Banitt, MR1
Cheng, JW1
Cheng, SW1
Wei, RL1
Lu, GC1
Koh, V1
Tatsios, J1
Chew, PT3
Amrith, S1
Dunn, HP1
Zheng, L1
White, AJ1
Healey, PR2
Morales, J3
Singh, P1
Kunhammad, S1
Huang, G1
Sidoti, PA4
Wang, BZ1
Meagher, P1
Liu, X2
Du, L1
Li, N1
Kashiwagi, K1
Kogure, S1
Mabuchi, F1
Chiba, T1
Issa de Fendi, L1
Cena de Oliveira, T1
Bigheti Pereira, C1
Pereira Bigheti, C1
Viani, GA1
Cui, QN1
Hsia, YC1
Rose-Nussbaumer, J1
Mehta, N1
Naseri, A1
Yang, K1
Jin, L1
Li, L1
Zeng, S3
Wei, R1
Li, G2
Man, P1
Congdon, N2
Jonckx, B1
Feyen, JH1
Schultheiss, M1
Schnichels, S1
Konrad, EM1
Bartz-Schmidt, KU1
Zahn, G1
Caldirola, P1
Fsadni, MG1
Caram-Lelham, N1
Spitzer, MS1
Ding, C1
Tanna, AP1
Rademaker, AW1
Godfrey, DG1
Vold, SD1
Rosentreter, A1
Bula, AM1
Alnawaiseh, M1
Rodriguez-Una, I1
Rotchford, AP1
Nash, DL1
Crouch, ER3
Suh, W2
Han, KE1
Han, JR1
Minckler, DS5
Francis, BA3
Hodapp, EA1
Jampel, HD4
Samples, JR1
Smith, SD1
Singh, K7
Alvarado, JA1
Hollander, DA1
Juster, RP1
Lee, LC1
Al Obeidan, SA1
Osman, EA1
Al-Muammar, AM1
Abu El-Asrar, AM1
Onol, M3
Aktaş, Z1
Hasanreisoğlu, B3
Giampani, J1
Borges-Giampani, AS1
Carani, JC1
Oltrogge, EW1
Siriwardena, D2
Georgoulas, S1
Dahlmann-Noor, A1
Brocchini, S1
Palanca-Capistrano, AM2
Hall, J1
Cantor, LB2
Morgan, L1
Hoop, J3
WuDunn, D3
Lim, LA1
Chindasub, P1
Kitnarong, N1
Kashkouli, MB1
Parvaresh, MM1
Mirzajani, H1
Astaraki, A1
Falavarjani, KG1
Ahadian, A1
Takagishi, M1
Baba, T1
Takenaka, H1
Shiraga, F1
Rauscher, FM1
Lee, RK1
Saricaoglu, MS2
Kalayci, D1
Guven, D1
Karakurt, A2
Hasiripi, H1
Shahabi, C1
Chin, S1
Yoshida, K1
Shinmei, Y1
Aoyagi, M1
Saito, A1
Ohno, S1
Lee, E1
Doyle, E1
Jenkins, C1
Palmiero, PM2
Tello, C3
Liebmann, J2
Khan, A1
Hau, S1
Okuda, T1
Fukuhira, Y1
Sumi, Y1
Shimomura, M1
Budenz, DL10
Radcliffe, N1
Blumenthal, EZ1
Liang, SY1
Whitehead, K1
Macdonald, E1
Mukherjee, S1
Jay, J1
Koshino, T1
Kawashima, H1
Numaga, J1
Tomidokoro, A1
Shirato, S1
Al-Mobarak, F1
Khan, AO1
Singh, M1
See, JL1
Aquino, MC1
Thean, LS1
Elner, VM2
Newman-Casey, PA1
Patil, AJ1
Flint, A1
Moroi, SE2
Pushparaj, V1
Edward, DP1
Sbeity, Z1
Goodkin, ML1
Grewal, DS1
Greenfield, DS9
Carpineto, P1
Agnifili, L1
Nubile, M1
Fasanella, V1
Doronzo, E1
Mastropasqua, A1
Ciancaglini, M1
Srinivasan, G1
Heuer, DK4
Parrish, RK5
Folgar, FA1
Teng, CC1
Nakano, N1
Hangai, M2
Nakanishi, H1
Inoue, R1
Unoki, N1
Hirose, F1
Ojima, T1
Yoshimura, N1
Breusegem, C1
Spielberg, L1
Van Ginderdeuren, R1
Renier, C1
Van de Veire, S1
Fieuws, S1
Zeyen, T2
Mahdy, RA1
Nada, WM1
Almasalamy, SM1
Anany, HA1
Almasary, AM1
Coppens, G1
Maudgal, P1
Crowston, JG1
Wells, AP3
Bissig, A1
Feusier, M1
Roy, S2
Lusthaus, JA1
Kubay, O1
Karim, R1
Wechsler, D3
Booth, F1
Razeghinejad, MR1
Nowroozzadeh, MH1
Emarah, AM1
El-Helw, MA1
Kim, TH2
Oh, HC1
Yoo, YH2
Rho, JH2
Park, WC2
Jeung, WJ1
Rho, SH2
Balikoglu-Yilmaz, M1
Bozdag-Pehlivan, S1
Sungu, N1
Aksakal, FN1
Altinok, A1
Tuna, T1
Unlu, N1
Ustun, H1
Koklu, G1
Öztürk, F1
Maestrini, HA1
Matoso, HD1
Reis, JR1
Mérula, RV1
Filho, AD1
Diniz, AF1
Sakurai, E1
Ferreira, GA1
Ye, H1
Qian, Y1
Lin, M1
Duan, Y1
Sun, X1
Zhuo, Y1
Chakrabarti, D1
Stead, RE1
Knape, RM1
Smith, MF6
Bochmann, F1
Kaufmann, C1
Becht, CN1
Guber, I1
Kaiser, M1
Bachmann, LM1
Thiel, MA1
Swinnen, S1
Stalmans, A1
Zhong, H1
Sun, G1
Lin, X1
Wu, K1
Yu, M1
Supawavej, C1
Ziakas, NG1
Kanonidou, ED1
Boboridis, KG1
Hong, B1
Winarko, J1
Kawji, S1
Dustin, L1
Chopra, V1
Cillino, S2
Di Pace, F2
Cillino, G1
Casuccio, A2
Beattie, AR2
Stoller, G1
Samuelson, DA2
Levkovitch-Verbin, H3
Katz, G1
Kalev-Landoi, M1
Goldenfeld, M2
Cankaya, AB1
Rai, P1
Kotecha, A1
Kaltsos, K1
Ruddle, JB1
Murdoch, IE2
Arslan, S1
Aydemir, O1
Güler, M1
Dağlı, AF1
Boey, PY1
Mehta, JS2
Tan, DT1
SooHoo, JR1
Seibold, LK1
Laing, AE1
Kahook, MY1
Stahnke, T1
Löbler, M1
Kastner, C1
Stachs, O1
Wree, A1
Sternberg, K1
Schmitz, KP1
Guthoff, R1
Bae, K1
Yang, J1
Sun, P1
Zhang, Y1
Sun, N1
Marey, HM1
Ellakwa, AF1
Sponsel, WE1
Groth, SL1
de Klerk, TA1
Moriarty, AP1
Min, JK1
Kee, CW1
Sohn, SW1
Lee, HJ1
Woo, JM2
Yim, JH1
Narayanaswamy, A1
Hoh, ST1
Seah, SK2
Aung, T1
Biteli, LG1
Ceballos, EM1
Beck, AD4
Lynn, MJ2
Taglia, DP1
Perkins, TW5
Gangnon, R3
Heatley, GA3
Kaufman, PL5
Jiang, B1
Jiang, YQ1
Celis Sánchez, J1
López Ferrando, N1
García Largacha, M1
González del Valle, F1
Ortiz de la Torre, MJ1
Ravinet, E1
Krommes, G1
Lieb, W1
Grehn, F2
Price, FW1
Nguyen, QH2
Feuer, W1
Nicolela, MT4
Bueche, M1
Palmberg, PF7
Alvi, NP1
Finley, C1
Lakhani, V1
Burnstein, A1
Knotts, SL1
Lubomski, LH1
Kempen, JH1
Quigley, H1
Robinson, KA1
Bass, EB1
Kim, C2
Kim, Y1
Choi, S1
Lee, S1
Ahn, B1
Bagga, H1
Nutheti, R1
Nanda, AK1
Peng, D1
Zheng, J1
Beckers, HJ1
Kinders, KC1
Webers, CA2
Ng, PW2
Yeung, BY2
Yick, DW2
Tsang, CW1
Lam, DS3
Georgopoulos, M3
Vass, C4
Vatanparast, Z2
Jordan, JF1
Mac, I1
Soltau, JB1
Hill, R1
Ohanesian, R1
Voskanyan, L1
Malayan, A1
Akarsu, C2
Ellingham, RB1
Morgan, WH1
Westlake, W1
House, PH1
Feng, Y1
Duan, X1
Jiang, Y2
Qing, G1
Fu, P1
Li, M1
Akyol, N1
Kükner, A1
Colakoğlu, N1
Laube, T1
Ritters, B1
Selbach, M1
Hudde, T1
Cordeiro, MF2
Fagerli, M1
Løfors, KT1
Elsås, T1
Willoch, CM1
Nicolaissen, B1
Hirata, A1
Kimura, A1
Sonoda, S1
Freedman, S2
Kammer, J1
Jin, J1
Shin, DB1
Lee, SB1
Kim, CS1
Higginbotham, EJ5
Yoon, KC2
Yang, KJ2
Seo, JS1
Lee, SE1
Heo, T1
Chun, BJ1
Jung, S1
Kim, KK1
Ahn, KY1
Heatley, G2
Kiland, J1
Faha, B1
Seeman, J1
Schlamp, CL1
Dawson, DG1
Gleiser, J1
Maneval, D1
Nickells, RW1
Yoon, PS1
Seo, MS1
Park, YG1
Rodrigues, AM1
Júnior, AP1
Montezano, FT1
de Arruda Melo, PA1
Prata, J1
Oyakhire, JO1
Azuara-Blanco, A5
Lesk, MR2
Arcieri, ES1
Oguz, H2
Hooi, ST1
Hooi, SH1
Fraser, S1
Edmunds, B1
Wormald, RP1
Muckley, ED1
Lehrer, RA1
Alwitry, A1
Patel, V1
King, AW1
Zaleska-Zmijewska, A2
Szaflik, J2
Klimczak-Slaczka, D1
Grałek, M1
Chipczyńska, B1
Kanigowska, K1
Grigorian, AP1
Spaeth, G1
Yalvac, IS2
Sungur, G1
Turhan, E1
Eksioglu, U1
Duman, S3
Alzafiri, Y1
Harasymowycz, P1
Shetty, RK1
Wartluft, L1
Ehrlich, R1
Snir, M1
Lusky, M1
Weinberger, D1
Friling, R1
Gaton, DD1
Du, LT1
Najafi, K1
Murthy, R1
Kurumety, U1
Rao, N1
Joshi, AB1
Feuer, WF1
Atherley, C1
Kano, K2
Mizunoya, H1
Al-Hazmi, A1
Awad, A1
Zwaan, J2
Al-Mesfer, SA1
Al-Jadaan, I1
Al-Mohammed, A1
Sony, P1
Maquet, JA1
Dios, E1
Aragón, J1
Bailez, C1
Ussa, F1
Laguna, N1
Collignon, NJ1
Watson, JC1
Kadri, OA1
Wilcox, MJ1
Agarwal, HC4
Saigal, D1
Mead, AL1
Funnell, CL1
Clowes, M2
Mietz, H11
Roters, S1
Krieglstein, GK12
Vysniauskiene, I1
Shaarawy, T3
Flammer, J4
Haefliger, IO1
Mansury, AM1
Vasudev, D1
Detry-Morel, M1
Pourjavan, S1
Teoh, SC1
Lee, JJ2
Fam, HB1
Sengun, A1
Colluoglu, Z1
Novak-Laus, K1
Mandić, Z1
Iveković, R1
Korsić, J1
Tedeschi-Reiner, E1
Masnec-Paskvalin, S1
Bojić, L1
Modjtahedi, SP1
Mansury, A1
Wilkins, M2
Indar, A2
Wormald, R3
Lattanzio, FA1
Mitrev, PV1
Williams, PB1
Allen, RC1
Polikoff, LA1
Taglienti, A1
Chanis, RA1
Ramos-Esteban, JC1
Donas, N1
Tsong, J1
Gagliuso, DJ1
Danias, J1
Serle, JB1
Ashraff, NN1
Hall, RC1
Purdie, G1
Arora, S2
Lin, YC1
Kau, HC1
Kao, SC1
Hsu, WM1
Tsai, CC1
Leung, DY1
Kwong, YY1
Yuen, HK1
Murthy, SK1
Damji, KF1
Pan, Y1
Hodge, WG1
Abraham, LM1
Selva, D1
Casson, R2
Leibovitch, I1
Kessing, SV1
Flesner, P1
Jensen, PK1
Cabarga, C1
Shingleton, BJ3
Price, RS1
O'Donoghue, MW2
Anis, S1
Shihadeh, W1
Mansouri, K1
Wedrich, A1
Blake, DA1
Sahiner, N1
John, VT1
Clinton, AD1
Galler, KE1
Walsh, M1
Arosemena, A1
Johnson, PY1
Kasner, O1
Park, UC1
Ahn, JK1
Yu, HG1
Ben Simon, GJ1
Glovinsky, Y1
Maurino, V2
Patel, H1
Kirwin, J1
Adjadj, E1
Zimmermann, C1
Drewe, J1
Zheng, K1
Huang, Z1
Zou, H1
Li, H1
Huang, Y1
Xie, M1
Wang, L1
Zhang, P1
Lin, J1
Jamil, AL1
Mills, RP1
Cabarga del Nozal, C1
Batman, A1
Soykan, E1
Chakraborty, D1
Dutta Choudhury, B1
Goldberg, I1
Noble, J1
Derzko-Dzulynsky, L1
Rabinovitch, T1
Birt, C1
Ramamurthi, S1
Girma, T1
Courtright, P1
Mengistu, F1
Tamirat, T1
Birhanu, Z1
Anand, S1
Dubey, S1
Agarwal, M1
Sathyan, P2
Singh, G2
Eong, KG1
Raman, GV1
Prashanth, S1
Kyprianou, I1
Nessim, M1
Kumar, V1
O'Neill, E1
Labbé, A1
Khammari, C1
Baudouin, C1
Ehongo, A1
Bremer, F1
Herndon, L1
Smiddy, W1
Zeppa, L1
Morreale, D1
Bocchetta, F1
Lodato, G1
Mohammadpour, M1
Jabbarvand, M1
Javadi, MA1
Leszczyński, R1
Gierek-Ciaciura, S1
Forminśka-Kapuścik, M1
Mrukwa-Kominek, E1
Rokita-Wala, I1
Wishart, PK1
Kim, SW1
Lee, DJ1
Park, JM1
Jeong, WJ1
Singh, J1
O'Brien, C1
Chawla, HB1
Diestelhorst, M5
Glover, TL1
Nasisse, MP1
Davidson, MG1
Annen, DJ1
Stürmer, J1
Dreyer, EB2
Chaturvedi, N1
Bazin, S1
Williamson, W1
Poirier, L1
Ducousso, F1
Ballion, JC1
Verin, P1
Magauran, RG1
Betchkal, J1
Doyle, JW6
Gray, TB1
Munden, PM1
Alward, WL4
Joos, KM2
Bueche, MJ1
Grajewski, AL1
Mégevand, GS1
Salmon, JF5
Scholtz, RP1
Murray, AD4
Cardakli, UF1
Eisele, JR1
Nuyts, RM2
Van Diemen, HA1
Greve, EL2
Lee, DA3
Takahashi, WY1
Duker, JS1
Shin, DH2
Tsai, CS1
Kupin, TH2
Olivier, MM2
Ichien, M1
Suemori-Matsushita, H1
Kitazawa, Y6
Gaspar, AZ2
Orgül, S1
Felten, PC1
Pels, E1
Langerhorst, CT1
Geijssen, HC1
Grossniklaus, HE1
Rozsíval, P1
Liehneová, I1
Karp, CL1
Griffin, EO1
Choi, WS1
Park, SJ1
Kim, DM2
Haynes, WL2
McKinney, JK1
Collignon-Brach, J1
Hong, C1
Hyung, SM4
Song, KY1
Youn, DH3
Ramakrishnan, R1
Michon, J1
Robin, AL2
Krishnadas, R1
Shields, MB2
Scroggs, MW1
Sloop, CM1
Simmons, RB2
Skuta, GL4
Wand, M2
Sood, NN2
Kaur, J1
Dogra, A1
Wilson, RP6
Schmidt, CM5
Gandham, S1
Prata, JA2
Koda, RT1
Baerveldt, G3
Lee, PP2
Wise, JB1
Pappa, KS1
Derick, RJ2
Weber, PA1
Kapetansky, FM1
Baker, ND2
Lehmann, DM1
Zacharia, PT3
Deppermann, SR1
Bank, A1
Allingham, RR2
Sarraf, D1
Eezzuduemhoi, RD1
Cheng, Q2
Wilson, MR1
Grierson, I2
Schultz, G1
McGorray, S3
Kawase, K1
Nishimura, K1
Jikihara, S1
Keller, C1
To, K1
Spaeth, GL5
Eiferman, RA1
Barron, A2
Straker, C1
Hung, PT1
Lin, LL1
Hsieh, JW1
Wang, TH1
Morinelli, EN1
LaBree, L1
Rump, AF2
Biederbick, W1
Botvinik-Helling, S1
Stemmler, M1
Schierholz, J1
Conrady, S1
Matthey, B1
Theisohn, M2
Gelber, EC1
Caronia, RM1
Friedman, R1
Cohen, H1
Stevens, RK1
Musch, DC3
Karp, KO1
Lichter, PR2
Bergstrom, TJ3
Katz, LJ2
Miller, MP3
Suner, IJ3
Kangas, TA1
Flynn, HW2
Merkli, A1
Heller, J1
Tabatabay, C1
Gurny, R1
Arnold, G1
Kirchhof, B1
Choi, MY2
Wu, L1
Yin, J1
Zhang, M1
Wei, H1
Mai, C1
Fan, Z1
Hu, Y2
Comegno, PE1
Vasconcelos, JP1
Malta, RF1
José, NK1
Taniguchi, T1
Haque, MS1
Yokoi, N2
Komuro, A2
Kinoshita, S2
Kiremitçi-Gümüşderelioglu, M1
Gökçe, M1
Akata, RF1
Hendrickson, P1
Gebhardt, DO1
Figueiredo, RS1
Araujo, SV1
Cohen, EJ1
Rapuano, CJ1
Cohen, JS2
Greff, LJ1
Novack, GD1
Wind, BE1
Mardelli, PG1
Lederer, CM1
Murray, PL1
Pastor, SA1
Hassanein, KM1
Hagiwara, Y1
Cheung, JC1
Wright, MM2
Murali, S1
Pederson, JE2
Masuda, K1
Berestka, JS1
Brown, SV1
Bair, JS2
Chen, CW2
Katz, GJ1
Johnson, AT1
Fourman, S1
Sakuma, T1
Belyea, DA2
Dan, JA2
Lieberman, MF2
Mehel, E2
Weber, M2
Stork Vabres, L1
Pechereau, A2
Carlson, DW1
Barad, JP1
Zimmerman, MB1
Carney, BL1
Vijaya, L1
Madhavan, HN1
Honda, Y3
Matsuda, T1
Chihara, E1
McGehee, RF1
Walton, DS1
John, T1
Jayagandan, A1
Spencer, WH1
Constable, PH1
Alexander, RA1
Bhattacharya, SS1
Tezel, G2
Kolker, AE2
Kass, MA2
Wax, MB2
Gupta, N1
Kang, SW1
Iliev, ME1
van der Zypen, E1
Frankhauser, F1
England, C1
Nuijts, RM1
Vernimmen, RC1
Buffenn, AN1
Saetre, SB1
Kincaid, MC1
Bond, JB1
Melamed, S1
Ram, J1
Mizoguchi, T1
Matsumura, M1
Kadowaki, H1
Kuroda, S1
Terauchi, H1
Nagata, M1
Lee, D1
Birt, CM1
Khatana, AK1
Reed, SY1
Waheed, S1
Ritterband, DC1
Sanga, L1
Honavar, SG2
Kasahara, N1
Smith, TJ1
Sibayan, SA1
Montenegro, MH1
Simmons, RJ1
Klaus, W1
Wallace, DK1
Plager, DA1
Snyder, SK1
Raiesdana, A1
Helveston, EM1
Ellis, FD1
Khoury, JM1
Shen, JH1
Davis, D1
O'Day, DM1
Stone, RT1
Chang, MR1
Schiffman, J1
Rueda, JC1
Tsai, JC2
Sharma, T1
Ladd, W2
Libby, CM1
Jee, J1
Harrison, DA1
Wheeler, DT1
Colotto, A1
Falsini, B1
Cesari, L1
Cermola, S1
Iarossi, G1
Scullica, L1
Good, D1
Moon, JI1
Beatty, S1
Potamitis, T1
Kheterpal, S1
O'Neill, EC1
Sano, T1
Fukuchi, T1
Sawaguchi, S1
Hara, H1
Watanabe, J1
Oota, A1
Shirakashi, M1
Abe, H1
Lai, JS1
Chua, JK1
Fan, DS1
Pieroth, L1
Vinals, AF1
Goldstein, MH1
Cooper, ML1
Mattox, C1
Frangie, JP1
Wu, HK1
Katz, SE1
Edelman, RE1
Lubow, M1
Cantor, L1
Burgoyne, J1
Sanders, S1
Bhavnani, V1
Brizendine, E1
Evans, J1
Menapace, R1
Strenn, K1
Rainer, G1
Jacobi, PC2
Chen, PP2
Basich, FM1
Khadem, E1
Nurözler, A1
Kahraman, C1
Kasim, R1
Ustundag, C1
Wilson, WR1
Lynch, MG1
Noe, R1
Gammon, RR1
Avery, N1
Mintz, PD1
Trible, JR1
Brown, DB1
Honjo, M1
Stork, L1
Xia, X1
Huang, P1
Wu, Z1
Cheng, B1
Xia, L1
Goyal, M1
Majji, AB1
Sen, PK1
Naduvilath, T1
Dandona, L1
Alfonso, E1
Augsburger, JJ3
Akova, YA1
Bulut, S1
Dabil, H1
Larrosa, JM1
Polo, V1
Pinilla, I1
Pablo, LE1
Martinez, MR1
Abecia, E1
Honrubia, FM1
Gandolfi, S1
Vása, M1
Samuelson, TW4
Migdal, CS1
Mullaney, PB1
Selleck, C1
Al-Awad, A1
Al-Mesfer, S1
Ozdemir, Y1
Onder, F1
Coşar, CB1
Usubütün, A1
Kural, G1
Pyfer, M1
Gordon, J1
Piltz-Seymour, J1
Keates, EU1
Hardten, DR1
Oshima, Y1
Sakamoto, T1
Nakamura, T1
Tahara, Y1
Goto, Y1
Ishibashi, T1
Inomata, H1
Chowers, I1
Ticho, U2
Naduvilath, TJ1
Loon, SC1
Yan, L1
Zhang, S1
Dong, Q1
Solomon, A1
Frucht-Pery, J1
Francoeur, AM1
Assalian, A1
Morin, I1
Tétreault, F1
Calleja, K1
Guttman, A1
Rauth, M1
Pan, SS1
Gayton, JL1
Van Der Karr, M1
Sanders, V1
Yücel, I1
Bagci, G1
Duranoglu, Y1
Aksu, G1
Lüleci, G1
Donohue, EK1
Stefan, C1
Cucea, R1
Nevyas, JY1
Nevyas-Wallace, A1
Choe, R1
Lanzl, IM1
Dudley, D1
Aslanides, IM1
El Sayyad, F1
Belmekki, M1
Helal, M1
Khalil, M1
El-Hamzawey, H1
Hisham, M1
Gross, RL1
Belmonte, SJ1
Nakaizumi, T1
Tsuji, H1
Ahn, DG1
el Menyawi, I1
Radda, S1
Nimmerrichter, P1
Ishioka, M1
Shimazaki, J1
Yamagami, J1
Fujishima, H1
Shimmura, S1
Quigley, HA2
Buhrmann, RR1
West, SK1
Isseme, I1
Scudder, M1
Oliva, MS1
Dunn, D1
Gupta, SD1
Arora, R1
Lehmann, OJ1
Matheson, MM1
Mehta, K1
Shaikh, NM1
Baerveldt, GS1
Shaikh, S1
Yu, CB1
Rockwood, EJ1
Larive, B1
Hahn, J1
Mutsch, YA1
Rodríguez-Bermejo Guijó , C1
Manners, T1
Willies, C1
Ophir, A1
Pikkel, J1
Paciuc, M1
Velasco, CF1
Freedman, SF1
Alm, A1
Rahman, R1
Xiong, X1
Lim, BA1
Lat-Luna, M1
Chew, P1
Tan, D1
Mutlukan, E1
Doe, EA1
Imami, NR1
Johnstone, MA1
Crandall, AS1
Brown, RH1
Wolfsberger, A1
Georgopoulos, A1
Li, J1
Pang, L1
DeBry, PW1
Kaufman, P1
Brumback, LC1
You, YA1
Gu, YS1
Fang, CT1
Ma, XQ1
Yamin, M1
Quentin, CD1
Macken, PL1
Boyd, SR1
Campbell, I1
Chang, D1
Rootman, DS1
Trope, GE1
Song, A1
Chaudhry, IM1
Hwang, JM1
Michalíková, L1
Ferková, S1
Jakabovicová, E1
Strmen, P1
Pasquale, LR1
Thibault, D1
Dorman-Pease, ME1
Wilkinson, WS1
Watnick, RL1
Huang, HT1
Lee, CC1

Clinical Trials (31)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Primary Tube Versus Trabeculectomy Study[NCT00666237]Phase 4242 participants (Actual)Interventional2008-04-01Completed
Effectiveness and Safety of Trabeculectomy and Peripheral Iridectomy Plus Goniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Non-inferiority Randomized Controlled Trial[NCT05163951]88 participants (Anticipated)Interventional2022-01-05Recruiting
Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement[NCT04454138]142 participants (Actual)Observational2019-06-25Completed
Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C[NCT04750447]30 participants (Anticipated)Observational [Patient Registry]2020-11-09Recruiting
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device[NCT02016898]Phase 2100 participants (Actual)Interventional2014-03-31Completed
Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for the Treatment of Open Angle Glaucoma in Patients With Cataract - a Randomised Controlled Trial[NCT04295122]Phase 4160 participants (Anticipated)Interventional2020-03-15Not yet recruiting
Glycerin-Preserved, Human-Donor, Corneoscleral Patch Grafts for Glaucoma Drainage Devices[NCT04949347]100 participants (Actual)Observational2017-02-22Completed
Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280]37 participants (Actual)Interventional2021-01-04Completed
[NCT02665884]40 participants (Anticipated)Observational2016-02-29Not yet recruiting
A Multi Center Study Comparing the Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma[NCT00444080]120 participants (Actual)Interventional2006-10-31Completed
Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma[NCT03323138]40 participants (Anticipated)Interventional2012-07-01Recruiting
Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy[NCT03782051]81 participants (Actual)Interventional2013-08-01Completed
Comparison of Conjunctival Vascularity Changes Using Optical Coherence Tomography Angiography After Trabeculectomy With Mitomycin and Ologen Implants[NCT04493073]Early Phase 1100 participants (Anticipated)Interventional2020-12-01Not yet recruiting
Tube Versus Trabeculectomy (TVT) Study[NCT00306852]212 participants (Actual)Interventional1999-10-31Completed
Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas[NCT04647929]0 participants (Actual)Interventional2020-12-01Withdrawn (stopped due to Funding for the study could not be found.)
Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647]61 participants (Actual)Interventional2018-03-01Completed
Effect of WeChat Application Combined Phone Reminder on Follow-up Adherence Improvement in Congenital Ectopia Lentis Patients : A Randomized Controlled Trial[NCT05628129]104 participants (Anticipated)Interventional2022-12-05Recruiting
A Randomized Controlled Trail to Determine the Impact of a SMS Reminder Associated With Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China[NCT02328456]209 participants (Actual)Interventional2014-12-31Completed
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery[NCT01440751]Phase 499 participants (Actual)Interventional2011-09-30Completed
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma[NCT02964676]246 participants (Anticipated)Interventional2017-01-31Not yet recruiting
Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study[NCT01633775]100 participants (Actual)Observational2007-12-31Completed
Comparison of ExPress Implantation Versus Partial Deep Sclerectomy Combined With ExPress Implantation With Simultaneously Phacoemulsification[NCT03800589]186 participants (Actual)Interventional2010-12-01Completed
Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt[NCT06174324]100 participants (Anticipated)Observational2021-10-12Recruiting
The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study[NCT02691455]50 participants (Actual)Interventional2016-02-29Terminated (stopped due to Difficulty in recruiting participants)
Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.[NCT00346489]Phase 470 participants Interventional2004-09-30Completed
IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient[NCT04052165]150 participants (Actual)Interventional2015-07-01Completed
The Ahmed Versus Baerveldt (AVB) Study: Prospective, Multicenter Trial Comparing the Ahmed-FP7 Valve With the Baerveldt-350 Implant in Treating Refractory Glaucoma[NCT00940823]238 participants (Actual)Interventional2005-07-31Completed
Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients[NCT00665756]40 participants (Actual)Interventional2006-01-31Active, not recruiting
Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747]95 participants (Actual)Interventional1998-01-31Completed
Modified Trabeculectomy With an Extended Subscleral Tunnel Versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma (POAG)[NCT03480711]40 participants (Actual)Interventional2018-07-10Completed
The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy[NCT01255306]60 participants (Actual)Observational2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Reoperation for Glaucoma

The number of participants requiring reoperation for glaucoma will be reported (NCT00666237)
Timeframe: Up to 5 years

InterventionParticipants (Count of Participants)
Tube Shunt Surgery Group21
Trabeculectomy With Mitomycin C12

Intraocular Pressure

Intraocular pressure will be reported in mmHg and measured using Goldmann applanation tonometry or a Tono-Pen. (NCT00666237)
Timeframe: At baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years

,
InterventionmmHg (Mean)
Intraocular Pressure: BaselineIntraocular Pressure: 1 yearIntraocular Pressure: 18 monthsIntraocular Pressure: 2 yearsIntraocular Pressure: 3 yearsIntraocular Pressure: 4 yearsIntraocular Pressure: 5 years
Trabeculectomy With Mitomycin C23.912.412.812.912.113.513.0
Tube Shunt Surgery Group23.313.813.513.613.913.513.4

Number of Glaucoma Medications

The need for supplemental glaucoma medications will be reported as the number of glaucoma medications used (NCT00666237)
Timeframe: At Baseline, At 1 year, At 18 months, At 2 years, At 3 years, At 4 years, At 5 years

,
Interventionglaucoma medications used (Mean)
Baseline1 year18 months2 years3 years4 years5 years
Trabeculectomy With Mitomycin C3.20.90.81.01.21.31.3
Tube Shunt Surgery Group3.12.12.12.22.12.32.2

Number of Participants With Reported Postoperative Complications

Number of participants with early and late postoperative complications will be reported as per treating physician assessment (NCT00666237)
Timeframe: Up to 5 years

,
InterventionParticipants (Count of Participants)
Early Postoperative ComplicationsLate Postoperative Complications
Trabeculectomy With Mitomycin C4032
Tube Shunt Surgery Group2427

Number of Participants With Surgical Failure

"Surgical failure is defined as:~Inadequate Intraocular Pressure (IOP) Reduction (IOP > 21 mmHg or reduced < 20% below baseline on 2 consecutive follow-up visits after 3 months)~Reoperation for glaucoma~Persistent hypotony (IOP ≤ 5 mmHg on 2 consecutive visits after 3 months)~Loss of light perception vision" (NCT00666237)
Timeframe: Up to 5 years

,
InterventionParticipants (Count of Participants)
Inadequate IOP reductionReoperation for GlaucomaLoss of light perception visionPersistent Hypotony
Trabeculectomy With Mitomycin C23915
Tube Shunt Surgery Group311800

Visual Acuity as Measured Using EDTRS Chart

Visual acuity will be reported as the number of correctly identified letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) chart. Total score ranges from 0-100 with the higher score indicating better visual acuity. (NCT00666237)
Timeframe: At baseline, At 5 years

,
Interventionletters (Mean)
Baseline5 years
Trabeculectomy With Mitomycin C7366
Tube Shunt Surgery Group7369

Visual Acuity Using a Snellen Chart

Visual acuity will be measured using a Snellen chart on logMAR (Logarithm of Minimal Angle of Resolution) scale. Letter-by letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. (NCT00666237)
Timeframe: At Baseline, At 5 years

,
InterventionlogMAR (Mean)
Baseline5 years
Trabeculectomy With Mitomycin C0.250.42
Tube Shunt Surgery Group0.200.30

Number of Participants With Postoperative Complications Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Non-targeted Placement.

"Presence or absence of the following complications:~i. Starting after POM1: shallow AC w/ iridocorneal touch, any hyphema, corneal edema, wound leak/dehiscience, choroidal effusion, malignant glaucoma, dellen/non-healing epithelial defect, ptosis, diplopia.~ii. At any point: additional glaucoma surgery, loss of light perception vision, vitreous hemorrhage, ≥2mm hyphema, hypotony maculopathy, implant migration/blockage/exposure/extrusion, macular edema, choroidal effusion/hemorrhage requiring drainage, suprachoroidal hemorrhage, retinal detachment, suture abscess/blebitis/endophthalmitis" (NCT04454138)
Timeframe: Post op year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4535
Targeted Supratenon's Placement of XEN 4548

Number of Participants With Postoperative Interventions Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Non-targeted Placement.

Presence or absence of the following management interventions (not considered complications): bleb needling, AC reformation, suture release, digital ocular compression, use of glaucoma medications, or laser/tpa to blocked ostomy or lumen. (NCT04454138)
Timeframe: Post op year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4532
Targeted Supratenon's Placement of XEN 4540

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement 2.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- Medications (NCT04454138)
Timeframe: Post op Year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4533
Targeted Supratenon's Placement of XEN 4522

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement 3.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4528
Targeted Supratenon's Placement of XEN 4518

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement 4.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤17 (mmHg) +/- medication (NCT04454138)
Timeframe: Post op Year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4541
Targeted Supratenon's Placement of XEN 4526

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement 5.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤21 (mmHg) on no medications (NCT04454138)
Timeframe: Post op Year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4531
Targeted Supratenon's Placement of XEN 4519

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement 6.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) +/- medications (NCT04454138)
Timeframe: Post op year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4547
Targeted Supratenon's Placement of XEN 4528

Postoperative Intraocular Pressure Changes Between Targeted Supratenon's Placement of XEN-45 Gelatin Stent and Nontargeted Placement.

Mean change in IOP from baseline, IOP thresholds of ≥6 and ≤14 (mmHg) on no medications (NCT04454138)
Timeframe: Post op year 1

InterventionParticipants (Count of Participants)
Non-targeted Placement of XEN 4520
Targeted Supratenon's Placement of XEN 4515

Change in Intraocular Pressure

To assess final intraocular pressure lowering between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6

InterventionmmHg (millimeters of mercury) (Mean)
Sponge Placement of Mitomycin-C-8.4
Irrigation Placement of MMC-8.2

Complication Rates

To assess complication rates between patients who receive mitomycin-C using a sponge versus irrigation (NCT02016898)
Timeframe: post-operative day 1 to month 6

InterventionParticipants (Count of Participants)
Sponge Placement of Mitomycin-C29
Irrigation Placement of MMC28

Efficacy - The Number of Participants With Qualified and Complete Success

The secondary effectiveness measure will be qualified and complete success rate defined as IOP≤18mmHg with or without medications in the test group as compared to qualified and complete success rate in the concurrent control group at 24 month (NCT00444080)
Timeframe: 24 months

Interventionparticipants (Number)
Control Arm48
Treatment Arm49

Medications

(NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m; 24 months reported

Interventionnumber of medications (Mean)
Control Arm0.7
Treatment Arm0.9

Postoperative Intraocular Pressure

Mean postoperative intraocular pressure (NCT00444080)
Timeframe: assessed at 1d, 1w, 1m, 3m, 6m, 12m, 18m, 24m. 24 months reported

InterventionmmHg (Mean)
Control Arm14.6
Treatment Arm14.7

Safety - Incidence of Adverse Events

Comparison of the incidence of all adverse events that occur during the intra-operative and postoperative periods between the two study arms. More than 1 complication may have occurred in the same subject. (NCT00444080)
Timeframe: 24 months

Interventioncomplications (Number)
Control Arm25
Treatment Arm11

Change in Intraocular Pressure

The data value from the Baseline visit and 5 year follow-up visit were combined. Specifically, values were calculated by subtracting the 5 Year Intraocular Pressure from the Baseline Intraocular Pressure. (NCT00306852)
Timeframe: Baseline to 5 years

Interventionmm Hg (Mean)
Trabeculectomy12.6
Implant14.4

Failure Rate

Failure was prospectively defined as IOP greater than 21 mm Hg or less than 20 percent reduction below baseline on 2 consecutive follow-up visits after 3 months, IOP less than or equal to 5 mm Hg on 2 consecutive follow-up visits after 3 months, re-operation for glaucoma, or loss of light perception vision. (NCT00306852)
Timeframe: 5 years

Interventionpercentage of participants (Number)
Trabeculectomy46.9
Implant29.8

Need for Supplemental Medical Therapy

The number of supplemental glaucoma medications required in the Implant Group and Trabeculectomy Group at 5 years (NCT00306852)
Timeframe: 5 years

Interventionnumber of medications (Mean)
Trabeculectomy1.2
Implant1.4

Reoperations for Glaucoma

Reoperations for glaucoma was defined as additional glaucoma surgery requiring a return to the operating room. (NCT00306852)
Timeframe: 5 years

Interventionparticipants (Number)
Trabeculectomy15
Implant20

Rate of Complications

Complications associated with both surgical procedures (NCT00306852)
Timeframe: 5 years

,
Interventionparticipants (Number)
EARLY POSTOPERATIVE COMPLICATIONSLATE POSTOPERATIVE COMPLICATIONS
Implant3336
Trabeculectomy3938

Visual Acuity

Visual acuity was measured by the total number of letters read (correctly) using a ETDRS eye chart (NCT00306852)
Timeframe: 5 years

,
InterventionLetters (Mean)
PATIENTS WITH COMPLICATIONSPATIENTS WITHOUT COMPLICATIONS
Implant3346
Trabeculectomy5644

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 1

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.03
Transscleral Cyclophotocoagulation0.12

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 12 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 12

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.06
Transscleral Cyclophotocoagulation0.09

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 3

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.10
Transscleral Cyclophotocoagulation0.08

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The month 6 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, month 6

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.03
Transscleral Cyclophotocoagulation0.05

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The week 1 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, week 1

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt0.16
Transscleral Cyclophotocoagulation0.14

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 2 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 2

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.28
Transscleral Cyclophotocoagulation0.24

Change in Visual Acuity as Assessed by the Snellen Chart Visual Acuity Test

The visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). The year 3 reading minus the baseline reading is reported, with a positive number indicating a decrease in visual acuity (that is, an increase in logMAR value indicates a decrease in visual acuity). (NCT02691455)
Timeframe: baseline, year 3

Interventionlog MAgnification Requirement (logMAR) (Mean)
Second Aqueous Shunt-0.23
Transscleral Cyclophotocoagulation0.49

Incidence of Pain

Number of participants who reported pain. (NCT02691455)
Timeframe: 1 month

InterventionParticipants (Count of Participants)
Second Aqueous Shunt10
Transscleral Cyclophotocoagulation10

Incidence of Pain

Number of participants who reported pain. (NCT02691455)
Timeframe: 1 week

InterventionParticipants (Count of Participants)
Second Aqueous Shunt12
Transscleral Cyclophotocoagulation11

Number of Eyes That Failed Treatment

"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 12 to year 3

Interventioneyes (Number)
Second Aqueous Shunt0
Transscleral Cyclophotocoagulation0

Number of Eyes That Failed Treatment

"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from month 6 to month 12

Interventioneyes (Number)
Second Aqueous Shunt3
Transscleral Cyclophotocoagulation2

Number of Eyes That Failed Treatment

"Treatment failure is defined as meeting one or more of the following 4 criteria:~Intraocular pressure (IOP) a) >18 mm Hg on maximum tolerated topical IOP-lowering medications, or b) Reduction of < 20% IOP on maximum tolerated topical IOP-lowering medications from medicated preoperative IOP, or c) ≤ 5 mm Hg without IOP-lowering medications on IOP confirmation visit, 6 months after initial study intervention; or~Reoperation for glaucoma; or~Addition of an oral CAI for the study eye on or after the 6-Month Study Visit; or~Loss of light perception vision (NLP)." (NCT02691455)
Timeframe: from time of intervention to month 6

Interventioneyes (Number)
Second Aqueous Shunt0
Transscleral Cyclophotocoagulation0

Number of Eyes That Lost Two or More Lines of Vision as Assessed by the Snellen Chart Visual Acuity Test

The Snellen visual acuity test is used to determine the smallest letters the participant can read on a standardized chart (Snellen chart). Loss of lines of vision indicates worsening visual acuity. (NCT02691455)
Timeframe: from time of intervention to year 3

Interventioneyes (Number)
Second Aqueous Shunt3
Transscleral Cyclophotocoagulation8

Number of Office Visits Per Participant From Baseline to 3 Months

(NCT02691455)
Timeframe: from baseline to 3 months

Interventionoffice visits per participant (Mean)
Second Aqueous Shunt3.73
Transscleral Cyclophotocoagulation0.95

Number of Office Visits Per Participant Per Month After Month 3

(NCT02691455)
Timeframe: from month 4 to year 3

Interventionoffice visits per participant per month (Mean)
Second Aqueous Shunt0.35
Transscleral Cyclophotocoagulation0.13

Severity of Pain

Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 month

Interventionscore on a scale (Mean)
Second Aqueous Shunt1.40
Transscleral Cyclophotocoagulation1.28

Severity of Pain

Severity of pain was assessed by the Universal Pain Assessment Tool, and the score ranges from 0 to 10, with a higher score indicating greater pain. (NCT02691455)
Timeframe: 1 week

Interventionscore on a scale (Mean)
Second Aqueous Shunt1.57
Transscleral Cyclophotocoagulation1.44

Vision-related Quality of Life as Assessed by the National Eye Institute (NEI) Visual Function Questionnaire (VFQ) 25 (NEI-VFQ-25) - General Health Subscale

The score on the National Eye Institute (NEI) Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt62.5
Transscleral Cyclophotocoagulation48.7

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Color Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt86.4
Transscleral Cyclophotocoagulation77.6

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Color Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt91.1
Transscleral Cyclophotocoagulation76.9

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Dependency Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt50.2
Transscleral Cyclophotocoagulation46.7

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Dependency Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt49.3
Transscleral Cyclophotocoagulation54.9

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Distance Activity Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt65.8
Transscleral Cyclophotocoagulation63.5

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Distance Activity Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt75.8
Transscleral Cyclophotocoagulation63.9

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Driving Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt63.1
Transscleral Cyclophotocoagulation55.4

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Driving Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt56.5
Transscleral Cyclophotocoagulation65.8

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - General Health Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt58.9
Transscleral Cyclophotocoagulation53.8

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - General Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt64.5
Transscleral Cyclophotocoagulation63.2

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - General Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt64.3
Transscleral Cyclophotocoagulation70.8

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Mental Health Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt55.4
Transscleral Cyclophotocoagulation56.9

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Mental Health Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt57.6
Transscleral Cyclophotocoagulation68.3

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Near Activity Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt66.3
Transscleral Cyclophotocoagulation62.7

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Near Activity Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt71.2
Transscleral Cyclophotocoagulation59.0

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Ocular Pain Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt76.2
Transscleral Cyclophotocoagulation70.4

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Ocular Pain Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt83.0
Transscleral Cyclophotocoagulation81.7

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Peripheral Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt60.2
Transscleral Cyclophotocoagulation59.2

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Peripheral Vision Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt62.5
Transscleral Cyclophotocoagulation63.5

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Role Difficulty Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt54.8
Transscleral Cyclophotocoagulation61.8

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Role Difficulty Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt63.4
Transscleral Cyclophotocoagulation70.2

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Social Functioning Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: baseline

Interventionscore on a scale (Mean)
Second Aqueous Shunt83.1
Transscleral Cyclophotocoagulation82.7

Vision-related Quality of Life as Assessed by the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) - Social Functioning Subscale

The score on the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) subscale ranges from 0 to 100, with a higher score indicating greater functioning. (NCT02691455)
Timeframe: month 12

Interventionscore on a scale (Mean)
Second Aqueous Shunt83.3
Transscleral Cyclophotocoagulation76.0

Number of Eyes With Vision-threatening Complications

(NCT02691455)
Timeframe: from the time of intervention to year 3

,
Interventioneyes (Number)
HyphemaHypotony persistentChoroidal EffusionCystoid/Diabetic Macular Edema ProgressionPrimary Tube ComplicationsCataract ProgressionMacular HoleHerpes Simplex KeratitisEctropionSecond Tube Migration AnteriorlyVitreous Clogging Second glaucoma drainage deviceIntraocular Lens DislocationPhacodonesis
Second Aqueous Shunt2212200111110
Transscleral Cyclophotocoagulation0003031000001

Anti-glaucoma Medications

(NCT00940823)
Timeframe: 5 years

Interventionglaucoma medications (Mean)
Ahmed Group1.8
Baerveldt Group1.2

Intraocular Pressure (IOP)

(NCT00940823)
Timeframe: 5 years

InterventionmmHg (Mean)
Ahmed Group16.6
Baerveldt Group13.6

LogMAR Snellen Visual Acuity

Visual acuity (VA) was tested monocularly (one eye at a time) using the manifest refraction adjusted for optical infinity using a standard Snellen Visual Acuity chart at 20 feet. Normal vision, or 20/20 vision, means that the participant can see at 20 feet what a healthy control can also see at 20 feet. Legal blindness, or 20/200 vision, means the participant can see at 20 feet what a healthy control can see at 200 feet. Hence, an increasing denominator implies visual impairment. Counting fingers was designated as 20/2000 vision, hand motions was 20/16000, light perception was 20/32000 and no light perception was 20/64000. To allow for appropriate statistical analysis, logMAR Snellen Visual Acuity was calculated using the formula: -logMAR (Snellen Acuity). This means that normal vision (20/20) would correspond to a value of 0, legal blindness (20/200) would correspond to a value of 1, and no light perception (20/64000) would correspond to 3.5. (NCT00940823)
Timeframe: 5 years

InterventionlogMAR units on a scale (Mean)
Ahmed Group1.6
Baerveldt Group1.6

Number of Participants With Complications During or After Surgery

(NCT00940823)
Timeframe: 5 years

InterventionParticipants (Count of Participants)
Ahmed Group78
Baerveldt Group79

Number of Participants With Interventions After Surgery

(NCT00940823)
Timeframe: 5 years

InterventionParticipants (Count of Participants)
Ahmed Group64
Baerveldt Group58

Number of Participants With Surgical Failure (Composite Measure)

"IOP out of target range (5-18 mmHg inclusive) or <20% reduction from baseline for 2 consecutive visits after 3 months.~De novo glaucoma surgery required (e.g., cyclodestructive procedure, additional tube shunt).~Removal of the implant.~Severe vision loss related to the surgery (endophthalmitis, suprachoroidal hemorrhage with vision loss, enucleation, evisceration, or phthisis bulbi) or progression to no light perception for any reason." (NCT00940823)
Timeframe: 5 years

Interventionparticipants (Number)
Ahmed Group63
Baerveldt Group40

Evidence of Retinal Nerve Fibre Layer Thickness Change Measured by Optical Coherence Tomography

Retinal nerve fiber layer thickness change measured by optical coherence tomography might be an additional parameter that could provide new insights into clinical decision making in patients with silicone oil tamponade. (NCT01255306)
Timeframe: 6 months

,
Interventionmicrometer (Mean)
RNFL thickness at 7th postop. dayRNFL thickness at 30th postop. dayRNFL thickness at 90th postop. dayRNFL thickness at 180th postop. day
CONTROL EYES87.0787.9387.3788.93
STUDY EYES96.2396.0997.56100.40

Retinal Nerve Fiber Layer Thickness Change in Patients With Raised Intraocular Pressure Secondary to Silicone Oil Endotamponade

To assess whether retinal nerve fiber layer thickness changes in patients with raised intraocular pressure secondary to silicone oil endotamponade. (NCT01255306)
Timeframe: 6 months

,,
Interventionmicrometer (Mean)
RNFL thickness at 7th postop. dayRNFL thickness at 30th postop. dayRNFL thickness at 90th postop. dayRNFL thickness at 180th postop. day
CONTROL87.0787.9387.3788.93
NO IOP96.0893.7696.44101.76
RAISED IOP96.3497.9198.4499.34

Reviews

65 reviews available for mitomycin and Glaucoma

ArticleYear
[Surgical advancement in glaucoma in the past 10 years. German version].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021, Volume: 118, Issue:12

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome

2021
Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review.
    Experimental eye research, 2022, Volume: 217

    Topics: Animals; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Mice; Mitomycin; Models, Anima

2022
[Pharmacological modulation of wound healing in glaucoma surgery].
    Vestnik oftalmologii, 2022, Volume: 138, Issue:4

    Topics: Filtering Surgery; Glaucoma; Humans; Mitomycin; Trabeculectomy; Wound Healing

2022
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
[The "Three Cherries Technique" for glaucoma drainage devices].
    Die Ophthalmologie, 2023, Volume: 120, Issue:2

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin

2023
The developments in amniotic membrane transplantation in glaucoma and vitreoretinal procedures.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Amnion; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Sclera; Trabeculectomy

2023
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
    Current opinion in ophthalmology, 2023, Mar-01, Volume: 34, Issue:2

    Topics: Adolescent; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; M

2023
[Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C].
    Die Ophthalmologie, 2023, Volume: 120, Issue:4

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy

2023
Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials.
    International journal of surgery (London, England), 2023, Apr-01, Volume: 109, Issue:4

    Topics: Child; Glaucoma; Humans; Mitomycin; Network Meta-Analysis; Randomized Controlled Trials as Topic; Re

2023
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
    Journal of glaucoma, 2020, Volume: 29, Issue:3

    Topics: Alkylating Agents; Female; Filtering Surgery; Glaucoma; History, 20th Century; History, 21st Century

2020
Needling after trabeculectomy - does augmentation by anti-metabolites provide better outcomes and is Mitomycin C better than 5-Fluoruracil? A systematic review with network meta-analyses.
    Acta ophthalmologica, 2020, Volume: 98, Issue:7

    Topics: Fluorouracil; Glaucoma; Humans; Immunosuppressive Agents; Intraocular Pressure; Mitomycin; Network M

2020
Overview of cicatricial modulators in glaucoma fistulizing surgery.
    International ophthalmology, 2020, Volume: 40, Issue:10

    Topics: Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Wound Healing

2020
[Glaucoma surgery today].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021, Volume: 118, Issue:3

    Topics: Germany; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Quality of Life; Retrospective Studies;

2021
Surgical interventions for primary congenital glaucoma.
    The Cochrane database of systematic reviews, 2020, 08-25, Volume: 8

    Topics: Child, Preschool; Glaucoma; Glaucoma Drainage Implants; Humans; Hyphema; Infant; Infant, Newborn; In

2020
History, presence, and future of mitomycin C in glaucoma filtration surgery.
    Current opinion in ophthalmology, 2021, Mar-01, Volume: 32, Issue:2

    Topics: Alkylating Agents; Drug Delivery Systems; Fibrosis; Filtering Surgery; Glaucoma; History, 20th Centu

2021
Is mytomicyn better than 5-fluorouracil as antimetabolite in trabeculectomy for glaucoma?
    Medwave, 2018, Jan-18, Volume: 18, Issue:1

    Topics: Antimetabolites; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Randomiz

2018
Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials.
    Ophthalmic research, 2018, Volume: 59, Issue:3

    Topics: Administration, Topical; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Bevacizumab; Glaucoma

2018
Trabeculectomy: A Brief History and Review of Current Trends.
    International ophthalmology clinics, 2018,Summer, Volume: 58, Issue:3

    Topics: Angiogenesis Inhibitors; Fluorouracil; Glaucoma; History, 20th Century; History, 21st Century; Human

2018
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.
    The Cochrane database of systematic reviews, 2019, 04-19, Volume: 4

    Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Mitomycin; Randomized Controlled Trials as Topic; Trea

2019
Mitomycin C versus 5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:8

    Topics: Alkylating Agents; Antimetabolites; Chemotherapy, Adjuvant; Epithelium, Corneal; Fluorouracil; Glauc

2013
Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Collagen; Glaucoma; Glycosaminoglycans; Humans; Mitomycin; Prostheses and Implants; Trabeculectomy;

2014
The optimal trabeculectomy: patient and procedure.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2014, Volume: 49, Issue:6

    Topics: Alkylating Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Patient Selection; Trabecular

2014
Surgical interventions for primary congenital glaucoma.
    The Cochrane database of systematic reviews, 2015, Jan-30, Volume: 1

    Topics: Child, Preschool; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; Infant, Newborn; Mitomycin;

2015
Pediatric Glaucoma: A Literature's Review and Analysis of Surgical Results.
    BioMed research international, 2015, Volume: 2015

    Topics: Adolescent; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Male; Mitomycin; Trabeculecto

2015
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.
    The Cochrane database of systematic reviews, 2015, Nov-06, Issue:11

    Topics: Antimetabolites; Chemotherapy, Adjuvant; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Press

2015
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.
    The Cochrane database of systematic reviews, 2015, Nov-25, Issue:11

    Topics: Antihypertensive Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Limbus Corneae; Mitom

2015
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
    The Cochrane database of systematic reviews, 2016, Jan-15, Issue:1

    Topics: Angiogenesis Inhibitors; Bevacizumab; Cicatrix; Glaucoma; Humans; Intraocular Pressure; Mitomycin; R

2016
The Effects of Bevacizumab in Augmenting Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Medicine, 2016, Volume: 95, Issue:15

    Topics: Angiogenesis Inhibitors; Antimetabolites; Bevacizumab; Drug Therapy, Combination; Glaucoma; Humans;

2016
Modulation of wound healing during and after glaucoma surgery.
    Progress in brain research, 2008, Volume: 173

    Topics: Antibiotics, Antineoplastic; Cicatrix; Dendrimers; Fibroblasts; Filtering Surgery; Glaucoma; Humans;

2008
Corneal complications of glaucoma surgery.
    Current opinion in ophthalmology, 2009, Volume: 20, Issue:2

    Topics: Corneal Diseases; Corneal Transplantation; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Graft

2009
Review of results from the Tube Versus Trabeculectomy Study.
    Current opinion in ophthalmology, 2010, Volume: 21, Issue:2

    Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu

2010
Interpretation and misinterpretation of results from the tube versus trabeculectomy study.
    International ophthalmology clinics, 2011,Summer, Volume: 51, Issue:3

    Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Incidence; Intraocular Pressure; In

2011
Current variations of glaucoma filtration surgery.
    Current opinion in ophthalmology, 2012, Volume: 23, Issue:2

    Topics: Alkylating Agents; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Surgical Flaps;

2012
The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice.
    Current opinion in ophthalmology, 2012, Volume: 23, Issue:2

    Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocu

2012
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review.
    Ophthalmology, 2002, Volume: 109, Issue:12

    Topics: Antimetabolites, Antineoplastic; Cataract; Cataract Extraction; Evidence-Based Medicine; Fluorouraci

2002
[Modulation of wound healing in filtration surgery for glaucoma].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:4

    Topics: Adolescent; Adult; Age Factors; Alkylating Agents; Animals; Antimetabolites; Child; Filtering Surger

2003
Glaucoma-filtering bleb infections.
    Current opinion in ophthalmology, 2003, Volume: 14, Issue:2

    Topics: Anti-Bacterial Agents; Drug Administration Schedule; Endophthalmitis; Fibrosis; Filtering Surgery; F

2003
Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery.
    Current opinion in ophthalmology, 2004, Volume: 15, Issue:2

    Topics: Antimetabolites, Antineoplastic; Cataract Extraction; Fibrosis; Fluorouracil; Glaucoma; Glaucoma Dra

2004
[Pharmacological methods improving the effectiveness of filtering procedures].
    Klinika oczna, 2004, Volume: 106, Issue:1-2 Suppl

    Topics: Antibiotics, Antineoplastic; Antibodies; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cy

2004
Wound healing after glaucoma surgery: how to manage it?
    Bulletin de la Societe belge d'ophtalmologie, 2005, Issue:295

    Topics: Adult; Aged; Antimetabolites; Filtering Surgery; Fluorouracil; Glaucoma; Guidelines as Topic; Humans

2005
Intra-operative mitomycin C for glaucoma surgery.
    The Cochrane database of systematic reviews, 2005, Oct-19, Issue:4

    Topics: Antimetabolites; Cicatrix; Glaucoma; Humans; Intraoperative Period; Mitomycin; Randomized Controlled

2005
Mitomycin: clinical applications in ophthalmic practice.
    Drugs, 2006, Volume: 66, Issue:3

    Topics: Antibiotics, Antineoplastic; Cicatrix; Conjunctival Neoplasms; Glaucoma; Humans; Melanoma; Mitomycin

2006
[Wound healing modulation in glaucoma surgery].
    Journal francais d'ophtalmologie, 2007, Volume: 30, Issue:6

    Topics: Adult; Animals; Cataract Extraction; Child; Cicatrix; Eye Diseases; Filtering Surgery; Fluorouracil;

2007
[Ocular side effects of glaucoma treatment agents].
    Bulletin de la Societe belge d'ophtalmologie, 2007, Issue:304

    Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Eye Diseases; Ginkg

2007
[Trabeculectomy with mitomycin C. Study apropos of 30 cases].
    Journal francais d'ophtalmologie, 1995, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorouracil; Follow-Up

1995
Antifibrosis agents and glaucoma surgery.
    Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:11

    Topics: Animals; Conjunctiva; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin

1994
[Mitomycin C in glaucoma surgery].
    Bulletin de la Societe belge d'ophtalmologie, 1993, Volume: 247, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Midd

1993
Antifibrotic agents in glaucoma filtering surgery.
    International ophthalmology clinics, 1993,Fall, Volume: 33, Issue:4

    Topics: Animals; Cataract Extraction; Fluorouracil; Glaucoma; Humans; Mitomycin; Rabbits; Sclerostomy; Wound

1993
Wound healing modulation in glaucoma filtration surgery.
    Ophthalmic surgery, 1993, Volume: 24, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Fluorouracil; Glaucoma; Humans; Intraocular

1993
[Current topics in glaucoma].
    Nippon Ganka Gakkai zasshi, 1996, Volume: 100, Issue:12

    Topics: Adult; Animals; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; M

1996
[Filtering glaucoma operations. Can growth factor blockers replace antimetabolites?].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1997, Volume: 94, Issue:3

    Topics: Antimetabolites, Antineoplastic; Cell Division; Combined Modality Therapy; Filtering Surgery; Fluoro

1997
Mitomycin C primary trabeculectomy in primary glaucoma of white patients.
    Journal of glaucoma, 1997, Volume: 6, Issue:5

    Topics: Antimetabolites; Cataract; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Intraoperati

1997
Basic science and clinical aspects of wound healing in glaucoma filtering surgery.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1998, Volume: 14, Issue:1

    Topics: Culture Techniques; Fibroblasts; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomy

1998
Management of coincident glaucoma and cataract.
    Current opinion in ophthalmology, 1995, Volume: 6, Issue:1

    Topics: Cataract; Cataract Extraction; Exfoliation Syndrome; Fluorouracil; Glaucoma; Humans; Lenses, Intraoc

1995
Management of coincident glaucoma and cataract.
    Current opinion in ophthalmology, 1996, Volume: 7, Issue:1

    Topics: Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Mitomycin; Trabeculectomy

1996
Current techniques in wound healing modulation in glaucoma surgery.
    Current opinion in ophthalmology, 1996, Volume: 7, Issue:2

    Topics: Animals; Antimetabolites; Cataract Extraction; Cicatrix; Filtering Surgery; Fluorouracil; Glaucoma;

1996
The toxicology of mitomycin C on the ciliary body.
    Current opinion in ophthalmology, 1996, Volume: 7, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Aqueous Humor; Ciliary Body; Conjunctiva; Filtering Surgery; G

1996
Ocular toxicity of mitomycin-C.
    International ophthalmology clinics, 1999,Spring, Volume: 39, Issue:2

    Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Eye; Eye Diseases; Filtering Surgery; Glaucoma;

1999
Management of coincident glaucoma and cataract.
    Current opinion in ophthalmology, 1999, Volume: 10, Issue:1

    Topics: Cataract; Cataract Extraction; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin;

1999
A major review of antimetabolites in glaucoma therapy.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1999, Volume: 213, Issue:4

    Topics: Antimetabolites; Cytarabine; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin; Ophthalmi

1999
Glaucoma surgery: are there new perspectives in perioperative pharmacology?
    Current opinion in ophthalmology, 1999, Volume: 10, Issue:2

    Topics: Antimetabolites; Chemotherapy, Adjuvant; Fibrinolytic Agents; Filtering Surgery; Fluorouracil; Glauc

1999
[The use of antimetabolites in the treatment of glaucoma].
    Oftalmologia (Bucharest, Romania : 1990), 1999, Volume: 48, Issue:3

    Topics: Antimetabolites; Chemotherapy, Adjuvant; Fluorouracil; Glaucoma; Humans; Intraoperative Care; Mitomy

1999
Intra-operative mitomycin C for glaucoma surgery.
    The Cochrane database of systematic reviews, 2001, Issue:1

    Topics: Antimetabolites; Cataract Extraction; Cicatrix; Glaucoma; Humans; Intraoperative Period; Mitomycin;

2001
The use of antimetabolites with trabeculectomy: a critical appraisal.
    Journal of glaucoma, 2001, Volume: 10, Issue:3

    Topics: Antimetabolites; Combined Modality Therapy; Delivery of Health Care; Fluorouracil; Glaucoma; Humans;

2001
Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy.
    Journal of glaucoma, 2001, Volume: 10, Issue:5 Suppl 1

    Topics: Antimetabolites; Chemotherapy, Adjuvant; Fluorouracil; Glaucoma; Humans; Intraoperative Period; Mito

2001
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.
    Ophthalmology, 2002, Volume: 109, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Bacteria; Endophthalmitis; Eye Infections, Bacteri

2002

Trials

84 trials available for mitomycin and Glaucoma

ArticleYear
Subtenon triamcinolone as an adjuvant in mitomycin-C-enhanced trabeculectomy in non-inflammatory glaucomas: A randomized clinical trial.
    PloS one, 2022, Volume: 17, Issue:5

    Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outc

2022
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
    Ophthalmology, 2022, Volume: 129, Issue:12

    Topics: Alkylating Agents; Blindness; Cataract; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum

2022
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.
    Ophthalmology, 2022, Volume: 129, Issue:12

    Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Tr

2022
Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Antiglaucoma Agents; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Prospecti

2023
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec

2022
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec

2022
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec

2022
Comparative evaluation of outcomes of novel approach of subconjunctival Mitomycin C (MMC) injection at the end of trabeculectomy versus intraTenon injection of MMC prior to the initial conjunctival incision - A pilot study.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Ocular Hypotension; Pilot Projects; Surgical Wound; Trabec

2022
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
    Ophthalmology, 2020, Volume: 127, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra

2020
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
    Ophthalmology, 2020, Volume: 127, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra

2020
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
    Ophthalmology, 2020, Volume: 127, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra

2020
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
    Ophthalmology, 2020, Volume: 127, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Follow-Up Studies; Glaucoma; Glaucoma Dra

2020
The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
    International ophthalmology, 2020, Volume: 40, Issue:4

    Topics: Adult; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Conjunctiva; Drug Therapy, Combinati

2020
Baerveldt implant versus trabeculectomy as the first filtering surgery for uncontrolled primary congenital glaucoma: a randomized clinical trial.
    Arquivos brasileiros de oftalmologia, 2020, Volume: 83, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans

2020
Combined Trabeculotomy-Trabeculectomy Versus Trabeculectomy for Treatment of Silicone Oil-induced Ocular Hypertension.
    Journal of glaucoma, 2021, 02-01, Volume: 30, Issue:2

    Topics: Adolescent; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Silicone Oils; Ton

2021
The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
    Journal of glaucoma, 2018, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
    Ophthalmology, 2018, Volume: 125, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Double-Blind Method; Female; Follow-Up Studies; G

2018
Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh.
    European journal of ophthalmology, 2019, Volume: 29, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Bangladesh; Collagen; Female; Glaucoma; Glycosaminoglycans; Huma

2019
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
    F1000Research, 2018, Volume: 7

    Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma

2018
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
    F1000Research, 2018, Volume: 7

    Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma

2018
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
    F1000Research, 2018, Volume: 7

    Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma

2018
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
    F1000Research, 2018, Volume: 7

    Topics: Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocyclitis; Ma

2018
Bleb Morphology After Mitomycin-C Augmented Trabeculectomy: Comparison Between Clinical Evaluation and Anterior Segment Optical Coherence Tomography.
    Journal of glaucoma, 2019, Volume: 28, Issue:5

    Topics: Aged; Anterior Eye Segment; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitom

2019
Phacotrabeculectomy using collagen matrix implant (Ologen
    Acta ophthalmologica, 2019, Volume: 97, Issue:6

    Topics: Aged; Alkylating Agents; Cataract; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma; Gly

2019
Augmented Subscleral Trabeculectomy With Beta Radiation and Mitomycin C in Egyptian Glaucoma Patients.
    Journal of glaucoma, 2019, Volume: 28, Issue:7

    Topics: Adult; Beta Particles; Combined Modality Therapy; Egypt; Female; Follow-Up Studies; Glaucoma; Humans

2019
[Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2014, Volume: 111, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Juvenile; Child; Child, Preschool; Combined Modality T

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study).
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Glaucoma; Glauco

2014
Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study.
    American journal of ophthalmology, 2014, Volume: 157, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cohort Studies; Female;

2014
[Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants in trabeculectomy].
    Archivos de la Sociedad Espanola de Oftalmologia, 2015, Volume: 90, Issue:2

    Topics: Aged; Bevacizumab; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Glaucoma; Humans; Male

2015
Excision of Tenon Capsule in Pediatric Trabeculectomy: A Controlled Study.
    Journal of glaucoma, 2016, Volume: 25, Issue:1

    Topics: Alkylating Agents; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Pressure; Male; M

2016
Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial.
    Journal of glaucoma, 2016, Volume: 25, Issue:5

    Topics: Adult; Aged; Alkylating Agents; Amnion; Double-Blind Method; Female; Glaucoma; Glaucoma Drainage Imp

2016
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
    Ophthalmology, 2015, Volume: 122, Issue:11

    Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctival Diseases;

2015
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
    JAMA ophthalmology, 2016, Oct-01, Volume: 134, Issue:10

    Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure

2016
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
    JAMA ophthalmology, 2016, Oct-01, Volume: 134, Issue:10

    Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure

2016
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
    JAMA ophthalmology, 2016, Oct-01, Volume: 134, Issue:10

    Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure

2016
Interventions to Promote Follow-up After Trabeculectomy Surgery in Rural Southern China: A Randomized Clinical Trial.
    JAMA ophthalmology, 2016, Oct-01, Volume: 134, Issue:10

    Topics: China; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure

2016
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial.
    BMC ophthalmology, 2016, Dec-29, Volume: 16, Issue:1

    Topics: Aged; Antifibrinolytic Agents; Antihypertensive Agents; Collagen; Combined Modality Therapy; Female;

2016
[Glaucoma Drainage Devices: Tube versus Trabeculectomy Study].
    Klinische Monatsblatter fur Augenheilkunde, 2018, Volume: 235, Issue:2

    Topics: Biocompatible Materials; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Glaucoma Drainage I

2018
Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Ophthalmology, 2009, Volume: 116, Issue:2

    Topics: Administration, Topical; Alkylating Agents; Antihypertensive Agents; Antimetabolites; Combined Modal

2009
Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up.
    American journal of ophthalmology, 2009, Volume: 147, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Diplopia; Female; Follow-Up Studies;

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Decision M

2009
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial.
    Ophthalmology, 2010, Volume: 117, Issue:7

    Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antihyper

2010
A freeze-dried (lyophilized) amniotic membrane transplantation with mitomycin C and trabeculectomy for pediatric glaucoma.
    Cutaneous and ocular toxicology, 2010, Volume: 29, Issue:3

    Topics: Amnion; Child; Child, Preschool; Conjunctiva; Freeze Drying; Glaucoma; Humans; Infant; Intraocular P

2010
Anterior lens capsule versus mitomycin-C as an adjunct to trabeculectomy in combined phacotrabeculectomy.
    Journal of glaucoma, 2011, Volume: 20, Issue:8

    Topics: Aged; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Lens Capsule, Cry

2011
Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blister; Cicatrix; Conjunctiva; Doxycyc

2010
ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol.
    BMC ophthalmology, 2011, Jan-17, Volume: 11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctiva; Drug Administration Schedule

2011
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
    Eye (London, England), 2011, Volume: 25, Issue:12

    Topics: Absorbable Implants; Aged; Collagen; Cross-Linking Reagents; Female; Glaucoma; Glycosaminoglycans; H

2011
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
    Journal of glaucoma, 2013, Volume: 22, Issue:3

    Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract;

2013
Comparison of the outcome of repeat trabeculectomy with adjunctive mitomycin C and initial trabeculectomy.
    Korean journal of ophthalmology : KJO, 2011, Volume: 25, Issue:6

    Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int

2011
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
    American journal of ophthalmology, 2012, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract Ext

2012
Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:3

    Topics: Adult; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans;

2013
Postoperative subconjunctival mitomycin-C injection after non-penetrating glaucoma surgery.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2002, Volume: 18, Issue:4

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctiva; Filtering Surgery; Follow-Up Stud

2002
A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.
    American journal of ophthalmology, 2002, Volume: 134, Issue:4

    Topics: Antimetabolites; Double-Blind Method; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intraope

2002
[Trabeculectomy combined with mitomycin C and removed suture in glaucoma].
    Yan ke xue bao = Eye science, 2003, Volume: 19, Issue:2

    Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera

2003
[Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma].
    Yan ke xue bao = Eye science, 2003, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum

2003
Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery.
    The British journal of ophthalmology, 2003, Volume: 87, Issue:8

    Topics: Aged; Chemotherapy, Adjuvant; Connective Tissue; Female; Follow-Up Studies; Glaucoma; Glaucoma Drain

2003
Effects of viscoelastic material on the corneal endothelial cells in trabeculectomy with adjunctive mitomycin-C.
    Korean journal of ophthalmology : KJO, 2003, Volume: 17, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Antimetabolites; Drug Therapy, Combina

2003
Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
    Ophthalmology, 2004, Volume: 111, Issue:6

    Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up St

2004
[Intraoperative use of mitomycin C in glaucoma filtering surgery--indications, results and complications].
    Klinika oczna, 2004, Volume: 106, Issue:1-2 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Endothelium, Corneal; F

2004
Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
    Indian journal of ophthalmology, 2001, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Child, Preschool; Female; Glaucoma; Humans; Infan

2001
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
    American journal of ophthalmology, 2005, Volume: 140, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glaucoma Drainage Implants; Gonioscopy; Humans; In

2005
Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Fibrosis; Follow-Up Studies; Glaucoma; Hu

2006
Prospective evaluation of preoperative factors associated with successful mitomycin C needling of failed filtration blebs.
    Journal of glaucoma, 2006, Volume: 15, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Follow-Up Studies; Glaucoma; Humans; Inject

2006
Comparison of 1-site versus 2-site phacotrabeculectomy.
    Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:5

    Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma;

2006
Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial.
    Journal of glaucoma, 2006, Volume: 15, Issue:3

    Topics: Aged; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular

2006
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female

2007
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female

2007
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female

2007
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Female

2007
[The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C].
    Yan ke xue bao = Eye science, 2005, Volume: 21, Issue:2

    Topics: Aged; Amnion; Antimetabolites; Female; Follow-Up Studies; Glaucoma; Humans; Male; Middle Aged; Mitom

2005
A placebo controlled double blind clinical trial of mitomycin C in primary trabeculectomy in Ethiopian patients.
    Ethiopian medical journal, 2006, Volume: 44, Issue:3

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Case-Control Studies; Double-Blind Method; Ethiopia;

2006
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
    Acta ophthalmologica, 2008, Volume: 86, Issue:3

    Topics: Aged; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocula

2008
Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment.
    Medical science monitor : international medical journal of experimental and clinical research, 2008, Volume: 14, Issue:2

    Topics: Aged; Drug Implants; Female; Glaucoma; Humans; Hyaluronic Acid; Intraocular Pressure; Male; Middle A

2008
[Effect of mitomycin C on aqueous humor flow after trabeculectomy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1995, Volume: 92, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Female; Follow-Up Stud

1995
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
    Ophthalmology, 1995, Volume: 102, Issue:1

    Topics: Adult; Aged; Case-Control Studies; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocul

1995
Adjunctive mitomycin C in Molteno implant surgery.
    Ophthalmology, 1995, Volume: 102, Issue:1

    Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Life Tables; Male;

1995
Intraoperative mitomycin C in complicated glaucomas.
    Indian journal of ophthalmology, 1993, Volume: 41, Issue:2

    Topics: Adult; Age Factors; Aged; Aphakia; Drug Evaluation; Female; Fluorouracil; Glaucoma; Glaucoma, Open-A

1993
Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations.
    International ophthalmology, 1995, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem

1995
Mitomycin-C concentration in human ocular aqueous humor after topical administration during trabeculectomy.
    Arzneimittel-Forschung, 1995, Volume: 45, Issue:12

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Aqueous Humor; Chromatography, High Pressure L

1995
The effect of low-and high-dose adjunctive mitomycin C in trabeculectomy.
    Korean journal of ophthalmology : KJO, 1996, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Dose-Response R

1996
[The effect of mitomycin C on filtration surgery of glaucoma with poor prognosis].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 1996, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Cicatrix; Female; Filtering Surgery; Follow-Up Studies;

1996
Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma.
    Journal of glaucoma, 1996, Volume: 5, Issue:3

    Topics: Aged; Alkylating Agents; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intraocular Pre

1996
A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures.
    Ophthalmology, 1996, Volume: 103, Issue:11

    Topics: Aged; Aged, 80 and over; Cell Count; Chemotherapy, Adjuvant; Double-Blind Method; Endothelium, Corne

1996
Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up.
    Ophthalmology, 1995, Volume: 102, Issue:9

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Filter

1995
A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy.
    Ophthalmology, 1997, Volume: 104, Issue:4

    Topics: Aged; Aged, 80 and over; Cataract Extraction; Double-Blind Method; Female; Glaucoma; Humans; Intraoc

1997
Mitomycin-C in congenital glaucoma.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:12

    Topics: Administration, Topical; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschoo

1997
Intraoperative mitomycin C and the corneal endothelium.
    Acta ophthalmologica Scandinavica, 1998, Volume: 76, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cell Count; Chemotherapy, Adjuvant; Endothelium, Corneal; Female; Gl

1998
The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.
    Journal of glaucoma, 1998, Volume: 7, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Glaucoma; Humans; Incidence; Intraocula

1998
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:9

    Topics: Aged; Aged, 80 and over; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure

1998
Oral prednisone in guarded filtration procedures supplemented with antimetabolites.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:2

    Topics: Administration, Oral; Aged; Chemotherapy, Adjuvant; Double-Blind Method; Female; Filtering Surgery;

1999
Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty.
    Journal of glaucoma, 1999, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Corneal Diseases; Female; Glaucoma; Graft Survival;

1999
Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation.
    Journal of cataract and refractive surgery, 1999, Volume: 25, Issue:9

    Topics: Cataract; Ciliary Body; Endoscopy; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intrao

1999
Simultaneous subconjunctival and subscleral mitomycin-C application in trabeculectomy.
    Ophthalmology, 2000, Volume: 107, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva;

2000
Postoperative application of mitomycin for trabeculectomies.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Female; Follow-Up Studies; Glaucoma; Hu

2000
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Evaluation; Female; Fluorouracil

2000
Mini-trabeculectomy in eyes with high risk of scarring: midterm follow-up.
    American journal of ophthalmology, 2001, Volume: 131, Issue:1

    Topics: Aged; Aged, 80 and over; Cicatrix; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure

2001
Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy.
    Journal of glaucoma, 2002, Volume: 11, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female; Follow-Up

2002
Amniotic membrane graft for late-onset glaucoma filtering leaks.
    American journal of ophthalmology, 2002, Volume: 133, Issue:6

    Topics: Adult; Amnion; Biological Dressings; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Ag

2002

Other Studies

540 other studies available for mitomycin and Glaucoma

ArticleYear
Longitudinal changes in complete avascular area assessed using anterior segmental optical coherence tomography angiography in filtering trabeculectomy bleb.
    Scientific reports, 2021, 12-03, Volume: 11, Issue:1

    Topics: Adult; Aged; Computed Tomography Angiography; Female; Glaucoma; Humans; Intraocular Pressure; Longit

2021
Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery.
    Translational vision science & technology, 2022, 01-03, Volume: 11, Issue:1

    Topics: Animals; Collagen Type I, alpha 1 Chain; Glaucoma; Intraocular Pressure; Mitomycin; Rabbits; Valproi

2022
Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma - A retrospective study.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:2

    Topics: Adolescent; Child; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci

2022
Surgical trends in glaucoma management: The current Indian scenario.
    International ophthalmology, 2022, Volume: 42, Issue:6

    Topics: Cataract; Child; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Trab

2022
Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:3

    Topics: Adolescent; Child; Conjunctivitis, Allergic; Female; Glaucoma; Humans; Intraocular Pressure; Male; M

2022
Survey of glaucoma surgical preferences among glaucoma specialists in Spain.
    Archivos de la Sociedad Espanola de Oftalmologia, 2022, Volume: 97, Issue:6

    Topics: Collagen; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Spain

2022
Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2023, Volume: 58, Issue:4

    Topics: Adult; Gelatin; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pres

2023
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis.
    The British journal of ophthalmology, 2023, Volume: 107, Issue:8

    Topics: Cohort Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabeculec

2023
Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022, Volume: 260, Issue:10

    Topics: Choroidal Effusions; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Myopia

2022
Current practice of trabeculectomy in a cohort of experienced glaucoma surgeons in Australia and New Zealand.
    Eye (London, England), 2023, Volume: 37, Issue:6

    Topics: Australia; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; New Zealand; Retrospecti

2023
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
    International ophthalmology, 2022, Volume: 42, Issue:11

    Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul

2022
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
    Journal of glaucoma, 2022, 07-01, Volume: 31, Issue:7

    Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit

2022
The Norwich trabeculectomy study: risk factor analysis for the development of adverse, thin cystic blebs.
    Acta ophthalmologica, 2022, Volume: 100, Issue:7

    Topics: Antimetabolites; Conjunctiva; Factor Analysis, Statistical; Fluorouracil; Glaucoma; Humans; Intraocu

2022
Glaucoma management in congenital ectropion uveae: Surgical outcomes from a large tertiary referral center in South India.
    European journal of ophthalmology, 2023, Volume: 33, Issue:1

    Topics: Ectropion; Follow-Up Studies; Glaucoma; Humans; Infant, Newborn; Intraocular Pressure; Mitomycin; Re

2023
Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series.
    International journal of environmental research and public health, 2022, 07-16, Volume: 19, Issue:14

    Topics: Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Mitomycin; Tonometry, Oc

2022
Two Year Outcomes of Trabeculectomy in Cytomegalovirus Anterior Uveitis with Uncontrolled Intraocular Pressure.
    Ocular immunology and inflammation, 2023, Volume: 31, Issue:7

    Topics: Cytomegalovirus; Cytomegalovirus Infections; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retr

2023
Effects of topical docosahexaenoic acid on postoperative fibrosis in an animal model of glaucoma filtration surgery.
    Acta ophthalmologica, 2023, Volume: 101, Issue:1

    Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Fibrosis; Filtering Surgery; Glaucoma; Intra

2023
Same-site trabeculectomy with mitomycin and Ologen™ following failed non-penetrating deep sclerectomy.
    European journal of ophthalmology, 2023, Volume: 33, Issue:1

    Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Scleros

2023
[Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy].
    Die Ophthalmologie, 2023, Volume: 120, Issue:1

    Topics: Glaucoma; Humans; Mitomycin; Retrospective Studies; Trabeculectomy; Treatment Outcome

2023
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts.
    Translational vision science & technology, 2022, 08-01, Volume: 11, Issue:8

    Topics: Animals; Collagen; Disease Models, Animal; Fibroblasts; Filtering Surgery; Flavonols; Glaucoma; Huma

2022
Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023, Volume: 261, Issue:2

    Topics: Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Iridocorneal

2023
Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.
    Investigative ophthalmology & visual science, 2022, 09-01, Volume: 63, Issue:10

    Topics: Animals; Antimetabolites; Conjunctiva; Dextrans; Fluorouracil; Glaucoma; Intraocular Pressure; Mice;

2022
Trabeculectomy Tenon Advancement Technique May Reduce Bleb-Related Infections.
    Journal of glaucoma, 2023, 02-01, Volume: 32, Issue:2

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Postoperative Complications;

2023
Differential effects of acetylsalicylic acid and mitomycin C on cytokine-induced Tenon's capsule myofibroblast transdifferentiation and activity: Implications for glaucoma surgery.
    Experimental eye research, 2022, Volume: 225

    Topics: Aspirin; Cell Transdifferentiation; Cells, Cultured; Chromatography, Liquid; Cicatrix; Collagen; Cyt

2022
Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C.
    Acta ophthalmologica, 2023, Volume: 101, Issue:3

    Topics: Cohort Studies; Endophthalmitis; Glaucoma; Humans; Mitomycin; Retrospective Studies; Trabeculectomy

2023
Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study.
    BMC ophthalmology, 2022, Nov-14, Volume: 22, Issue:1

    Topics: Cross-Sectional Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Protein Kinase Inhibitor

2022
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
Reoperations for complications within 90 days after gel stent implantation or trabeculectomy.
    International ophthalmology, 2023, Volume: 43, Issue:5

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Reoperation; Retrosp

2023
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros

2022
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros

2022
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros

2022
A comparative analysis of surgical outcome in uveitic and non-uveitic steroid-induced glaucoma in children.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Glaucoma; Humans; Male; Mitomycin; Retros

2022
Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023, Volume: 261, Issue:5

    Topics: Adolescent; Adult; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Male;

2023
Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma.
    Journal of glaucoma, 2023, 05-01, Volume: 32, Issue:5

    Topics: Glaucoma; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ph

2023
One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
    Journal of glaucoma, 2023, 05-01, Volume: 32, Issue:5

    Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Prospective Studies; Treatm

2023
Inadvertent filtering bleb due to extracapsular cataract extraction wound reopening after mitomycin C use: a case report.
    Journal of medical case reports, 2023, Feb-18, Volume: 17, Issue:1

    Topics: Aged, 80 and over; Cataract Extraction; Female; Glaucoma; Humans; Mitomycin; Postoperative Complicat

2023
ALK5 Inhibition of Subconjunctival Scarring From Glaucoma Surgery: Effects of SB-431542 Compared to Mitomycin C in Human Tenon's Capsule Fibroblasts.
    Translational vision science & technology, 2023, 02-01, Volume: 12, Issue:2

    Topics: Cicatrix; Collagen; Fibroblasts; Glaucoma; Humans; Matrix Metalloproteinase 9; Mitomycin; Tenon Caps

2023
The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits.
    Experimental eye research, 2023, Volume: 229

    Topics: Animals; Cicatrix; Conjunctiva; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pressure; Matrix

2023
Analysis of the Systemic Exposure of Mitomycin C Used in Glaucoma Filtering Surgery Among Women in the Reproductive Age Group.
    Current eye research, 2023, Volume: 48, Issue:7

    Topics: Adolescent; Adult; Chromatography, Liquid; Female; Filtering Surgery; Glaucoma; Humans; Intraocular

2023
Impact of postoperative choroidal detachment on trabeculectomy outcomes: a four-year comparative study.
    BMC ophthalmology, 2023, Mar-17, Volume: 23, Issue:1

    Topics: Aged; Eye; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retros

2023
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 5 years of follow-up (Ophthalmology. 2022;129:1344-1356).
    Ophthalmology, 2023, Volume: 130, Issue:7

    Topics: Eye; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomyci

2023
A retrospective study to assess visual field improvement following augmented trabeculectomy.
    Indian journal of ophthalmology, 2023, Volume: 71, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; M

2023
Effect of Intraoperative Mitomycin C on the Surgical Outcomes of Ahmed Glaucoma Valve Implantation with Ciliary Sulcus Tube Placement.
    Korean journal of ophthalmology : KJO, 2023, Volume: 37, Issue:3

    Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ocular Hypotension; Treatment Outcome

2023
Augmented trabeculectomy - The surgical journey and road trip forward.
    Indian journal of ophthalmology, 2023, Volume: 71, Issue:6

    Topics: Eye; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy; Treatment Outcome

2023
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
    Journal of glaucoma, 2023, 08-01, Volume: 32, Issue:8

    Topics: Fibrosis; Glaucoma; Humans; Infant; Intraocular Pressure; Mitomycin; Retrospective Studies; Tonometr

2023
Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes.
    American journal of ophthalmology, 2023, Volume: 256

    Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies

2023
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
    Journal of glaucoma, 2023, 11-01, Volume: 32, Issue:11

    Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Female; Follow-Up Studies; Glaucoma; Glaucoma, O

2023
Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023, Volume: 261, Issue:12

    Topics: Exfoliation Syndrome; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospe

2023
A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient.
    BMC ophthalmology, 2023, Oct-10, Volume: 23, Issue:1

    Topics: Adult; Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mal

2023
Surgical outcomes of trabeculectomy augmented with sub-Tenon injected mitomycin C.
    Bratislavske lekarske listy, 2023, Volume: 124, Issue:12

    Topics: Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Trabecul

2023
Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2019, Volume: 257, Issue:12

    Topics: Aged; Female; Follow-Up Studies; Gels; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pre

2019
Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
    Journal of glaucoma, 2019, Volume: 28, Issue:11

    Topics: Adult; Aged; Alkylating Agents; Collagen; Female; Fibrosis; Follow-Up Studies; Glaucoma; Glaucoma Dr

2019
Trabeculectomy followed by phacoemulsification versus trabeculectomy alone: The Collaborative Bleb-Related Infection Incidence and Treatment Study.
    PloS one, 2019, Volume: 14, Issue:10

    Topics: Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Ma

2019
Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C.
    International journal of molecular sciences, 2019, Dec-20, Volume: 21, Issue:1

    Topics: Animals; Antimetabolites; Conjunctiva; Disease Models, Animal; Dogs; Filtering Surgery; Glaucoma; In

2019
Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report.
    Medicine, 2020, Volume: 99, Issue:2

    Topics: Antibiotics, Antineoplastic; Choroidal Effusions; Chronic Disease; Glaucoma; Humans; Intraocular Pre

2020
The Tenons' Layer Reposition Approach of Trabeculectomy: A Longitudinal Case Series of a Mixed Group of Glaucoma Patients.
    Journal of glaucoma, 2020, Volume: 29, Issue:5

    Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula

2020
Reoperations for Complications Within 90 Days After Glaucoma Surgery.
    Journal of glaucoma, 2020, Volume: 29, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Ciliary Body; Female; Glaucoma; Glaucoma Drainage

2020
A Comparison of Trabeculectomy Surgery Outcomes With Mitomycin-C Applied by Intra-Tenon Injection Versus Sponge.
    American journal of ophthalmology, 2020, Volume: 216

    Topics: Aged; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Injections, Intraocula

2020
Bleb-related tuberculous endophthalmitis following combined phacoemulsification and trabeculectomy with mitomycin C.
    BMJ case reports, 2020, Mar-24, Volume: 13, Issue:3

    Topics: Aged; Antitubercular Agents; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Mycobacterium tuber

2020
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
    Journal of glaucoma, 2020, Volume: 29, Issue:6

    Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin

2020
Response to: Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
    Journal of glaucoma, 2020, Volume: 29, Issue:6

    Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin

2020
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
    Journal of glaucoma, 2020, Volume: 29, Issue:8

    Topics: Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin

2020
Response to letter to the Editor Regarding MMC and pH.
    Journal of glaucoma, 2020, Volume: 29, Issue:8

    Topics: Blister; Filtering Surgery; Glaucoma; Humans; Hydrogen-Ion Concentration; Intraocular Pressure; Mito

2020
Glaucoma Drainage Device Technique in a Cohort of Experienced Glaucoma Surgeons in Australia and New Zealand.
    Journal of glaucoma, 2020, Volume: 29, Issue:12

    Topics: Adult; Aged; Alkylating Agents; Australia; Cohort Studies; Female; Glaucoma; Glaucoma Drainage Impla

2020
Alteration of gene expression in mice after glaucoma filtration surgery.
    Scientific reports, 2020, 09-14, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Conjunctiva; Filtering Surgery; Glaucoma; Mice; Mice, Inbred BALB C;

2020
Outcomes and risk factors for failure after trabeculectomy in Taiwanese patients: medical chart reviews from 2006 to 2017.
    The British journal of ophthalmology, 2022, Volume: 106, Issue:3

    Topics: Adult; Aged; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Retr

2022
[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021, Volume: 118, Issue:11

    Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin;

2021
A PVDF electrospun antifibrotic composite for use as a glaucoma drainage implant.
    Materials science & engineering. C, Materials for biological applications, 2021, Volume: 119

    Topics: Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin

2021
Long-term Efficacy of Mitomycin C Augmented Trabeculectomy in a Mixed Pediatric Glaucoma Cohort.
    Journal of glaucoma, 2021, 04-01, Volume: 30, Issue:4

    Topics: Child; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies;

2021
National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK.
    International ophthalmology, 2021, Volume: 41, Issue:4

    Topics: Glaucoma; Humans; Intraocular Pressure; Ireland; Mitomycin; Trabeculectomy; United Kingdom

2021
Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model.
    Clinical & experimental ophthalmology, 2021, Volume: 49, Issue:1

    Topics: Animals; Conjunctiva; Disease Models, Animal; Fibrosis; Filtering Surgery; Glaucoma; Intraocular Pre

2021
Common and rare complications following filtering surgery for children with congenital glaucoma; a5 years study.
    European journal of ophthalmology, 2021, Volume: 31, Issue:6

    Topics: Child; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complicat

2021
Effect of oral statin use on mitomycin-C augmented trabeculectomy outcomes.
    PloS one, 2021, Volume: 16, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antimetabolites; Female; Fluorouracil; Follow-Up Studies; Glaucom

2021
Evaluating CO
    International ophthalmology, 2021, Volume: 41, Issue:4

    Topics: Adult; Carbon Dioxide; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lasers; Mitomyc

2021
The effect of halofugınone and pirfenidone on wound healing in experimental glaucoma filtration surgery.
    Journal francais d'ophtalmologie, 2021, Volume: 44, Issue:3

    Topics: Animals; Filtering Surgery; Glaucoma; Intraocular Pressure; Male; Mitomycin; Pyridones; Rabbits; Tra

2021
Long-term treatment outcomes for congenital ectropion uveae with ptosis and glaucoma.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2020, Volume: 24, Issue:6

    Topics: Ectropion; Glaucoma; Humans; Intraocular Pressure; Iris Diseases; Mitomycin; Trabeculectomy; Treatme

2020
Augmented trabeculectomy-outcomes of first hundred versus second hundred surgeries of a fellowship-trained glaucoma surgeon.
    European journal of ophthalmology, 2022, Volume: 32, Issue:1

    Topics: Fellowships and Scholarships; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin;

2022
Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma.
    Journal of glaucoma, 2021, 07-01, Volume: 30, Issue:7

    Topics: Child; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomy

2021
Long-term outcomes of initial trabeculectomy in glaucoma associated with granulomatous and non-granulomatous uveitis.
    International ophthalmology, 2021, Volume: 41, Issue:10

    Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; R

2021
Trabeculectomy with Mitomycin-C in Post-Traumatic Angle Recession Glaucoma in Phakic Eyes With no Prior Intraocular Intervention.
    Seminars in ophthalmology, 2022, Feb-17, Volume: 37, Issue:2

    Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci

2022
Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
    Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:9

    Topics: Collagen; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intraocular Pressure; Mitomycin;

2022
Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique.
    Eye (London, England), 2022, Volume: 36, Issue:7

    Topics: Glaucoma; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin;

2022
RETINAL TOXICITY FOLLOWING PRESUMED INADVERTENT INTRAOCULAR INJECTION OF MITOMYCIN C DURING TRABECULECTOMY.
    Retinal cases & brief reports, 2023, May-01, Volume: 17, Issue:3

    Topics: Glaucoma; Humans; Injections, Intraocular; Intraocular Pressure; Mitomycin; Retina; Trabeculectomy

2023
Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2021, Volume: 259, Issue:12

    Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Trabecu

2021
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
    Journal of glaucoma, 2017, Volume: 26, Issue:7

    Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma;

2017
Outcomes for Ab Interno Bleb Revision With a Novel Translimbal Sclerostomy Spatula.
    Journal of glaucoma, 2017, Volume: 26, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; F

2017
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
    Ophthalmology, 2017, Volume: 124, Issue:11

    Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag

2017
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
    Ophthalmology, 2017, Volume: 124, Issue:11

    Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag

2017
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
    Ophthalmology, 2017, Volume: 124, Issue:11

    Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag

2017
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
    Ophthalmology, 2017, Volume: 124, Issue:11

    Topics: Aged; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Gelatin; Glaucoma; Glaucoma Drainag

2017
Regular Versus Releasable Sutures in Surgery for Primary Congenital Glaucoma.
    Journal of pediatric ophthalmology and strabismus, 2017, Sep-01, Volume: 54, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Eq

2017
Inhibition of Monocyte Chemoattractant Protein 1 Prevents Conjunctival Fibrosis in an Experimental Model of Glaucoma Filtration Surgery.
    Investigative ophthalmology & visual science, 2017, 07-01, Volume: 58, Issue:9

    Topics: Animals; Antifibrinolytic Agents; Cell Survival; Chemokine CCL2; Collagen; Conjunctiva; Disease Mode

2017
Intermediate Term Outcomes of Early Posttrabeculectomy Bleb Leaks Managed by Large Diameter Soft Bandage Contact Lens.
    Journal of glaucoma, 2017, Volume: 26, Issue:9

    Topics: Adult; Alkylating Agents; Bandages; Contact Lenses, Hydrophilic; Female; Glaucoma; Humans; Intraocul

2017
Posterior Surgical Revision of Failed Fornix-based Trabeculectomy.
    Journal of glaucoma, 2017, Volume: 26, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antihypertensive Agents; Conjunctiva; F

2017
Primary Trabeculectomy Outcomes by Glaucoma Fellows in a Tertiary Hospital in Brazil.
    Journal of glaucoma, 2017, Volume: 26, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Brazil; Education, Medical, Graduate; Fe

2017
Same-site surgical revision of failed trabeculectomy blebs with mitomycin C augmentation: long-term follow-up.
    Eye (London, England), 2018, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studie

2018
Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M

2017
Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
    Journal of glaucoma, 2018, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Female; Follow-Up Studies; Glaucoma; Glycosami

2018
Trabeculectomy bleb needling and antimetabolite administration practices in the UK: a glaucoma specialist national survey.
    The British journal of ophthalmology, 2018, Volume: 102, Issue:9

    Topics: Antimetabolites; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fluorouracil; Glaucoma;

2018
Trabeculectomy Outcomes After Glaucoma Drainage Device Surgery.
    Journal of glaucoma, 2018, Volume: 27, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Hum

2018
Mitomycin C in Filtering Surgery for Primary Congenital Glaucoma: A Comparison of Exposure Durations.
    Journal of pediatric ophthalmology and strabismus, 2018, May-01, Volume: 55, Issue:3

    Topics: Aged; Alkylating Agents; Female; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Intraocular

2018
Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery.
    Journal of glaucoma, 2018, Volume: 27, Issue:4

    Topics: Adult; Combined Modality Therapy; Glaucoma; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mito

2018
Results of an Adaptive Surgical Approach for Managing Late Onset Hypotony After Trabeculectomy With Mitomycin C.
    Journal of glaucoma, 2018, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Blister; Combined Modality Therapy; Female; Glaucoma; Humans; Intrao

2018
Ab Interno Gel Implant-associated Bleb-related Infection.
    American journal of ophthalmology, 2018, Volume: 189

    Topics: Aged; Alkylating Agents; Anti-Bacterial Agents; Endophthalmitis; Female; Follow-Up Studies; Gelatin;

2018
Combined trabeculotomy-trabeculectomy using the modified Safer Surgery System augmented with MMC: its long-term outcomes of glaucoma treatment in Asian children.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2018, Volume: 256, Issue:6

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Equipment Design; Female; Follow-U

2018
Comment on: Viscoelastic-augmented trabeculectomy - A newer concept.
    Indian journal of ophthalmology, 2018, Volume: 66, Issue:4

    Topics: Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postoperative Complications; Sclera; Trabeculecto

2018
[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant].
    Klinische Monatsblatter fur Augenheilkunde, 2019, Volume: 236, Issue:9

    Topics: Collagen; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Glycosaminoglycans; Humans; Intrao

2019
Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European Descent: Five-Year Results.
    JAMA ophthalmology, 2018, 10-01, Volume: 136, Issue:10

    Topics: Aged; Alkylating Agents; Black or African American; Combined Modality Therapy; Female; Follow-Up Stu

2018
Determining If Race Should Be Considered Within the Choice of Glaucoma Surgery.
    JAMA ophthalmology, 2018, 10-01, Volume: 136, Issue:10

    Topics: Glaucoma; Humans; Mitomycin; Sclera; Trabeculectomy

2018
Healing modulation in glaucoma surgery after application of subconjunctival triamcinolone acetate alone or combined with mitomycin C: an experimetal study.
    Revista do Colegio Brasileiro de Cirurgioes, 2018, Jul-30, Volume: 45, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Blister; Conjunctiva; Disease Models, Animal; Drug Therapy, Combi

2018
Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.
    Eye (London, England), 2018, Volume: 32, Issue:12

    Topics: Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male

2018
Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report.
    European journal of ophthalmology, 2019, Volume: 29, Issue:4

    Topics: Alkylating Agents; Anterior Chamber; Chronic Disease; Filtering Surgery; Glaucoma; Humans; Intraocul

2019
Outcomes of Laser Goniopuncture Following Nonpenetrating Deep Sclerectomy With Mitomycin C: A Large Retrospective Cohort Study.
    Journal of glaucoma, 2019, Volume: 28, Issue:1

    Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma

2019
Determinants of Corneal Endothelial Cell Loss After Trabeculectomy With Mitomycin C.
    Journal of glaucoma, 2019, Volume: 28, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Combined Modality Therapy; Corneal En

2019
Ex-PRESS glaucoma shunt implantation and trabeculectomy combined with mitomycin C in the treatment of uveitic glaucoma.
    Minerva medica, 2019, Volume: 110, Issue:3

    Topics: Adult; Combined Modality Therapy; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Male; Middle

2019
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.
    Indian journal of ophthalmology, 2019, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Child; Child, Preschool; Do

2019
The effectiveness of trabeculectomy with mitomycin C and releasable suture in posner-schlossman syndrome with secondary glaucoma: A case series.
    Nigerian journal of clinical practice, 2019, Volume: 22, Issue:1

    Topics: Adult; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomyc

2019
Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.
    ACS applied materials & interfaces, 2019, Mar-13, Volume: 11, Issue:10

    Topics: Adsorption; Cell-Derived Microparticles; Coated Materials, Biocompatible; Drug Liberation; Fibrosis;

2019
[Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety].
    Klinische Monatsblatter fur Augenheilkunde, 2020, Volume: 237, Issue:1

    Topics: Aged; Bevacizumab; Collagen; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Mitomycin; Trabecu

2020
Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model.
    Journal of glaucoma, 2019, Volume: 28, Issue:6

    Topics: Absorbable Implants; Animals; Drug Delivery Systems; Drug Implants; Drug Liberation; Endophthalmitis

2019
Phacotrabeculectomy in Eyes With Uveitic Glaucoma: A Retrospective Case-Control Study.
    Journal of glaucoma, 2019, Volume: 28, Issue:7

    Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Female; Glaucoma; Glaucoma, Open-Angle

2019
Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2019, Volume: 54, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma;

2019
Outcomes of Wider Area Bleb Revision Using Bleb Knife With Adjunctive Mitomycin C.
    Journal of glaucoma, 2019, Volume: 28, Issue:8

    Topics: Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Filtering Surgery; Glaucoma;

2019
[Ocular decompression retinopathy with pre-retinal hemorrhage after trabeculectomy: A case report].
    Journal francais d'ophtalmologie, 2019, Volume: 42, Issue:8

    Topics: Child; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Mitomycin; Postoperative Hemorr

2019
Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops.
    Acta ophthalmologica, 2020, Volume: 98, Issue:1

    Topics: Female; Follow-Up Studies; Glaucoma; Humans; Incidence; Intraocular Pressure; Japan; Male; Middle Ag

2020
Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
    Journal of glaucoma, 2015, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca

2015
Mitomycin solution (Mitosol) for glaucoma surgery.
    The Medical letter on drugs and therapeutics, 2013, Mar-18, Volume: 55, Issue:1412

    Topics: Cicatrix; Glaucoma; Humans; Mitomycin; Solutions

2013
Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study.
    Eye (London, England), 2013, Volume: 27, Issue:6

    Topics: Alkylating Agents; Analysis of Variance; Child; Child, Preschool; Female; Glaucoma; Glaucoma Drainag

2013
Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series.
    Retina (Philadelphia, Pa.), 2014, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Endotamponade; Female; Follow-Up Studies; Glaucom

2014
Comparison of trabeculectomy with mitomycin-C versus medical treatment in moderate stage of steroid induced glaucoma.
    Mymensingh medical journal : MMJ, 2013, Volume: 22, Issue:2

    Topics: Administration, Topical; Adolescent; Adult; Alkylating Agents; Child; Combined Modality Therapy; Fem

2013
Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery.
    Investigative ophthalmology & visual science, 2013, Jul-24, Volume: 54, Issue:7

    Topics: Administration, Topical; Analysis of Variance; Animals; Anti-Infective Agents, Local; Antibiotics, A

2013
Ocular surface complications after trabeculectomy: incidence, risk factors, time course and prognosis.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2013, Volume: 230, Issue:2

    Topics: Alkylating Agents; Corneal Diseases; Female; Glaucoma; Humans; Incidence; Male; Middle Aged; Mitomyc

2013
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
    JAMA ophthalmology, 2013, Volume: 131, Issue:9

    Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporin

2013
Anterior lens capsule application in phacotrabeculectomy.
    Journal of glaucoma, 2013, Volume: 22, Issue:7

    Topics: Alkylating Agents; Female; Glaucoma; Humans; Lens Capsule, Crystalline; Male; Mitomycin; Phacoemulsi

2013
Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery.
    Experimental eye research, 2013, Volume: 116

    Topics: Cell Proliferation; Cicatrix; Drug Delivery Systems; Filtering Surgery; Glaucoma; Humans; Mitomycin;

2013
Prognostic factors in trabeculectomy with mitomycin C having history of previous glaucoma surgery.
    Japanese journal of ophthalmology, 2013, Volume: 57, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Child, Preschool; Female; Glau

2013
Outcomes of same-site re-operation with minimal use of mitomycin in failed trabeculectomy.
    International ophthalmology, 2014, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Female; Glaucom

2014
Epiconjunctival mitomycin-C application for early failing filtering blebs.
    Seminars in ophthalmology, 2014, Volume: 29, Issue:1

    Topics: Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma; Humans; Intraocular Pressure; Male; Midd

2014
Postoperative flat anterior chamber: incidence, risk factors, and effect on the long-term success of trabeculectomy.
    Japanese journal of ophthalmology, 2013, Volume: 57, Issue:6

    Topics: Alkylating Agents; Anterior Chamber; Female; Glaucoma; Humans; Incidence; Intraocular Pressure; Male

2013
Fornix-based Trabeculectomy With Mitomycin C Using the Horizontal Conjunctival Suture Technique.
    Journal of glaucoma, 2015, Volume: 24, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula

2015
Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
    Journal of glaucoma, 2014, Volume: 23, Issue:9

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Collagen; Combined Modality Therapy; Female; Glaucoma; G

2014
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
    Journal of glaucoma, 2014, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Anterior Eye Segment; Combined Modality Therapy; Cross-S

2014
Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C.
    JAMA ophthalmology, 2014, Volume: 132, Issue:3

    Topics: Aged; Alkylating Agents; Female; Fluorouracil; Glaucoma; Gonioscopy; Humans; Intraocular Pressure; L

2014
Reply to Kivelä et al.
    Eye (London, England), 2014, Volume: 28, Issue:3

    Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy

2014
Interval censoring and competing risks when reporting results of glaucoma surgery.
    Eye (London, England), 2014, Volume: 28, Issue:3

    Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy

2014
The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2.
    Ophthalmology, 2014, Volume: 121, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Anti-Bacterial Agents; Cohort Studies

2014
Long-term outcomes of resident- versus attending-performed primary trabeculectomy with mitomycin C in a United States residency program.
    American journal of ophthalmology, 2014, Volume: 157, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Clinical Competence; Cohort Studies; Combined Mod

2014
Novel technique for posterior placement of mitomycin-soaked sponges in glaucoma surgery.
    Clinical & experimental ophthalmology, 2014, Volume: 42, Issue:9

    Topics: Alkylating Agents; Glaucoma; Humans; Mitomycin; Sclera; Surgical Sponges; Tenon Capsule; Trabeculect

2014
Traumatic aniridia after trabeculectomy.
    Eye (London, England), 2014, Volume: 28, Issue:6

    Topics: Aniridia; Eye Injuries; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Middle Aged; Mitomycin;

2014
Efficacy and safety of mitomycin C--augmented revisions of non-functioning filtering blebs after trabeculectomy--7 year results.
    Klinika oczna, 2013, Volume: 115, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Male; M

2013
Qualitative and quantitative analysis of filtering blebs with optical coherence tomography.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2014, Volume: 49, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Glaucoma; Humans; Intraocula

2014
CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
    Current eye research, 2014, Volume: 39, Issue:10

    Topics: Alkylating Agents; Animals; Chitosan; Conjunctiva; Disease Models, Animal; Drug Carriers; Fibrosis;

2014
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Adult; Aged; Blister; Female; Glaucoma; Humans; Intraocular Pressure; Kaplan-Meier Estimate; Male; M

2014
Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Animals; Antibodies, Monoclonal; Fibroblast Growth Factors; Filtering Surgery; Glaucoma; Infliximab;

2014
Meibomian gland loss due to trabeculectomy.
    Japanese journal of ophthalmology, 2014, Volume: 58, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Conjunctiva; Cross-Sectional Studies; Ey

2014
Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
    International ophthalmology, 2015, Volume: 35, Issue:3

    Topics: Aged; Alkylating Agents; Anthracenes; Antihypertensive Agents; Collagen; Combined Modality Therapy;

2015
Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Animals; Apoptosis; Biocompatible Materials; Drug Delivery Systems; Drug Implants; Filtering Surgery

2014
Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique.
    BMC ophthalmology, 2014, Sep-06, Volume: 14

    Topics: Administration, Topical; Adult; Cysts; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implan

2014
Conjunctival Advancement With Subconjunctival Amniotic Membrane Draping Technique for Leaking Cystic Blebs.
    Journal of glaucoma, 2016, Volume: 25, Issue:2

    Topics: Adult; Aged; Alkylating Agents; Amnion; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure;

2016
Long-term outcomes of needle revision of failing deep sclerectomy blebs.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:1

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans

2015
Incidence of Postoperative Ptosis Following Trabeculectomy With Mitomycin C.
    Journal of glaucoma, 2015, Volume: 24, Issue:6

    Topics: Adult; Aged; Alkylating Agents; Blepharoptosis; Female; Glaucoma; Humans; Incidence; Intraocular Pre

2015
The Long-term Outcomes of Glaucoma Drainage Device in Pediatric Glaucoma.
    Journal of glaucoma, 2016, Volume: 25, Issue:3

    Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucom

2016
Reply to "Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use".
    Journal of glaucoma, 2015, Volume: 24, Issue:3

    Topics: Alkylating Agents; Anterior Eye Segment; Female; Glaucoma; Humans; Male; Mitomycin; Sclera; Sclerost

2015
Combined deep sclerectomy and descemet stripping automated endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:12

    Topics: Aged; Aged, 80 and over; Cell Count; Cornea; Corneal Edema; Descemet Stripping Endothelial Keratopla

2014
Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
    Journal of glaucoma, 2015, Volume: 24, Issue:3

    Topics: Alkylating Agents; Anterior Eye Segment; Female; Glaucoma; Humans; Male; Mitomycin; Sclera; Sclerost

2015
Risk Factors for a Severe Bleb Leak Following Trabeculectomy: A Retrospective Case-Control Study.
    Journal of glaucoma, 2015, Volume: 24, Issue:7

    Topics: Age Factors; Aged; Alkylating Agents; Case-Control Studies; Female; Glaucoma; Humans; Intraocular Pr

2015
Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:3

    Topics: Aged; Alkylating Agents; Aqueous Humor; Conjunctiva; Cross-Sectional Studies; Female; Fistula; Glauc

2015
Outcomes of chronic hypotony following trabeculectomy.
    Clinical & experimental ophthalmology, 2015, Volume: 43, Issue:5

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Chronic Disease; Female; Glaucoma; Humans; Intraocular P

2015
Nonpenetrating deep sclerectomy for glaucoma after descemet stripping automated endothelial keratoplasty: three consecutive case reports.
    Medicine, 2015, Volume: 94, Issue:6

    Topics: Administration, Topical; Aged; Descemet Stripping Endothelial Keratoplasty; Female; Glaucoma; Humans

2015
Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010.
    JAMA ophthalmology, 2015, Volume: 133, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Child, Preschool; Female; Foll

2015
Surgical results of trabeculectomy and Ahmed valve implantation following a previous failed trabeculectomy in primary congenital glaucoma patients.
    Korean journal of ophthalmology : KJO, 2015, Volume: 29, Issue:2

    Topics: Child, Preschool; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; I

2015
Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome.
    Journal of glaucoma, 2016, Volume: 25, Issue:7

    Topics: Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Period; Iridocorne

2016
Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.
    Acta ophthalmologica, 2015, Volume: 93, Issue:7

    Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Bevacizumab; Chemotherapy, Adjuvant; Disease Mo

2015
The effect of adjustable suture (Khaw) trabeculectomy on intraocular pressure: a retrospective case series.
    International ophthalmology, 2016, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mi

2016
Fluctuation of Bacteria on Bleb Surface After Trabeculectomy With Adjunctive Mitomycin C.
    Journal of glaucoma, 2016, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Bacteria; Combined Modality Therapy; Conjunctiva;

2016
Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
    Ophthalmology, 2015, Volume: 122, Issue:11

    Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-U

2015
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.
    Eye (London, England), 2015, Volume: 29, Issue:11

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure

2015
[One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C].
    Journal francais d'ophtalmologie, 2015, Volume: 38, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Filtering Surgery; Glaucoma; Humans; Intr

2015
A Novel Method for the Delivery of Antimetabolites During Glaucoma Surgery.
    Journal of glaucoma, 2016, Volume: 25, Issue:1

    Topics: Antimetabolites; Drug Delivery Systems; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Postopera

2016
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Bevacizumab; Bl

2015
Management of Elevated Intraocular Pressure Associated With Subluxated/Dislocated Lenses by Combining Trabeculectomy With Adjunctive Mitomycin C With Lensectomy, Vitrectomy, and Scleral Fixation of Intraocular Lens.
    Journal of glaucoma, 2016, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Aged; Child; Female; Glaucoma; Humans; Intraocular Pressure; Lens Subluxation; Le

2016
Concentration Accuracy of Compounded Mitomycin C for Ophthalmic Surgery.
    JAMA ophthalmology, 2016, Volume: 134, Issue:2

    Topics: Alkylating Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Storage; Fibrosis; G

2016
A role for antimetabolites in glaucoma tube surgery: current evidence and future directions.
    Current opinion in ophthalmology, 2016, Volume: 27, Issue:2

    Topics: Animals; Antimetabolites; Fibrosis; Fluorouracil; Glaucoma; Humans; Mitomycin; Trabeculectomy

2016
A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
    Ophthalmology, 2016, Volume: 123, Issue:4

    Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Syndrome; F

2016
Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification.
    Indian journal of ophthalmology, 2015, Volume: 63, Issue:12

    Topics: Aged; Alkylating Agents; Blepharoptosis; Cataract; Combined Modality Therapy; Female; Glaucoma; Huma

2015
Intraoperative transconjunctival mitomycin-C application for needle revision of trabeculectomy.
    Clinical & experimental ophthalmology, 2016, Volume: 44, Issue:7

    Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Follow-Up Studies; Glaucoma

2016
Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease.
    Journal of glaucoma, 2016, Volume: 25, Issue:6

    Topics: Adult; Alkylating Agents; Cohort Studies; Combined Modality Therapy; Conjunctiva; Female; Glaucoma;

2016
Visual rehabilitation and intraocular pressure control after combined manual small incision cataract surgery and mitomycin-C augmented trabeculectomy.
    Nepal Medical College journal : NMCJ, 2014, Volume: 16, Issue:2-4

    Topics: Adult; Aged; Aged, 80 and over; Cataract Extraction; Female; Glaucoma; Humans; Intraocular Pressure;

2014
Transconjunctival Revision With Mitomycin-C Following Failed Trabeculectomy.
    Journal of glaucoma, 2016, Volume: 25, Issue:7

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fluorour

2016
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
    Journal of glaucoma, 2016, Volume: 25, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human

2016
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
    Acta ophthalmologica, 2016, Volume: 94, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio

2016
Tube Fenestration in the Tube Versus Trabeculectomy Study.
    Ophthalmology, 2016, Volume: 123, Issue:10

    Topics: Aged; Alkylating Agents; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure;

2016
Additive Effect of Risk Factors for Trabeculectomy Failure in Glaucoma Patients: A Risk-group From a Cohort Study.
    Journal of glaucoma, 2016, Volume: 25, Issue:10

    Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Predictiv

2016
Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation.
    Clinical & experimental ophthalmology, 2017, Volume: 45, Issue:2

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Drug T

2017
The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery.
    Investigative ophthalmology & visual science, 2016, 08-01, Volume: 57, Issue:10

    Topics: Animals; Anterior Chamber; Blood Proteins; Cicatrix; Disease Models, Animal; Filtering Surgery; Glau

2016
α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
    Acta ophthalmologica, 2017, Volume: 95, Issue:1

    Topics: Administration, Topical; Alkylating Agents; Aminoquinolines; Animals; Collagen; Conjunctiva; Disease

2017
Re: Panarelli et al.: A retrospective comparison of primary Baerveldt implantation versus trabeculectomy with mitomycin C (Ophthalmology 2016;123:789-95).
    Ophthalmology, 2016, Volume: 123, Issue:10

    Topics: Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Postoperative Complic

2016
Revision of trabeculectomy filtering blebs with mitomycin C: Long term results.
    Indian journal of ophthalmology, 2016, Volume: 64, Issue:11

    Topics: Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Nucleic Ac

2016
Outcome of repeat trabeculectomies: long-term follow-up.
    The British journal of ophthalmology, 2017, Volume: 101, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Stud

2017
Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.
    Journal of glaucoma, 2017, Volume: 26, Issue:2

    Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Glaucoma;

2017
Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.
    Journal of glaucoma, 2017, Volume: 26, Issue:5

    Topics: Adult; Alkylating Agents; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma; Humans; Intr

2017
Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery.
    Journal of Korean medical science, 2017, Volume: 32, Issue:4

    Topics: Animals; Ciliary Body; Conjunctiva; Cornea; Glaucoma; Hydroxamic Acids; Indoles; Matrix Metalloprote

2017
Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology.
    Ophthalmology, 2008, Volume: 115, Issue:6

    Topics: Academies and Institutes; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor;

2008
Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes.
    American journal of ophthalmology, 2008, Volume: 146, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Cataract Extraction; Combined Modalit

2008
Efficacy and safety of deep sclerectomy in uveitic glaucoma.
    International ophthalmology, 2009, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Child; Drug Delivery Systems; Female; Glaucoma; Glaucoma Drainage Implants; Human

2009
A modified technique of Ahmed glaucoma valve implantation with adjunctive use of antifibrotic agents.
    American journal of ophthalmology, 2008, Volume: 146, Issue:2

    Topics: Alkylating Agents; Combined Modality Therapy; Fibrosis; Fluorouracil; Glaucoma; Glaucoma Drainage Im

2008
Enhancement of the success rate in trabeculectomy: large-area mitomycin-C application.
    Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:4

    Topics: Aged; Blister; Glaucoma; Humans; Incidence; Intraocular Pressure; Intraoperative Care; Middle Aged;

2008
Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.
    Clinics (Sao Paulo, Brazil), 2008, Volume: 63, Issue:4

    Topics: Adolescent; Age Distribution; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modalit

2008
Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery.
    Journal of glaucoma, 2008, Volume: 17, Issue:6

    Topics: Antimetabolites; Australia; Cross-Sectional Studies; Fluorouracil; Glaucoma; Glucocorticoids; Health

2008
The surgical outcome of primary trabeculectomy with mitomycin C and A fornix-based conjunctival flap technique in Thailand.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Child; Female; Glaucoma; Humans; Male

2008
Intraoperative mitomycin C use during filtration surgery and lacrimal drainage system obstruction.
    American journal of ophthalmology, 2009, Volume: 147, Issue:3

    Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Dacryocystorhinostomy; Female

2009
Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap.
    Acta ophthalmologica, 2010, Volume: 88, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma; Glauco

2010
Decompression retinopathy and possible risk factors.
    Acta ophthalmologica, 2009, Volume: 87, Issue:1

    Topics: Child; Decompression, Surgical; Eye Diseases; Glaucoma; Humans; Intraocular Pressure; Male; Mitomyci

2009
Superior versus inferior Ahmed glaucoma valve implantation.
    Ophthalmology, 2009, Volume: 116, Issue:2

    Topics: Adult; Antihypertensive Agents; Equipment Safety; Female; Follow-Up Studies; Glaucoma; Glaucoma Drai

2009
Block suture for trabeculectomy using only 2 anchors.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:12

    Topics: Alkylating Agents; Conjunctiva; Glaucoma; Humans; Intraocular Pressure; Intraoperative Complications

2008
Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C.
    Acta ophthalmologica, 2008, Volume: 86, Issue:8

    Topics: Aged; Blister; Choroid Diseases; Cysts; Eye Diseases; Glaucoma; Humans; Hyphema; Injections; Intraoc

2008
Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb.
    Acta ophthalmologica, 2010, Volume: 88, Issue:8

    Topics: Aged; Alkylating Agents; Blister; Combined Modality Therapy; Conjunctival Diseases; Diagnostic Techn

2010
Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
    Journal of glaucoma, 2009, Volume: 18, Issue:7

    Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Fluorouracil; F

2009
A thin honeycomb-patterned film as an adhesion barrier in an animal model of glaucoma filtration surgery.
    Journal of glaucoma, 2009, Volume: 18, Issue:3

    Topics: Absorbable Implants; Animals; Blister; Conjunctival Diseases; Disease Models, Animal; Filtering Surg

2009
Late-onset bleb leakage.
    Journal of glaucoma, 2009, Volume: 18, Issue:3

    Topics: Aged; Blister; Fluorescein; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Ocular Hypotens

2009
Histopathology of a functioning mitomycin-C trabeculectomy.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:3

    Topics: Anterior Eye Segment; Blister; Eye Enucleation; Glaucoma; Humans; Iris Neoplasms; Male; Melanoma; Mi

2009
The increasingly iatrogenic indications for mitomycin C trabeculectomy over 10 years.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:2

    Topics: Alkylating Agents; Combined Modality Therapy; Corneal Transplantation; Female; Glaucoma; Humans; Iat

2009
Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis.
    Eye (London, England), 2009, Volume: 23, Issue:7

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Education, Medical, Co

2009
Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C.
    Ophthalmology, 2009, Volume: 116, Issue:10

    Topics: Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Glaucoma Drainage

2009
High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:4

    Topics: Aged; Anterior Eye Segment; Blister; Combined Modality Therapy; Cross-Sectional Studies; Female; Gla

2009
Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:8

    Topics: Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Fibroblasts; Fibrosis; Glaucoma; Humans;

2009
Noncontact in vivo scanning laser microscopy of filtering blebs.
    Journal of glaucoma, 2009, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Blister; Combined Modality Therapy; Conju

2009
Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy after glaucoma filtration surgery.
    Journal of glaucoma, 2010, Volume: 19, Issue:6

    Topics: Aged; Alkylating Agents; Female; Glaucoma; Humans; Imaging, Three-Dimensional; Intraocular Pressure;

2010
Conjunctival and corneal findings in bleb-associated endophthalmitis: an in vivo confocal microscopy study.
    Acta ophthalmologica, 2011, Volume: 89, Issue:4

    Topics: Aged; Aged, 80 and over; Blister; Case-Control Studies; Conjunctivitis; Endophthalmitis; Female; Gla

2011
Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma.
    Eye (London, England), 2010, Volume: 24, Issue:6

    Topics: Cornea; Female; Glaucoma; Graft Survival; Humans; Intraocular Pressure; Keratoplasty, Penetrating; M

2010
Glaucoma surgery decreases the rates of localized and global visual field progression.
    American journal of ophthalmology, 2010, Volume: 149, Issue:2

    Topics: Algorithms; Disease Progression; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular P

2010
Early trabeculectomy bleb walls on anterior-segment optical coherence tomography.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Blister; Conjunctiva; Cross-Sectional Studies; Fe

2010
Three-year follow-up of the tube versus trabeculectomy study.
    American journal of ophthalmology, 2010, Volume: 149, Issue:4

    Topics: Antihypertensive Agents; Cataract Extraction; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implant

2010
Corneal complications of intraoperative Mitomycin C in glaucoma surgery.
    Bulletin de la Societe belge d'ophtalmologie, 2010, Issue:314

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Antifibrinolytic Agents; Corneal Diseases; Epithelium, C

2010
Pediatric Ahmed valves.
    Ophthalmology, 2010, Volume: 117, Issue:6

    Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant;

2010
Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma.
    International ophthalmology, 2010, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Anterior Chamber; Equipment Design; Female; Follow-Up Studies; Glaucoma; Hu

2010
Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
    Clinical & experimental ophthalmology, 2010, Volume: 38, Issue:9

    Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Mi

2010
Mitomycin-C and pediatric Ahmed valves.
    Ophthalmology, 2010, Volume: 117, Issue:7

    Topics: Alkylating Agents; Combined Modality Therapy; Glaucoma; Glaucoma Drainage Implants; Humans; Infant;

2010
An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with mitomycin-C and a histone deacetylase inhibitor.
    Archives of pharmacal research, 2010, Volume: 33, Issue:8

    Topics: Alkylating Agents; Animals; Apoptosis; Cells, Cultured; Conjunctiva; Drug Therapy, Combination; Epit

2010
Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study.
    Ophthalmology, 2011, Volume: 118, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Combined Modality Therapy; Eye In

2011
Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium.
    Ophthalmology, 2011, Volume: 118, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Cell Count; Child; Chi

2011
Cationic nano-copolymers mediated IKKβ targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery.
    Molecular vision, 2010, Nov-26, Volume: 16

    Topics: Animals; Biological Assay; Cations; Cell Count; Cell Proliferation; Cell Survival; Disease Models, A

2010
Update on congenital glaucoma.
    Indian journal of ophthalmology, 2011, Volume: 59 Suppl

    Topics: Adrenergic Agents; Adrenergic Antagonists; Carbonic Anhydrase Inhibitors; Cryotherapy; Glaucoma; Gla

2011
Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Cross-Linking Reagents; Femal

2011
Antimetabolite application technique in trabeculectomy surgery.
    Clinical & experimental ophthalmology, 2011, Volume: 39, Issue:6

    Topics: Antimetabolites; Drug Delivery Systems; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraoperative Car

2011
Reversal of optic disc cupping with improvement of visual field and stereometric parameters after trabeculectomy in young adult patients (two case reports).
    Bulletin de la Societe belge d'ophtalmologie, 2010, Issue:316

    Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Male; Mitomycin; Optic Disk; Trabecu

2010
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
    Investigative ophthalmology & visual science, 2011, May-16, Volume: 52, Issue:6

    Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Ce

2011
Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.
    Journal of glaucoma, 2013, Volume: 22, Issue:1

    Topics: Aged; Alkylating Agents; Combined Modality Therapy; Cornea; Female; Glaucoma; Humans; Intraocular Pr

2013
Childhood orbitotemporal neurofibromatosis masked by congenital glaucoma and buphthalmos.
    Journal of pediatric ophthalmology and strabismus, 2011, Jul-19, Volume: 48 Online

    Topics: Alkylating Agents; Diagnosis, Differential; Glaucoma; Humans; Hydrophthalmos; Infant; Magnetic Reson

2011
Vision loss and recovery after trabeculectomy: risk and associated risk factors.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:8

    Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Postoperative Complications;

2011
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
    Journal of glaucoma, 2013, Volume: 22, Issue:2

    Topics: Alkylating Agents; Animals; Antibodies, Monoclonal, Humanized; Cicatrix; Conjunctiva; Disease Models

2013
Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia.
    Eye (London, England), 2012, Volume: 26, Issue:1

    Topics: Aged; Analysis of Variance; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Mal

2012
Changing trends in the incidence of bleb-related infection in trabeculectomy.
    The British journal of ophthalmology, 2012, Volume: 96, Issue:7

    Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Endophthalmitis; Eye Infecti

2012
Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
    Current eye research, 2012, Volume: 37, Issue:3

    Topics: Administration, Topical; Alkylating Agents; Animals; Cicatrix; Conjunctival Diseases; Disease Models

2012
Outcomes of trabeculectomy after descemet stripping automated endothelial keratoplasty: a comparison with penetrating keratoplasty.
    American journal of ophthalmology, 2012, Volume: 153, Issue:6

    Topics: Alkylating Agents; Case-Control Studies; Descemet Stripping Endothelial Keratoplasty; Female; Glauco

2012
Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C.
    Molecular vision, 2012, Volume: 18

    Topics: Animals; Anterior Chamber; Collagen; Conjunctiva; Delayed-Action Preparations; Dexamethasone; Filter

2012
Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Administration, Topical; Animals; Blood Platelets; Cicatrix; Disease Models, Animal; Eye; Fibrosis;

2012
Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy.
    Experimental eye research, 2012, Volume: 100

    Topics: Adipose Tissue; Cell Culture Techniques; Cell Proliferation; Choroid; Extracellular Matrix Proteins;

2012
Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy.
    Japanese journal of ophthalmology, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Glaucoma; Huma

2012
Comparative study of encapsulated blebs following Ahmed glaucoma valve implantation and trabeculectomy with mitomycin-C.
    Korean journal of ophthalmology : KJO, 2012, Volume: 26, Issue:4

    Topics: Adult; Blister; Female; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; Male; Middle Aged; Mit

2012
Histological and ultrastructural features for proliferation inhibition by delivery of exogenous p27Kip1 to rabbit models after glaucoma filtration surgery.
    Eye science, 2012, Volume: 27, Issue:3

    Topics: Adenoviridae; Animals; Cell Proliferation; Cicatrix; Conjunctiva; Cyclin-Dependent Kinase Inhibitor

2012
Mitomycin-augmented non-penetrating deep sclerectomy: preoperative gonioscopy and postoperative perimetric, tonometric and medication trends.
    The British journal of ophthalmology, 2013, Volume: 97, Issue:3

    Topics: Aged; Antibiotics, Antineoplastic; Female; Follow-Up Studies; Glaucoma; Gonioscopy; Humans; Intraocu

2013
Interval censoring for survival curves when reporting the results of glaucoma surgery.
    Eye (London, England), 2013, Volume: 27, Issue:2

    Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy

2013
Response to Dulku and de Klerk and Moriarty.
    Eye (London, England), 2013, Volume: 27, Issue:2

    Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy

2013
Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'.
    Eye (London, England), 2013, Volume: 27, Issue:2

    Topics: Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Pseudophakia; Sclera; Sclerostomy

2013
Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy.
    Journal of glaucoma, 2013, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Collagen; Cross-Linking Reagents; Female; Follow-U

2013
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:6

    Topics: Absorbable Implants; Aged; Alkylating Agents; Cataract; Collagen; Female; Glaucoma; Glycosaminoglyca

2013
Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas.
    International ophthalmology, 2013, Volume: 33, Issue:6

    Topics: Aged; Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Bevac

2013
[Where should we go in the post-mitomycin era of glaucoma surgery?].
    Nippon Ganka Gakkai zasshi, 2002, Volume: 106, Issue:6

    Topics: Glaucoma; Humans; Mitomycin

2002
Trabeculectomy with antiproliferative agents in uveitic glaucoma.
    Journal of glaucoma, 2002, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineopla

2002
Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant.
    Journal of glaucoma, 2002, Volume: 11, Issue:4

    Topics: Adult; Aged; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Life Tables; Middle

2002
[Long-term follow-up of mitomycin C in trabeculectomy].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Jun-28, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Female; Follow-Up Studies; Glaucoma; Humans; Male; Microsurgery; Mitomycin; Nucle

2000
[Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid].
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:9

    Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Disease Progression; Drug Evaluation; Drug Therapy, Co

2002
Standardization of the dose of intraoperative mitomycin C in trabeculectomy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2002, Volume: 240, Issue:7

    Topics: Antibiotics, Antineoplastic; Glaucoma; Humans; Intraoperative Period; Mitomycin; Trabecular Meshwork

2002
Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata.
    Cornea, 2002, Volume: 21, Issue:7

    Topics: Corneal Diseases; Endothelium, Corneal; Glaucoma; Humans; Mitomycin; Trabeculectomy

2002
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma.
    Journal of glaucoma, 2002, Volume: 11, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glau

2002
Clinical experience of e-PTFE membrane implant surgery for refractory glaucoma.
    The British journal of ophthalmology, 2003, Volume: 87, Issue:1

    Topics: Adult; Aged; Equipment Design; Female; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Huma

2003
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
    Eye (London, England), 2003, Volume: 17, Issue:1

    Topics: Adolescent; Aphakia, Postcataract; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Child; Chi

2003
[Interferon-alpha 2b inhibits proliferation of human tenon capsule fibroblasts].
    Yan ke xue bao = Eye science, 1998, Volume: 14, Issue:4

    Topics: Antimetabolites; Cell Division; Cells, Cultured; Conjunctiva; Fibroblasts; Filtering Surgery; Fluoro

1998
Five-year results of trabeculectomy with mitomycin C.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2003, Volume: 241, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pre

2003
Fornix-based trabeculectomy using the 'anchoring' corneal suture technique.
    Clinical & experimental ophthalmology, 2003, Volume: 31, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Asian People; Combined Modality Therapy; Conjunctiva; Cornea; Fe

2003
Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application.
    Current eye research, 2002, Volume: 25, Issue:4

    Topics: Analysis of Variance; Diffusion; Dose-Response Relationship, Drug; Glaucoma; Humans; In Vitro Techni

2002
The Armenian Eye Care Project: surgical outcomes of complicated paediatric glaucoma.
    The British journal of ophthalmology, 2003, Volume: 87, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Armenia; Child; Cohort Studies; Glaucoma; Humans; Intraocular Pre

2003
Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C.
    Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Connective Tissue; Female; Glaucom

2003
Mitomycin C eliminates the short-term intraocular pressure rise found following Molteno tube implantation.
    Clinical & experimental ophthalmology, 2003, Volume: 31, Issue:3

    Topics: Adult; Aged; Glaucoma; Humans; Intraoperative Care; Male; Middle Aged; Mitomycin; Molteno Implants;

2003
Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up.
    Clinical & experimental ophthalmology, 2003, Volume: 31, Issue:3

    Topics: Adult; Aged; Female; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Intrao

2003
[Improve the quality of glaucoma surgery].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 1998, Volume: 34, Issue:3

    Topics: Filtering Surgery; Glaucoma; Humans; Mitomycin

1998
Effects of systemic octreotide, local mytomycine-C and local corticosteroids on wound-healing reaction after glaucoma surgery.
    International ophthalmology, 2001, Volume: 24, Issue:5

    Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Ciliary Body; Conjunctiva; Fibroblasts; F

2001
[Clinical experiences and results of application of mitomycin C in trabeculectomy].
    Klinische Monatsblatter fur Augenheilkunde, 2003, Volume: 220, Issue:9

    Topics: Aged; Choroid Diseases; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Intr

2003
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.
    Ophthalmology, 2003, Volume: 110, Issue:11

    Topics: Adult; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Conjunctival Diseases; Cysts;

2003
Needling revision of failed filtering blebs after trabeculectomy: a retrospective study.
    Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Child, Preschool; Conjunctiva; Female; Fluorouracil; Follow-Up Studi

2003
Amnion-shielded trabeculectomy.
    Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:6

    Topics: Amnion; Aqueous Humor; Biological Dressings; Chronic Disease; Glaucoma; Humans; Intraocular Pressure

2003
Mitomycin C trabeculectomy in an eye with cicatricial conjunctiva following amniotic membrane transplantation.
    Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:6

    Topics: Adult; Amnion; Antibiotics, Antineoplastic; Biological Dressings; Cicatrix; Conjunctival Diseases; G

2003
Aqueous shunt devices compared with trabeculectomy with Mitomycin-C for children in the first two years of life.
    American journal of ophthalmology, 2003, Volume: 136, Issue:6

    Topics: Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Glaucoma; Glaucoma Drainage I

2003
The case against glaucoma drainage implant surgery in patients with a poor prognosis for standard filtering procedure.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:1

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Fibrosis; Fluorouracil; Glaucoma; Glau

2004
Effect of human RAD50 gene therapy on glaucoma filtering surgery in rabbit eye.
    Current eye research, 2004, Volume: 28, Issue:3

    Topics: Animals; Cell Division; Conjunctiva; DNA-Binding Proteins; Fibroblasts; Fibrosis; Genetic Therapy; G

2004
Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension.
    Gene therapy, 2004, Volume: 11, Issue:12

    Topics: Adenoviridae; Animals; Antimetabolites; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins;

2004
Consultation section. Refractive surgical problem.
    Journal of cataract and refractive surgery, 2004, Volume: 30, Issue:3

    Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Astigmatism; Corneal

2004
Recurrent retinal haemorrhages after glaucoma surgery.
    Acta ophthalmologica Scandinavica, 2004, Volume: 82, Issue:3 Pt 1

    Topics: Adolescent; Antibiotics, Antineoplastic; Combined Modality Therapy; Fluorescein Angiography; Glaucom

2004
Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C.
    Journal of glaucoma, 2004, Volume: 13, Issue:3

    Topics: Antibiotics, Antineoplastic; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies;

2004
Clinical and anatomical reversal of long-term hypotony maculopathy.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Antibiotics, Antineoplastic; Conjunctiva; Female; Glaucoma; Humans; Intraocular Pressure; Middle Age

2004
Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life.
    American journal of ophthalmology, 2004, Volume: 137, Issue:6

    Topics: Antibiotics, Antineoplastic; Aqueous Humor; Glaucoma; Glaucoma Drainage Implants; Humans; Infant; In

2004
Trabeculectomy outcomes in a Malaysian general hospital.
    The Medical journal of Malaysia, 2003, Volume: 58, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Chemotherapy, Adjuvant; Combined Modality Therapy;

2003
Trabeculectomy and antimetabolites.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:7

    Topics: Antimetabolites; Cicatrix; Clinical Competence; Fluorouracil; Glaucoma; Humans; Mitomycin; Trabecule

2004
National survey of antimetabolite use in glaucoma surgery in the United Kingdom.
    The British journal of ophthalmology, 2004, Volume: 88, Issue:7

    Topics: Antimetabolites; Fluorouracil; Glaucoma; Health Care Surveys; Humans; Intraoperative Care; Mitomycin

2004
Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
    Optometry and vision science : official publication of the American Academy of Optometry, 2004, Volume: 81, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cataract Extraction

2004
Fornix vs limbal-based trabeculectomy with mitomycin C.
    Eye (London, England), 2005, Volume: 19, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chi-Square Distribution; Cornea; Female

2005
[Surgical management of pathologic filtering blebs in pediatric glaucoma].
    Klinika oczna, 2004, Volume: 106, Issue:1-2 Suppl

    Topics: Adolescent; Anti-Bacterial Agents; Blister; Child; Endophthalmitis; Female; Glaucoma; Humans; Male;

2004
An explanation of transient visual loss associated with leaking filtering bleb.
    American journal of ophthalmology, 2004, Volume: 138, Issue:5

    Topics: Aqueous Humor; Cornea; Female; Fluorophotometry; Glaucoma; Humans; Middle Aged; Mitomycin; Postopera

2004
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
    Journal of glaucoma, 2004, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu

2004
Foldable acrylic versus rigid polymethylmethacrylate intraocular lens in combined phacoemulsification and trabeculectomy.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2004, Volume: 39, Issue:6

    Topics: Aged; Antibiotics, Antineoplastic; Biocompatible Materials; Cataract; Glaucoma; Hospitals, Universit

2004
Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C.
    Journal of glaucoma, 2005, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Conjunct

2005
Augmented trabeculectomy in paediatric glaucoma.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:2

    Topics: Antimetabolites; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorouracil; Glaucoma;

2005
Histopathologic features of conjunctival filtering blebs.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:2

    Topics: Cell Count; Conjunctiva; Epithelial Cells; Fibrosis; Fluorouracil; Glaucoma; Goblet Cells; Humans; M

2005
2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use.
    Journal of glaucoma, 2005, Volume: 14, Issue:2

    Topics: Antineoplastic Agents; Drug Utilization; Fibrosis; Filtering Surgery; Fluorouracil; Glaucoma; Glauco

2005
Deep sclerectomy augmented with mitomycin C.
    Eye (London, England), 2005, Volume: 19, Issue:4

    Topics: Aged; Antihypertensive Agents; Blister; Cicatrix; Conjunctiva; Epidemiologic Methods; Exudates and T

2005
[Clinical results of fornix-based trabeculectomy with a scleral tunnel].
    Nippon Ganka Gakkai zasshi, 2005, Volume: 109, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M

2005
Correlation between surgical success rate and severity of congenital glaucoma.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:4

    Topics: Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intraocular Press

2005
Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:8

    Topics: Child; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Retinal H

2005
Protocol for mitomycin C use in glaucoma surgery.
    Acta ophthalmologica Scandinavica, 2005, Volume: 83, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Clinical Protocols; Conjunctiva; Female; Glaucoma; Humans; Intrao

2005
Effectiveness of octreotide, an antiproliferative agent, on wound healing reaction after glaucoma surgery in an experimental rabbit model.
    International ophthalmology, 2004, Volume: 25, Issue:3

    Topics: Animals; Antineoplastic Agents, Hormonal; Ciliary Body; Glaucoma; Mitomycin; Octreotide; Uveal Disea

2004
Effects of mitomycin C on glaucoma filtration capsules.
    Biomedical sciences instrumentation, 2005, Volume: 41

    Topics: Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fibrosis; Glaucoma; Glaucoma Drainage

2005
Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
    Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme Inhibito

2005
Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:6

    Topics: Aged; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Intraoper

2005
Bullous keratopathy as a complication of trabeculectomy with mitomycin C.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:12

    Topics: Adult; Corneal Diseases; Endothelium, Corneal; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans;

2005
[Characteristics of filtering blebs after fornix-based trabeculectomy with a scleral tunnel].
    Nippon Ganka Gakkai zasshi, 2005, Volume: 109, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula

2005
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:7

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma;

2005
Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:8

    Topics: Aged; Aged, 80 and over; Biometry; Cataract; Cornea; Eye; Female; Glaucoma; Humans; Intraocular Pres

2005
Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
    Bulletin de la Societe belge d'ophtalmologie, 2005, Issue:296

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Follow-Up Studies; Glauco

2005
Corneal honeybee sting.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:4

    Topics: Aged; Animals; Bees; Corneal Diseases; Corneal Injuries; Eye Foreign Bodies; Glaucoma; Humans; Insec

2005
Autosomal dominant Weill-Marchesani syndrome and glaucoma management.
    Saudi medical journal, 2005, Volume: 26, Issue:9

    Topics: Abnormalities, Multiple; Adolescent; Chromosome Disorders; Dwarfism; Eye Abnormalities; Follow-Up St

2005
Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
    Collegium antropologicum, 2005, Volume: 29 Suppl 1

    Topics: Adult; Antimetabolites; Croatia; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care

2005
Intermediate-term comparison of trabeculectomy with intraoperative mitomycin-C between Asian American and Caucasian glaucoma patients: a case-controlled comparison.
    Eye (London, England), 2007, Volume: 21, Issue:1

    Topics: Adult; Aged; Asian; Combined Modality Therapy; Epidemiologic Methods; Female; Glaucoma; Humans; Intr

2007
Cyclosporin as an adjunct to glaucoma filtration surgery.
    Journal of glaucoma, 2005, Volume: 14, Issue:6

    Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiv

2005
Is intraocular pressure in the early postoperative period predictive of antimetabolite-augmented filtration surgery success?
    Journal of glaucoma, 2005, Volume: 14, Issue:6

    Topics: Aged; Antimetabolites; Combined Modality Therapy; Female; Fluorouracil; Glaucoma; Humans; Intraocula

2005
Deep sclerectomy with mitomycin C in failed trabeculectomy.
    Eye (London, England), 2007, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Administration Schedu

2007
Comparison of two clinical Bleb grading systems.
    Ophthalmology, 2006, Volume: 113, Issue:1

    Topics: Blister; Diagnostic Techniques, Ophthalmological; Fluorouracil; Glaucoma; Humans; Mitomycin; Prospec

2006
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:2

    Topics: Aged; Blister; Conjunctiva; Conjunctival Diseases; Female; Fluorouracil; Glaucoma; Humans; Intraocul

2006
Short and long term effect of combined cataract and glaucoma surgery with MMC on ocular dimensions.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:2

    Topics: Antihypertensive Agents; Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Mitomycin

2006
Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:2

    Topics: Antihypertensive Agents; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Trabeculectomy

2006
Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Cataract; Follow-Up Studies; Glaucoma; Humans; Intraocular Press

2006
Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C.
    Journal of glaucoma, 2006, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Antimetabolites; Blister; Child; Combined Modality Therapy; Conjunctiva; Co

2006
Surgical reduction of symptomatic, circumferential, filtering blebs.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:6

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Conjunctiv

2006
Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels.
    Journal of glaucoma, 2006, Volume: 15, Issue:4

    Topics: Adult; Cell Proliferation; Cells, Cultured; Conjunctiva; Dose-Response Relationship, Drug; Drug Deli

2006
Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:4

    Topics: Aged; Aged, 80 and over; Antimetabolites; Cataract; Female; Fluorouracil; Glaucoma; Humans; Intraocu

2006
Phacotrabeculectomy with mitomycin C in patients with uveitis.
    American journal of ophthalmology, 2006, Volume: 142, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co

2006
Refractory glaucoma--here there be dragons.
    Clinical & experimental ophthalmology, 2006, Volume: 34, Issue:8

    Topics: Ciliary Body; Combined Modality Therapy; Glaucoma; Humans; Intraocular Pressure; Laser Coagulation;

2006
Trabeculectomy with brief exposure to mitomycin C.
    Clinical & experimental ophthalmology, 2006, Volume: 34, Issue:8

    Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Female; Glaucoma; Humans; Int

2006
Immediate postoperative intraocular pressure measurements after trabeculectomy with releasable sutures.
    Clinical & experimental ophthalmology, 2006, Volume: 34, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; False Negative Reactions; Female; Fluorou

2006
[Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye].
    Journal francais d'ophtalmologie, 2006, Volume: 29, Issue:9

    Topics: Animals; Cicatrix; Collagen; Drug Delivery Systems; Filtering Surgery; Glaucoma; Mitomycin; Prosthes

2006
[An experimental trial of glaucoma filtering surgery with amniotic membrane].
    Yan ke xue bao = Eye science, 2005, Volume: 21, Issue:2

    Topics: Amnion; Animals; Antimetabolites; Fibroblasts; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ra

2005
Glaucoma tube or trabeculectomy? That is the question.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Glaucoma; Glaucoma Drainage Implants; Humans;

2007
[Mitomycin C versus 5-FU in failing blebs needling].
    Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:12

    Topics: Filtering Surgery; Fluorouracil; Glaucoma; Humans; Mitomycin; Punctures; Treatment Failure

2006
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
    Journal of glaucoma, 2007, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M

2007
Phacotrabeculectomy study.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:2

    Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr

2007
Mietz H, Krieglstein GK: Postoperative application of mitomycin C improves the complete success rate of primary trabeculectomy: a prospective, randomized trial. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1429-1436.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2007, Volume: 245, Issue:8

    Topics: Alkylating Agents; Fibrosis; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; P

2007
Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Combined Mod

2007
The use of a "cheese-wire" suture in trabeculectomy.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care;

2007
Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
    Eye (London, England), 2008, Volume: 22, Issue:8

    Topics: Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular

2008
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
    Transactions of the American Ophthalmological Society, 2006, Volume: 104

    Topics: Alkylating Agents; Animals; Antimetabolites; Blister; Conjunctiva; Connective Tissue; Connective Tis

2006
A case of Sturge-Weber syndrome in association with phacomatosis pigmentovascularis and developmental glaucoma.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2007, Volume: 11, Issue:4

    Topics: Adolescent; Female; Glaucoma; Humans; Mitomycin; Neurocutaneous Syndromes; Sturge-Weber Syndrome; Tr

2007
Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:6

    Topics: Aged; Alkylating Agents; Cataract; Choroid Hemorrhage; Combined Modality Therapy; Exfoliation Syndro

2007
Long-term results of trabeculectomy with mitomycin C applied under the scleral flap.
    International ophthalmology, 2007, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Combined Modality Therapy; Female; Follow-Up Stud

2007
Surgical revision of failed filtration surgery with mitomycin C augmentation.
    Journal of glaucoma, 2007, Volume: 16, Issue:5

    Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; F

2007
Management of suprachoroidal hemorrhage.
    Journal of glaucoma, 2007, Volume: 16, Issue:6

    Topics: Aged, 80 and over; Choroid Hemorrhage; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocu

2007
Focal corneal decompensation after filtering surgery with mitomycin C.
    Cornea, 2007, Volume: 26, Issue:10

    Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Edema; Glaucoma; Humans; Intraocular Pr

2007
Trabeculectomy is not the best surgical option for glaucoma.
    Eye (London, England), 2008, Volume: 22, Issue:5

    Topics: Glaucoma; Humans; Mitomycin; Trabeculectomy

2008
Co-treatment of suberoylanilide hydroxamic acid and mitomycin-C induces the apoptosis of rabbit tenon's capsule fibroblast and improves the outcome of glaucoma filtration surgery.
    Current eye research, 2008, Volume: 33, Issue:3

    Topics: Alkylating Agents; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Caspase 3; C

2008
Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery.
    Eye (London, England), 1995, Volume: 9 ( Pt 4)

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucom

1995
Effects of topically applied mitomycin-C on intraocular pressure, facility of outflow, and fibrosis after glaucoma filtration surgery in clinically normal dogs.
    American journal of veterinary research, 1995, Volume: 56, Issue:7

    Topics: Animals; Collagen; Conjunctiva; Connective Tissue; Dogs; Drug Implants; Fibroblasts; Fibrosis; Filte

1995
[Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 minute). Independent evaluation of a retrospective nonrandomized study].
    Klinische Monatsblatter fur Augenheilkunde, 1995, Volume: 206, Issue:5

    Topics: Aged; Aged, 80 and over; Cataract Extraction; Dose-Response Relationship, Drug; Female; Follow-Up St

1995
Antiproliferative agents and the prevention of scarring after surgery: friend or foe?
    The British journal of ophthalmology, 1995, Volume: 79, Issue:7

    Topics: Cicatrix; Filtering Surgery; Glaucoma; Humans; Mitomycin

1995
Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:5

    Topics: Aged; Anterior Eye Segment; Cataract; Cell Count; Chemotherapy, Adjuvant; Female; Fluorouracil; Glau

1995
Treatment of postfiltration bleb leaks with autologous blood.
    Ophthalmology, 1995, Volume: 102, Issue:6

    Topics: Aged; Anterior Chamber; Blood; Female; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Ma

1995
Removable sutures in glaucoma surgery.
    Australian and New Zealand journal of ophthalmology, 1994, Volume: 22, Issue:3

    Topics: Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Suture Techniques; Time Factors; Tr

1994
Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C.
    American journal of ophthalmology, 1995, Volume: 119, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma;

1995
One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction.
    Ophthalmology, 1995, Volume: 102, Issue:1

    Topics: Adult; Aged; Astigmatism; Cataract; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Gl

1995
Occlusion of the retinal vasculature after trabeculectomy with mitomycin C.
    International ophthalmology, 1994, Volume: 18, Issue:3

    Topics: Cataract Extraction; Glaucoma; Humans; Lenses, Intraocular; Male; Middle Aged; Mitomycin; Retinal Ar

1994
Mitomycin C as adjunctive therapy with glaucoma implant surgery.
    Ophthalmic surgery, 1994, Volume: 25, Issue:7

    Topics: Adult; Aged; Biocompatible Materials; Chemotherapy, Adjuvant; Female; Fibrosis; Follow-Up Studies; G

1994
Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C.
    Ophthalmic surgery, 1994, Volume: 25, Issue:7

    Topics: Administration, Topical; Adult; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Mitomyci

1994
Retained cellulose sponge after trabeculectomy with adjunctive subconjunctival mitomycin C.
    American journal of ophthalmology, 1994, Jul-15, Volume: 118, Issue:1

    Topics: Cataract Extraction; Eye Foreign Bodies; Glaucoma; Humans; Lenses, Intraocular; Male; Middle Aged; M

1994
[Trabeculectomy for normal-tension glaucoma].
    Nippon Ganka Gakkai zasshi, 1994, Volume: 98, Issue:6

    Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; M

1994
Mitomycin C for trabeculectomy in complicated glaucoma: preliminary results after 6 months.
    German journal of ophthalmology, 1994, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Int

1994
[Experiences with mitomycin C].
    Klinische Monatsblatter fur Augenheilkunde, 1994, Volume: 204, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Huma

1994
Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony.
    American journal of ophthalmology, 1994, Aug-15, Volume: 118, Issue:2

    Topics: Adult; Aged; Ciliary Body; Combined Modality Therapy; Conjunctiva; Female; Fluorouracil; Glaucoma; H

1994
[Initial experience with the use of mitomycin C in anti-glaucoma filtering surgery].
    Ceskoslovenska oftalmologie, 1994, Volume: 50, Issue:4

    Topics: Adult; Aged; Female; Glaucoma; Humans; Male; Middle Aged; Mitomycin; Postoperative Complications; Wo

1994
Adjunctive use of transconjunctival mitomycin-C in ab externo diode laser sclerostomy surgery in rabbits.
    Ophthalmic surgery, 1994, Volume: 25, Issue:1

    Topics: Animals; Chemotherapy, Adjuvant; Conjunctiva; Glaucoma; Intraocular Pressure; Laser Therapy; Mitomyc

1994
Residual mitomycin C dosage in surgical sponges removed at the time of trabeculectomy.
    American journal of ophthalmology, 1994, May-15, Volume: 117, Issue:5

    Topics: Chromatography, High Pressure Liquid; Glaucoma; Humans; Mitomycin; Sclera; Surgical Sponges; Trabecu

1994
Mitomycin C in anterior chamber tube shunt to a surgical membrane.
    Korean journal of ophthalmology : KJO, 1993, Volume: 7, Issue:2

    Topics: Animals; Anterior Chamber; Glaucoma; Intraocular Pressure; Mitomycin; Polytetrafluoroethylene; Prost

1993
Low-energy argon laser suture lysis after trabeculectomy.
    American journal of ophthalmology, 1994, Jun-15, Volume: 117, Issue:6

    Topics: Cataract Extraction; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Surgical Flap

1994
Effects of topical mitomycin C on glaucoma filtration surgery.
    Korean journal of ophthalmology : KJO, 1993, Volume: 7, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Combined Modality Therapy; Female; Follow-Up Studi

1993
Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study.
    Ophthalmology, 1993, Volume: 100, Issue:11

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Child; Combined Modality Therap

1993
Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C.
    American journal of ophthalmology, 1993, Dec-15, Volume: 116, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Conjunctiva; Female; Fibrosis

1993
Minimizing conjunctival wound leaks in filtration surgery with mitomycin C.
    Ophthalmic surgery, 1993, Volume: 24, Issue:10

    Topics: Conjunctiva; Glaucoma; Humans; Mitomycin; Surgical Flaps; Surgical Sponges; Surgical Wound Dehiscenc

1993
Glaucoma surgery: new approaches.
    Indian journal of ophthalmology, 1993, Volume: 41, Issue:2

    Topics: Developing Countries; Glaucoma; Humans; India; Intraoperative Period; Mitomycin

1993
Effects of topical mitomycin C on primary trabeculectomies and combined procedures.
    The British journal of ophthalmology, 1993, Volume: 77, Issue:11

    Topics: Administration, Topical; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Mitomycin; Post

1993
Mitomycin-C concentration in human aqueous humour following trabeculectomy.
    Eye (London, England), 1993, Volume: 7 ( Pt 5)

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Child; Child, Preschool; Chromatography,

1993
Trabeculectomy with mitomycin C for refractory glaucoma in blacks.
    American journal of ophthalmology, 1993, Jul-15, Volume: 116, Issue:1

    Topics: Adult; Aged; Black People; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; I

1993
Mitomycin-compatible suture technique for fornix-based conjunctival flaps in glaucoma filtration surgery.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:7

    Topics: Conjunctiva; Follow-Up Studies; Glaucoma; Humans; Mitomycin; Surgical Flaps; Suture Techniques; Trab

1993
Late argon laser suture lysis after mitomycin C trabeculectomy.
    Ophthalmology, 1993, Volume: 100, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male;

1993
Ocular hypotony after trabeculectomy with mitomycin C.
    American journal of ophthalmology, 1993, Sep-15, Volume: 116, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glaucoma; Humans; Intraoperative

1993
Application of mitomycin C during filtering surgery.
    American journal of ophthalmology, 1993, Sep-15, Volume: 116, Issue:3

    Topics: Glaucoma; Humans; Mitomycin; Postoperative Complications; Surgical Sponges; Trabeculectomy

1993
Aqueous and vitreous concentration of mitomycin C by topical administration after glaucoma filtration surgery in rabbits.
    Ophthalmology, 1993, Volume: 100, Issue:10

    Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Glaucoma; Mit

1993
Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:2

    Topics: Animals; Biopsy; Conjunctiva; Disease Models, Animal; Drug Evaluation, Preclinical; Fibroblasts; Flu

1993
Anterior chamber reaction after mitomycin and 5-fluorouracil trabeculectomy: a comparative study.
    Ophthalmic surgery, 1993, Volume: 24, Issue:1

    Topics: Anterior Chamber; Aqueous Humor; Biological Transport, Active; Blood; Chemotherapy, Adjuvant; Eye Pr

1993
Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.
    Ophthalmology, 1993, Volume: 100, Issue:3

    Topics: Animals; Double-Blind Method; Drug Evaluation, Preclinical; Fluorouracil; Glaucoma; Intraocular Pres

1993
Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin C.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:4

    Topics: Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Mitomycin; Ocular Hypotension; Postoperative

1993
Surgical management of post-traumatic angle recession glaucoma.
    Ophthalmology, 1993, Volume: 100, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Child; Combined Modality Therapy; Drai

1993
Preoperative mitomycin-C subconjunctival injection and glaucoma filtering surgery.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1995,Fall, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Conjunctiva;

1995
Laser suture lysis after mitomycin C trabeculectomy.
    Ophthalmology, 1996, Volume: 103, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi

1996
Mitomycin C in glaucoma triple procedure.
    Ophthalmology, 1996, Volume: 103, Issue:3

    Topics: Animals; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Lenses, Intraocular; Mitomyc

1996
Trabeculectomy at the inferior limbus.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Chemotherapy, Adjuvant; Child; Chi

1996
Bleb-related endophthalmitis after trabeculectomy with mitomycin C.
    Ophthalmology, 1996, Volume: 103, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Aqueous Humor; Bacteria

1996
Formula revealed.
    Ophthalmology, 1996, Volume: 103, Issue:5

    Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Filtering Surgery; Glaucoma; Humans; Mitomycin;

1996
Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with mitomycin C.
    American journal of ophthalmology, 1996, Volume: 122, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract Extraction; Chemotherapy, Adju

1996
Endophthalmitis after filtering surgery with mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bact

1996
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems.
    Biomaterials, 1996, Volume: 17, Issue:9

    Topics: Argon; Biocompatible Materials; Drug Delivery Systems; Drug Stability; Drug Storage; Fluorouracil; G

1996
Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1996, Volume: 234, Issue:6

    Topics: Actins; Adult; Aged; Antibiotics, Antineoplastic; Cell Division; Child; Connective Tissue; Female; F

1996
Effects of postoperative mitomycin C eyedrop on trabeculectomy in refractory glaucoma patients.
    Korean journal of ophthalmology : KJO, 1996, Volume: 10, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Hum

1996
Intraoperative use of mitomycin in trabeculectomy.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1996, Volume: 16, Issue:1

    Topics: Female; Glaucoma; Humans; Intraoperative Period; Male; Mitomycin; Trabeculectomy

1996
Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits.
    Journal of glaucoma, 1996, Volume: 5, Issue:1

    Topics: Administration, Topical; Animals; Aqueous Humor; Drainage; Filtering Surgery; Glaucoma; Intraocular

1996
Epithelial barrier function of the filtering bleb conjunctiva and the cornea after trabeculectomy with mitomycin C.
    Journal of glaucoma, 1996, Volume: 5, Issue:4

    Topics: Aged; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Epinephrine; Epithelium; Female; Fluorescein

1996
Experimentally designed glaucoma implant surgery with mitomycin C in rabbit.
    Korean journal of ophthalmology : KJO, 1995, Volume: 9, Issue:2

    Topics: Animals; Anterior Eye Segment; Antibiotics, Antineoplastic; Aqueous Humor; Chemotherapy, Adjuvant; G

1995
A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies.
    Journal of biomaterials science. Polymer edition, 1996, Volume: 7, Issue:10

    Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Conjunctiva; Cornea; Delayed-Action P

1996
Regression of rubeosis iridis after trabeculectomy combined with mitomycin-C.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:8

    Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; H

1996
Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:10

    Topics: Anti-Bacterial Agents; Blindness; Conjunctiva; Glaucoma; Humans; Injections; Intraocular Pressure; M

1996
Bleb rupture following filtering surgery with mitomycin-C: clinicopathologic correlations.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:10

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Female

1996
Combined phacoemulsification, intraocular lens implant, and trabeculectomy with intraoperative mitomycin-C: comparison between 3.2- and 6.0-mm incisions.
    Journal of glaucoma, 1996, Volume: 5, Issue:5

    Topics: Aged; Female; Glaucoma; Humans; Intraocular Pressure; Intraoperative Care; Lenses, Intraocular; Male

1996
Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:11

    Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Child; Corneal Diseases; Female; Follow-Up Studies;

1996
Slit-lamp needle revision of failed filtering blebs using mitomycin C.
    Ophthalmology, 1996, Volume: 103, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies

1996
Use of a scleral shield for the application of mitomycin-C during trabeculectomy: preliminary clinical results.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:12

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Cell Division; Drug Delivery Systems; Female; Glaucoma; Hu

1996
Surgery for refractory glaucoma.
    Australian and New Zealand journal of ophthalmology, 1996, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intrao

1996
Intermediate-term outcome of variable dose mitomycin C filtering surgery.
    Ophthalmology, 1997, Volume: 104, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocular Pressu

1997
Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery.
    Ophthalmology, 1997, Volume: 104, Issue:2

    Topics: Aged; Cataract; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Lens

1997
Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment.
    Ophthalmology, 1997, Volume: 104, Issue:2

    Topics: Adult; Aged; Cataract Extraction; Chemotherapy, Adjuvant; Cornea; Female; Filtering Surgery; Follow-

1997
Trabeculectomy with multiple applications of mitomycin-C in monkeys with experimental glaucoma.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:2

    Topics: Animals; Autoradiography; Conjunctiva; Eye; Glaucoma; Intraocular Pressure; Intraoperative Period; M

1997
Scleritis after glaucoma filtering surgery with mitomycin C.
    Ophthalmology, 1995, Volume: 102, Issue:10

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Age

1995
An ultrasound biomicroscopic study of filtering blebs after mitomycin C trabeculectomy.
    Ophthalmology, 1995, Volume: 102, Issue:12

    Topics: Adolescent; Adult; Aged; Anterior Eye Segment; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant;

1995
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
    Journal of glaucoma, 1997, Volume: 6, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula

1997
Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
    Journal of glaucoma, 1997, Volume: 6, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Adjuvant

1997
[Does the dosage of mitomycin-C applied during filtering surgery of glaucoma vary with the individual surgeon?].
    Journal francais d'ophtalmologie, 1997, Volume: 20, Issue:3

    Topics: Antimetabolites; Filtering Surgery; Glaucoma; Humans; Mitomycin; Surgical Sponges

1997
In vitro effects of mitomycin C on human Tenon's capsule fibroblasts & correlation with surgical outcome in glaucoma patients.
    The Indian journal of medical research, 1997, Volume: 105

    Topics: Antibiotics, Antineoplastic; Cell Line; Connective Tissue; Connective Tissue Cells; Eye; Fibroblasts

1997
Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy.
    American journal of ophthalmology, 1997, Volume: 123, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Biological Transport; Cell Membrane Permeability; Chemothe

1997
Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C.
    Japanese journal of ophthalmology, 1996, Volume: 40, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Fem

1996
Intraoperative mitomycin-C for glaucoma associated with ocular inflammation.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chi

1997
Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma.
    Ophthalmology, 1997, Volume: 104, Issue:6

    Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo

1997
Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C.
    American journal of ophthalmology, 1997, Volume: 124, Issue:1

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Adjuvant; Conjunctiva; Female; Flu

1997
Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit.
    Investigative ophthalmology & visual science, 1997, Volume: 38, Issue:8

    Topics: Animals; Cicatrix; Conjunctiva; Eye; Filtering Surgery; Glaucoma; Injections; Mitomycin; Rabbits; Wo

1997
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:7

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Follow-Up

1997
Filtering bleb infection as a complication of orthokeratology.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Contact Lenses; Drug Therapy, Combination

1997
Management of chronic hypotony following trabeculectomy with mitomycin C.
    Korean journal of ophthalmology : KJO, 1997, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood; Chronic Disease; Follow-Up Studies; Gla

1997
Transconjunctival application of mitomycin C in combination with laser sclerostomy ab interno: a long-term morphological study of the postoperative healing process.
    Experimental eye research, 1997, Volume: 64, Issue:6

    Topics: Administration, Topical; Animals; Collagen; Glaucoma; Intraoperative Care; Laser Therapy; Microscopy

1997
Combined phacoemulsification and trabeculectomy with mitomycin-C.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:9

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Female; Foll

1997
Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits.
    Journal of glaucoma, 1997, Volume: 6, Issue:5

    Topics: Animals; Conjunctiva; Eye; Filtering Surgery; Glaucoma; Mitomycin; Postoperative Care; Preoperative

1997
Encapsulated filtering blebs after trabeculectomy with mitomycin-C.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:10

    Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-U

1997
Fornix-based trabeculectomy with mitomycin-C.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-

1997
Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:11

    Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Follow-Up Studies; Glaucoma; Huma

1997
[The long-term cystic bleb appearance and safety after trabeculectomy with mitomycin C].
    Nippon Ganka Gakkai zasshi, 1997, Volume: 101, Issue:11

    Topics: Female; Glaucoma; Humans; Infections; Male; Mitomycin; Postoperative Complications; Retrospective St

1997
The effect of adjunctive mitomycin C in Molteno implant surgery.
    Ophthalmology, 1997, Volume: 104, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucom

1997
Bleb-related ocular infection in children after trabeculectomy with mitomycin C.
    Ophthalmology, 1997, Volume: 104, Issue:12

    Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool;

1997
Midterm reversible failure in trabeculectomies with adjunctive mitomycin-C.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:12

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucom

1997
Simultaneous use of mitomycin-C with Baerveldt implantation.
    Ophthalmic surgery and lasers, 1997, Volume: 28, Issue:12

    Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Filtering Surgery; Follow-Up Studies; G

1997
Ocular concentrations of mitomycin C using different delivery devices.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1998, Volume: 212, Issue:1

    Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid;

1998
Surgical results of secondary glaucomas in childhood.
    Ophthalmology, 1998, Volume: 105, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Ciliary Body; Cryotherapy; Eye Abnormalities; Follow-Up Studies

1998
Half corneal light shield as a delivery system for standardized application of mitomycin C.
    Journal of glaucoma, 1998, Volume: 7, Issue:1

    Topics: Absorption; Animals; Antibiotics, Antineoplastic; Cornea; Drug Delivery Systems; Filtering Surgery;

1998
Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.
    Journal of glaucoma, 1998, Volume: 7, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glau

1998
Outcomes of primary trabeculectomy with the use of adjunctive mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:3

    Topics: Administration, Topical; Aged; Chemotherapy, Adjuvant; Cohort Studies; Female; Glaucoma; Humans; Int

1998
Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics.
    Journal of glaucoma, 1998, Volume: 7, Issue:2

    Topics: Aged; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pr

1998
Molteno implant with mitomycin C: intermediate-term results.
    Journal of glaucoma, 1998, Volume: 7, Issue:2

    Topics: Adult; Chemotherapy, Adjuvant; Cohort Studies; Female; Filtering Surgery; Follow-Up Studies; Glaucom

1998
Late-onset bleb leaks after glaucoma filtering surgery.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aqueous Humor; Cataract Extraction; Chemotherapy, Adjuva

1998
Penetrating keratoplasty with a valved glaucoma drainage implant for congenital glaucoma and corneal scarring secondary to hydrops.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:4

    Topics: Administration, Topical; Anterior Chamber; Antibiotics, Antineoplastic; Corneal Edema; Corneal Opaci

1998
Antimetabolites in glaucoma surgery: our experiences and results.
    Acta ophthalmologica Scandinavica. Supplement, 1997, Issue:224

    Topics: Antimetabolites; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraopera

1997
Permanent glaucomatous visual loss after photorefractive keratectomy.
    Journal of cataract and refractive surgery, 1998, Volume: 24, Issue:5

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cornea; Dexamethasone; Filtering Surgery;

1998
The effect of paclitaxel powder on glaucoma filtration surgery in rabbits.
    Journal of glaucoma, 1998, Volume: 7, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Filtering Surgery; Glaucoma; Intraocular Pr

1998
Trabeculectomy augmented with mitomycin C application under the scleral flap.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:4

    Topics: Adult; Combined Modality Therapy; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Life Ta

1998
[Influences of trabeculectomy combined with the use of mitomycin C on corneal endothelial cells].
    Nippon Ganka Gakkai zasshi, 1998, Volume: 102, Issue:6

    Topics: Administration, Topical; Endothelium, Corneal; Female; Glaucoma; Humans; Male; Middle Aged; Mitomyci

1998
Needling revision of glaucoma drainage device filtering blebs.
    Ophthalmology, 1998, Volume: 105, Issue:7

    Topics: Chemotherapy, Adjuvant; Drainage; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pre

1998
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
    Ophthalmology, 1998, Volume: 105, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciliary Body; Drainage; Female; Follow-Up Studies; Glauc

1998
The imposter of Seidel.
    Journal of glaucoma, 1998, Volume: 7, Issue:4

    Topics: Aged; Antimetabolites; Aqueous Humor; Contrast Media; Diagnosis, Differential; Fluorescein; Glaucoma

1998
Trabeculectomy with mitomycin C: intermediate-term results.
    Journal of glaucoma, 1998, Volume: 7, Issue:4

    Topics: Adult; Aged; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Postopera

1998
Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glauc

1998
Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoper

1998
Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1998, Volume: 236, Issue:9

    Topics: Adolescent; Adult; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular

1998
Trabeculectomy with long-term-stored mitomycin C in West Indian population.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1998, Volume: 212, Issue:6

    Topics: Adult; Aged; Animals; Drug Storage; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Age

1998
The results of trabeculectomy with and without mitomycin C in young patients.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1998, Volume: 212, Issue:6

    Topics: Adolescent; Adult; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Nucleic Acid Synthesis Inhibit

1998
Effect of mitomycin C on aqueous humor flow, flare and intraocular pressure in eyes with glaucoma 2 years after trabeculectomy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1998, Volume: 236, Issue:10

    Topics: Adolescent; Adult; Aged; Antimetabolites; Aqueous Humor; Female; Glaucoma; Humans; Intraocular Press

1998
Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma.
    American journal of ophthalmology, 1998, Volume: 126, Issue:5

    Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma; Hu

1998
Rapid preparation of small-volume autologous fibrinogen concentrate and its same day use in bleb leaks after glaucoma filtration surgery.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:12

    Topics: Administration, Topical; Adult; Aged; Female; Fibrin Tissue Adhesive; Follow-Up Studies; Glaucoma; H

1998
Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control.
    Ophthalmology, 1998, Volume: 105, Issue:12

    Topics: Aged; Antimetabolites; Aqueous Humor; Female; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Hu

1998
Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva.
    American journal of ophthalmology, 1998, Volume: 126, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Cicatrix; Conjunctival Diseases; Follow-Up S

1998
A novel method for controlling the quantity of mitomycin-C applied during filtering surgery for glaucoma.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1998, Volume: 14, Issue:6

    Topics: Antibiotics, Antineoplastic; Filtering Surgery; Glaucoma; Humans; Mitomycin; Surgical Sponges

1998
[Mitomycin C concentrations in rabbit ocular tissues after topical administration during glaucoma filtration surgery].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 1997, Volume: 22, Issue:4

    Topics: Administration, Topical; Animals; Eye; Female; Filtering Surgery; Glaucoma; Intraoperative Period; M

1997
Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments.
    Ophthalmology, 1999, Volume: 106, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciliary Body; Cryotherapy; Female; Follow-Up Stud

1999
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.
    Ophthalmology, 1999, Volume: 106, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Corneal Diseases; Female; Glaucoma; Graft Survival; Humans; Intraocu

1999
Late bleb-related endophthalmitis after trabeculectomy with mitomycin C.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial;

1999
Quantification of intraoperative administration of mitomycin-C in filtering surgery with surgical sponge material.
    Journal of glaucoma, 1999, Volume: 8, Issue:1

    Topics: Absorption; Animals; Biological Assay; Conjunctiva; Delayed-Action Preparations; Fibrin Foam; Filter

1999
Management of congenital glaucoma.
    Journal of glaucoma, 1999, Volume: 8, Issue:1

    Topics: Adrenergic beta-Antagonists; Child, Preschool; Ciliary Body; Cryosurgery; Decision Making; Filtering

1999
[Modulation of wound healing in glaucoma filtration surgery].
    Acta medica (Hradec Kralove). Supplementum, 1998, Volume: 41, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Female; Filtering Surgery; Glau

1998
Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:4

    Topics: Chemotherapy, Adjuvant; Child, Preschool; Corneal Opacity; Female; Glaucoma; Humans; Infant; Infant,

1999
Results of medical management and mitomycin C-augmented excisional bleb revision for encapsulated filtering blebs.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:4

    Topics: Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Ophthalmic Solutions; Postoper

1999
Clinical and histopathologic findings of iris nevus (Cogan-Reese) syndrome.
    Acta ophthalmologica Scandinavica, 1999, Volume: 77, Issue:2

    Topics: Adult; Corneal Edema; Glaucoma; Humans; Intraocular Pressure; Iris Neoplasms; Male; Mitomycin; Nevus

1999
Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:5

    Topics: Aged; Cataract; Chemotherapy, Adjuvant; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraocular Pressu

1999
The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model.
    Ophthalmology, 1999, Volume: 106, Issue:6

    Topics: Animals; Bleomycin; Chemotherapy, Adjuvant; Conjunctiva; Cornea; Drug Delivery Systems; Electroporat

1999
Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma.
    Ophthalmic surgery and lasers, 1999, Volume: 30, Issue:6

    Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intra

1999
Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.
    The British journal of ophthalmology, 1999, Volume: 83, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Combined Modality Therapy; Female; Filtering Surgery; Follow-Up

1999
[The effect of heterogeneous scleral transplantation on hypotony after filtration surgery of glaucoma with mitomycin C].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 1997, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Cicatrix; Female; Filtering Surgery; Follow-Up Studies; Glaucoma; Humans; Male; M

1997
Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1999, Volume: 15, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Endophthalmitis; Female; Filtration; Fluoro

1999
A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery.
    Journal of glaucoma, 1999, Volume: 8, Issue:4

    Topics: Buffers; Chemotherapy, Adjuvant; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage;

1999
The effect of hydroxyurea on rabbit subconjunctival fibroblast culture and use of hydroxyurea in rabbits after glaucoma filtration surgery.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1999, Volume: 213, Issue:5

    Topics: Animals; Cell Adhesion; Cells, Cultured; Conjunctiva; Dose-Response Relationship, Drug; Fibroblasts;

1999
Combination of autologous blood injection and bleb compression sutures to treat hypotony maculopathy.
    Journal of glaucoma, 1999, Volume: 8, Issue:6

    Topics: Aged; Aged, 80 and over; Alkylating Agents; Blood; Combined Modality Therapy; Female; Glaucoma; Huma

1999
Paired parallel locking forceps.
    Journal of cataract and refractive surgery, 2000, Volume: 26, Issue:1

    Topics: Alkylating Agents; Equipment Design; Filtering Surgery; Glaucoma; Humans; Mitomycin; Postoperative C

2000
Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.
    Ophthalmology, 2000, Volume: 107, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Corneal Diseases; Endothelium,

2000
Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.
    Transactions of the American Ophthalmological Society, 1999, Volume: 97

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Ascorbic Acid; Cells, Cultured; Child;

1999
Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas.
    Ophthalmology, 2000, Volume: 107, Issue:3

    Topics: Adolescent; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fo

2000
[Sinusotomy with intraoperative mitomycin C administration in selected eyes with advanced glaucomatous damage].
    Nippon Ganka Gakkai zasshi, 2000, Volume: 104, Issue:3

    Topics: Adult; Aged; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle

2000
Midterm follow-up of necrotic bleb excision and advancement of the fornical conjunctiva.
    Korean journal of ophthalmology : KJO, 1999, Volume: 13, Issue:2

    Topics: Adult; Alkylating Agents; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraoperative P

1999
Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:6

    Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Chronic Disease; Female; Glaucoma; Humans

2000
Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution.
    Experimental eye research, 2000, Volume: 70, Issue:5

    Topics: Absorption; Administration, Topical; Chromatography, High Pressure Liquid; Dose-Response Relationshi

2000
Trabeculectomy with mitomycin C for post-keratoplasty glaucoma.
    The British journal of ophthalmology, 2000, Volume: 84, Issue:7

    Topics: Adult; Aged; Female; Glaucoma; Graft Rejection; Humans; Intraocular Pressure; Keratoplasty, Penetrat

2000
Long term results of glaucoma surgery among participants in an east African population survey.
    The British journal of ophthalmology, 2000, Volume: 84, Issue:8

    Topics: Africa, Eastern; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Midd

2000
Treating glaucoma.
    AORN journal, 2000, Volume: 72, Issue:3

    Topics: Antibiotics, Antineoplastic; Glaucoma; Humans; Mitomycin

2000
Conjunctival dysfunction and mitomycin C-induced hypotony.
    Journal of glaucoma, 2000, Volume: 9, Issue:5

    Topics: Adolescent; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Conjunctival Dise

2000
Risk factors for development of post-trabeculectomy endophthalmitis.
    The British journal of ophthalmology, 2000, Volume: 84, Issue:12

    Topics: Aged; Antimetabolites; Case-Control Studies; Diabetes Complications; Endophthalmitis; Female; Fluoro

2000
Fornix-based trabeculectomy with Wise's suture technique in Chinese patients.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Antimetabolites, Antineoplastic; Asian People; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gl

2000
Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.
    American journal of ophthalmology, 2000, Volume: 130, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Cataract; Cataract Extraction; Female;

2000
Success criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC).
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2000, Volume: 238, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Female; Fluorouracil; Glaucoma; Humans; Intraocular

2000
[Trabeculectomy with mitomycin C in aphakic glaucoma].
    Archivos de la Sociedad Espanola de Oftalmologia, 2000, Volume: 75, Issue:1

    Topics: Aphakia; Glaucoma; Humans; Mitomycin; Postoperative Complications; Trabeculectomy

2000
Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:2

    Topics: Adolescent; Adult; Aged; Eye Injuries; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pres

2001
Trabeculectomy with mitomycin-C in pediatric glaucomas.
    Ophthalmology, 2001, Volume: 108, Issue:5

    Topics: Child; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Patient Education as Topic; Surgical Woun

2001
Trabeculectomy with mitomycin-C in pediatric glaucomas.
    Ophthalmology, 2001, Volume: 108, Issue:5

    Topics: Endophthalmitis; Glaucoma; Humans; Incidence; Infant; Mitomycin; Risk Factors; Surgical Wound Infect

2001
Should antiproliferatives be used in filtering surgery of normal tension glaucoma?
    The British journal of ophthalmology, 2001, Volume: 85, Issue:6

    Topics: Antineoplastic Agents; Filtering Surgery; Fluorouracil; Glaucoma; Humans; Intraocular Pressure; Mito

2001
Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:6

    Topics: Aged; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Middle Aged; Mit

2001
Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, May-05, Volume: 755, Issue:1-2

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Chromatography, High Pressure Liquid; Glaucoma; Human

2001
Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.
    Ophthalmology, 2001, Volume: 108, Issue:10

    Topics: Adult; Antihypertensive Agents; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follow-Up Stud

2001
Glaucoma surgery treatment patterns of ASCRS members--2000 survey.
    Journal of cataract and refractive surgery, 2001, Volume: 27, Issue:11

    Topics: Cross-Sectional Studies; Filtering Surgery; Fluorouracil; Glaucoma; Health Surveys; Humans; Middle A

2001
Activity of dissolved mitomycin C after different methods of long-term storage.
    Journal of glaucoma, 2002, Volume: 11, Issue:1

    Topics: Antibiotics, Antineoplastic; Cold Temperature; Drug Stability; Drug Storage; Glaucoma; Microbial Sen

2002
[Influence on tear film of postoperative 5-fluourouracil and intraoperative mitomycin C in glaucoma filtration surgery].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2001, Volume: 37, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Conjunctiva; Dry Eye Synd

2001
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En

2002
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En

2002
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En

2002
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En

2002
[Results and complications after deep sclerectomy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2002, Volume: 99, Issue:3

    Topics: Cataract Extraction; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Compl

2002
Haemophilus aphrophilus bleb infection after a mitomycin trabeculectomy.
    Australian and New Zealand journal of ophthalmology, 1995, Volume: 23, Issue:4

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glaucoma; Gluco

1995
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
    Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:6

    Topics: Aged; Aged, 80 and over; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lens Implan

2002
[Antimetabolites in glaucoma surgery--long-term results].
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2002, Volume: 58, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Glaucoma; Humans; Intraocular Pressur

2002
Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts.
    International ophthalmology, 1992, Volume: 16, Issue:4-5

    Topics: Animals; Cell Division; Cells, Cultured; Conjunctiva; Fibroblasts; Fluorouracil; Glaucoma; Injection

1992
Who should receive antimetabolites after filtering surgery?
    Archives of ophthalmology (Chicago, Ill. : 1960), 1992, Volume: 110, Issue:8

    Topics: Antimetabolites; Fluorouracil; Glaucoma; Humans; Mitomycin; Postoperative Care

1992
Effect of topical mitomycin C on glaucoma filtration surgery in monkeys.
    Ophthalmology, 1992, Volume: 99, Issue:1

    Topics: Administration, Topical; Animals; Anterior Eye Segment; Disease Models, Animal; Glaucoma; Intraocula

1992
The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1991, Volume: 109, Issue:12

    Topics: Administration, Topical; Animals; Cicatrix; Combined Modality Therapy; Glaucoma; Intraocular Pressur

1991
Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma.
    Journal of ocular pharmacology, 1990,Fall, Volume: 6, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Follow-Up

1990